Systems and methods for treating aneurysms

The embolic device with a double-layer mesh tube expands within the aneurysm to securely occlude it, addressing invasiveness and inefficiency issues of existing treatments, ensuring stable and long-term aneurysm closure.

JP2024156925APending Publication Date: 2024-11-06GALAXY THERAPEUTICS INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2024130738
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-04-05
Filing Date
2024-08-07
Publication Date
2024-11-06

AI Technical Summary

Technical Problem

Existing embolic devices for treating aneurysms face challenges such as invasiveness, time consumption, and inefficiency in filling the aneurysm volume, leading to potential recurrence and the need for additional procedures.

Method used

Development of an embolic device comprising an inverted mesh tube with a double-layer structure that expands within the aneurysm to cover the neck and internal volume, utilizing materials like nickel titanium alloy for superelastic properties and radiopaque markers for precise placement.

Benefits of technology

The device effectively occludes the aneurysm, minimizing invasiveness, reducing procedural time, and ensuring long-term stability by self-expanding to fit securely within the aneurysm, thereby preventing recurrence.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024156925000001_ABST
    Figure 2024156925000001_ABST
Patent Text Reader

Abstract

To provide an apparatus for treating an aneurysm in a blood vessel.SOLUTION: The apparatus includes an occlusion element configured to be releasably coupled to an elongate delivery shaft and having a distal end, a proximal end, and a longitudinal axis extending between the distal end and the proximal end. The occlusion element is configured to be delivered in a collapsed configuration and further configured to expand to an expanded configuration. The occlusion element comprises an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning to the inner layer at an inversion fold located at or near the distal end of the occlusion element, the inversion fold defining an inner diameter. The occlusion element further comprises a maximum outer diameter, where the inner diameter is about 35% to about 85% of the maximum outer diameter, and where an outer diameter of the occlusion element increases along the longitudinal axis to the maximum outer diameter.SELECTED DRAWING: Figure 5
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001]

[0001] The field of the invention relates generally to embolic devices for filling spaces in the vascular system, including cerebral aneurysms or the left atrial appendage. In some cases, the embolic devices may be used to embolize native blood vessels. [Background technology]

[0002] Embolic devices can be used as stand-alone devices for occlusions and aneurysms or can be used in conjunction with auxiliary devices or materials. Summary of the Invention

[0003]

[0003] In one embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft and having a distal end, a proximal end, and a longitudinal axis extending between the distal end and the proximal end, the occlusion element including an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning to the inner layer at an inverted fold, the inverted fold defining a first inner diameter, the inner layer defining a maximum inner diameter, the outer layer defining a maximum outer diameter, both the maximum inner diameter and the maximum outer diameter lying in a first plane transverse to the longitudinal axis, and the first inner diameter lying in a second plane transverse to the longitudinal axis.

[0004]

[0004] In another embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel comprises an occlusion element configured to be releasably coupled to an elongate delivery shaft and having a distal end, a proximal end, and a longitudinal axis extending between the distal and proximal ends, the occlusion element configured to be delivered in a collapsed configuration through a lumen of a delivery catheter, the lumen having a proximal and distal end, the occlusion element further configured to expand to an unfolded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm, the occlusion element comprising an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning to the inner layer at an inverted fold located at or adjacent to the distal end of the occlusion element, the inverted fold defining an inner diameter, the occlusion element further comprising a maximum outer diameter, the inner diameter being about 35% to about 85% of the maximum outer diameter, the outer diameter of the occlusion element increasing along the longitudinal axis to the maximum outer diameter.

[0005]

[0005] In another embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element comprising a cover having a mesh material and configured to be delivered in a collapsed state through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the cover being further configured to expand to an expanded configuration when the cover is advanced from the distal end of the lumen of the delivery catheter into the aneurysm, the cover including a diameter greater than a diameter or maximum lateral dimension of the aneurysm neck and a distal concave surface configured such that the cover faces away from the aneurysm neck; and a first tubular mesh having one end, a second end, a wall and a lumen, the first end and the second end of the first tubular mesh being coupled to a central portion of the covering such that an intermediate portion of the first tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the first tubular mesh extending from the distal concave surface of the covering, the intermediate portion of the first tubular mesh having a folded configuration configured to be delivered through a lumen of a delivery catheter, and the intermediate portion of the first tubular mesh configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0006]

[0006] In another embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element having a mesh material and configured to be delivered in a collapsed state through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the cover being further configured to expand to an unfolded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm, the cover including a diameter greater than a diameter or maximum lateral dimension of the neck of the aneurysm; and a first tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the first tubular mesh being coupled to a central portion of the cover such that an intermediate portion of the first tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the first tubular mesh extending from a distal concave surface of the cover and extending from a distal concave surface of the cover to a central portion of the first tubular mesh. and a second tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the second tubular mesh being coupled to a central portion of the covering such that an intermediate portion of the second tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the second tubular mesh extending from the distal concave surface of the covering, the intermediate portion of the second tubular mesh having a folded configuration configured to be delivered through the lumen of a delivery catheter, the intermediate portion of the second tubular mesh being configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0007]

[0007] In yet another embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element having a mesh material and a covering configured to be delivered in a collapsed state through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the cover being further configured to expand to an expanded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm, the cover in the expanded configuration having a lateral dimension that is greater than a maximum lateral dimension of a neck portion of the aneurysm, and a first end, a second end, a wall and and a first tubular mesh having a lumen, a first end and a second end of the first tubular mesh coupled to a central portion of the covering such that an intermediate portion of the first tubular mesh between the first and second ends includes a substantially 180 degree turn, the intermediate portion of the first tubular mesh extending distally from the central portion of the covering, the intermediate portion of the first tubular mesh having a folded configuration configured to be delivered through a lumen of a delivery catheter, and the intermediate portion of the first tubular mesh configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0008]

[0008] In yet another embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including a first tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the first tubular mesh being coupled together at a proximal end of the occlusion element such that an intermediate portion of the first tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the first tubular mesh extends distally from the proximal end of the occlusion element, the intermediate portion of the first tubular mesh has a collapsed configuration configured to be delivered through a lumen of a delivery catheter, and the intermediate portion of the first tubular mesh is configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter. In some embodiments, the device further includes a second tubular mesh having a first end, a second end, a wall and a lumen, the first and second ends of the second tubular mesh being coupled to the proximal end of the occlusion element such that an intermediate portion of the second tubular mesh between the first and second ends includes a substantially 180 degree turn, the intermediate portion of the second tubular mesh extending distally from the proximal end of the occlusion element, the intermediate portion of the second tubular mesh having a collapsed configuration configured to be delivered through the lumen of the delivery catheter, and the intermediate portion of the second tubular mesh configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0009]

[0009] In another embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including a mesh body configured to be delivered in a collapsed configuration through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the body further configured to expand to an unfolded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm, the body including a proximal portion having a proximal maximum lateral dimension A and a distal maximum lateral dimension B, and a frustoconical portion extending between the proximal maximum lateral dimension A and the distal maximum lateral dimension B, the body further including a distal portion having a maximum lateral dimension C, and a waist portion between the proximal and distal portions, wherein dimension A is about 50% to about 100% of dimension B.

[0010]

[0010] In another embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning into the inner layer at an inverted fold, at least the outer layer formed into an expanded shape having a proximal section having a first diameter, a distal section having a second diameter, and a waist portion having a third diameter, the third diameter being smaller than the first diameter and the third diameter being smaller than the second diameter.

[0011]

[0011] In yet another embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element comprising an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning into the inner layer at an inverted fold, at least the outer layer formed into an expanded shape having a proximal section having a first diameter, a distal section having a second diameter, a first waist portion having a third diameter, an intermediate section having a fourth diameter, and a second waist portion having a fifth diameter, the first diameter, the second diameter, and the fourth diameter each being greater than the third diameter, and the first diameter, the second diameter, and the fourth diameter each being greater than the fifth diameter.

[0012]

[0012] In yet another embodiment of the present disclosure, a method for forming a device for treating an aneurysm in a blood vessel includes forming a mesh tube, inverting the mesh tube to form an outer layer and an inner layer, where the outer layer transitions to the inner layer at the inverted fold, forming at least the outer layer into an expanded shape having a proximal section having a first diameter and a distal section having a second diameter, and etching the distal section to reduce its stiffness.

[0013]

[0013] In yet another embodiment of the present disclosure, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element comprising an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning to the inner layer at an inverted fold, the occlusion element configured to be delivered in a folded configuration through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the occlusion element further configured to expand to an expanded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm, wherein in the expanded configuration at least the outer layer of the inverted mesh tube is formed into an expanded shape including a proximal section having a first transverse dimension, a distal section having a second transverse dimension, and a waist portion having a third transverse dimension, the third transverse dimension being smaller than the first transverse dimension and the third transverse dimension being smaller than the second transverse dimension, and wherein in the expanded configuration the waist portion is configured to be deformed by an externally applied force such that a distance between the distal section and the proximal section is decreased.

[0014]

[0014] In another embodiment of the present disclosure, a vascular occlusion system is configured to embolize an aneurysm, the aneurysm having a neck and a sac, the system including an elongated pusher configured to be slidably positioned within a delivery catheter, the delivery catheter having a proximal end, a distal end and a delivery lumen extending therebetween, and an implantable vascular occlusion device coupled to the distal end of the pusher, the vascular occlusion device configured to be implanted into the aneurysm sac, the vascular occlusion device configured to have a collapsed delivery configuration when restrained within the delivery lumen of the delivery catheter, and a collapsed delivery configuration when delivered from the delivery lumen of the delivery catheter to the aneurysm sac. and an implantable vaso-occlusive device having an expanded and deployed configuration after being implanted with the aneurysm implanted into the aneurysm, the vaso-occlusive device including a proximal surface configured to seat against a lower wall portion of the aneurysm sac against the neck of the aneurysm and a concave surface opposite the proximal surface, the vaso-occlusive device having a periphery that enters the sac and extends away from the neck of the aneurysm, the concave surface being disposed about the longitudinal axis, the vaso-occlusive device being configured to be releasably coupled to a distal end of a pusher at a releasable joint, the distal end of the pusher extending from the releasable joint at an angle of about 30 degrees to about 120 degrees formed with the central longitudinal axis.

[0015]

[0015] In another embodiment of the present disclosure, a vascular occlusion system is configured to embolize an aneurysm, the aneurysm having a neck and a sac, the system including an elongated pusher configured to be slidably disposed within a delivery catheter, the delivery catheter having a proximal end, a distal end and a delivery lumen extending therebetween, and an implantable vascular occlusion device coupled to the distal end of the pusher, the vascular occlusion device configured to be implanted into the aneurysm sac, the vascular occlusion device having a collapsed delivery configuration when restrained within the delivery lumen of the delivery catheter and an implantable vascular occlusion device configured to be implanted into the aneurysm sac and configured to extend from the delivery lumen of the delivery catheter into the aneurysm sac. and an implantable vaso-occlusive device having an expanded, deployed configuration after delivery, the vaso-occlusive device including a proximal surface configured to seat against a lower wall portion of the aneurysm sac against the neck of the aneurysm and a concave surface opposite the proximal surface, the concave surface having a periphery that enters the sac and extends away from the neck of the aneurysm, the concave surface being disposed about the longitudinal axis, the vaso-occlusive device being configured to be releasably coupled to the distal end of the pusher at a releasable joint, the releasable joint being coupled at a location on the proximal surface of the vaso-occlusive device that is radially offset from the central longitudinal axis.

[0016]

[0016] In yet another embodiment of the present disclosure, a vascular occlusion system is configured to embolize an aneurysm, the aneurysm having a neck and a sac, the system including: an elongated pusher configured to be slidably disposed within a delivery catheter, the delivery catheter including a proximal end, a distal end and a delivery lumen extending therebetween; and an implantable vascular occlusion device coupled to the distal end of the pusher, the vascular occlusion device configured to be implanted into the aneurysm sac, the implantable vascular occlusion device having a collapsed delivery configuration when restrained within the delivery lumen of the delivery catheter and an expanded, deployed configuration after exiting the delivery lumen of the delivery catheter and being delivered to the aneurysm sac, the vascular occlusion device the aneurysm includes a proximal surface configured to seat against a lower wall portion of the aneurysm sac against the neck of the aneurysm, and a concave surface opposite the proximal surface, having a periphery extending into the sac away from the neck of the aneurysm, the concave surface being disposed about the longitudinal axis, and the vaso-occlusive device is configured to be releasably coupled to a distal end of the pusher at a releasable joint, the releasable joint having characteristics selected from the list consisting of: (1) the distal end of the pusher extends from the releasable joint at an angle of about 30 degrees to about 120 degrees formed with the central longitudinal axis, and (2) the releasable joint is coupled at a location on the proximal surface of the vaso-occlusive device that is radially offset from the central longitudinal axis.

[0017]

[0017] In yet another embodiment of the present disclosure, a system for embolizing an aneurysm includes an expandable implant configured for placement within the aneurysm, the expandable implant having a collapsed configuration and an expanded configuration, the expanded configuration having an asymmetric shape relative to a longitudinal axis, and a delivery catheter having a proximal end, a distal end and a lumen extending from the proximal end to the distal end, the lumen having a non-circular cross-section in at least a distal region adjacent the distal end of the delivery catheter, the expandable implant in the collapsed configuration configured to fit into the lumen of the distal region in a keyed manner such that the expandable implant is deliverable from the lumen of the distal end of the delivery catheter at a specific rotational position relative to the longitudinal axis.

[0018]

[0018] In yet another embodiment of the present disclosure, a method for inserting an expandable implant includes providing an introducer having a proximal end, a distal end, and an introducer lumen extending between the proximal end of the introducer and the distal end of the introducer, the introducer lumen being configured to hold the expandable implant in its collapsed configuration while the expandable implant is introduced at its proximal end into a lumen of a delivery catheter, the lumen of the delivery catheter having a non-circular shape and the expandable implant in its collapsed configuration having a substantially non-circular shape, pushing the expandable implant from the introducer lumen into the lumen of the delivery catheter such that the substantially non-circular shape of the expandable implant in its collapsed configuration is oriented in a keyed manner with the non-circular shape of the lumen of the delivery catheter, and advancing the expandable implant such that the expandable implant is completely within the lumen of the delivery catheter.

[0019] In yet another embodiment of the present disclosure, a vascular occlusion system is configured to embolize an aneurysm, the aneurysm having a neck and a sac, the system including an elongated pusher configured to be slidably disposed within a delivery catheter, the delivery catheter including a proximal end, a distal end and a delivery lumen extending therebetween, and an implantable vascular occlusion device coupled to the distal end of the pusher, the vascular occlusion device configured to be implanted into the aneurysm sac, the implantable vascular occlusion device having a collapsed delivery configuration when restrained within the delivery lumen of the delivery catheter and an expanded, deployed configuration after exiting the delivery lumen of the delivery catheter and being delivered to the aneurysm sac; The vascular occlusion device includes a proximal end configured to seat against the aneurysm adjacent the neck of the aneurysm, a distal end configured to extend into the sac away from the neck of the aneurysm, and a central longitudinal axis, and the vascular occlusion device is configured to be releasably coupled to the distal end of the pusher at a releasable joint, the releasable joint including any one or both of the following configurations: (1) the distal end of the pusher extends from the releasable joint at an angle of about 30 degrees to about 120 degrees formed with the central longitudinal axis, and (2) the releasable joint is coupled at a location on the proximal end of the vascular occlusion device that is radially offset from the central longitudinal axis. [Brief description of the drawings]

[0020] [Figure 1] 1 is a cross-sectional view of an occlusion device according to one embodiment of the present disclosure. [Diagram 2] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Diagram 3] FIG. 3 is a perspective view of the occlusion device of FIG. 2. [Figure 4] FIG. 3 is a perspective view of the occlusion device of FIG. 2. [Diagram 5] FIG. 2 is a perspective view of the occlusion device of FIG. 1. [Figure 6] 3 is a partial cross-sectional view of the occlusion device of FIG. 2 delivered to a terminal aneurysm. [Figure 7] 1 illustrates an occlusion device delivered to an end aneurysm according to one embodiment of the present disclosure. [Figure 8] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Figure 9] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Figure 10A] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Figure 10B] 10B is a detailed view of an alternative distal end of the occlusion device of FIG. 10A in accordance with an embodiment of the present disclosure. [Figure 10C] 10B is a detailed view of an alternative distal end of the occlusion device of FIG. 10A in accordance with an embodiment of the present disclosure. [Figure 10D] 10B is a detailed view of an alternative distal end of the occlusion device of FIG. 10A in accordance with an embodiment of the present disclosure. [Figure 10E] 10B is a detailed view of an alternative distal end of the occlusion device of FIG. 10A in accordance with an embodiment of the present disclosure. [Figure 11A] FIG. 10B is a side view of the occlusion device of FIG. 10A. [Figure 11B] FIG. 10B is a detailed view of the removal portion of the occlusion device of FIG. 10A prior to removal. [Figure 11C] FIG. 10B is a detailed view of the removal portion of the occlusion device of FIG. 10A during removal. [Figure 12] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Figure 13] 13 is a perspective view of the occlusion device of FIG. 12 delivered to an aneurysm. [Figure 14] 1 is a perspective view of an occlusion device delivered to an aneurysm according to one embodiment of the present disclosure. [Figure 15] FIG. 15 is a perspective view of the occlusion device of FIG. 14. [Figure 16] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Figure 17] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Figure 18] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Figure 19] 19 is a cross-sectional view of the occlusion device of FIG. 18 within a delivery catheter. [Figure 20] 20 is a cross-sectional view of the occlusion device of FIG. 18 taken through line 20-20. [Figure 21] FIG. 13 is a cross-sectional view of an alternative embodiment of the present disclosure. [Figure 22] 22 is a cross-sectional view of the occlusion device of FIG. 18 taken through line 22-22. [Diagram 23] 19 illustrates the implantation of the occlusion device of FIG. 18 in an aneurysm in a patient's blood vessel. [Figure 24] 19 is another view showing implantation of the occlusion device of FIG. 18 in an aneurysm in a patient's blood vessel. [Diagram 25] 19 is yet another diagram illustrating implantation of the occlusion device of FIG. 18 in an aneurysm in a patient's blood vessel. [Figure 26] 19 is yet another diagram illustrating implantation of the occlusion device of FIG. 18 in an aneurysm in a patient's blood vessel. [Figure 27] 1 is a perspective view of an occlusion device according to an alternative embodiment of the present disclosure. [Figure 28] 28 is a cross-sectional view of the occlusion device of FIG. 27 within a delivery catheter. [Figure 29] 29 is a cross-sectional view of the occlusion device of FIG. 27 taken through line 29-29. [Diagram 30] 30 is a cross-sectional view of the occlusion device of FIG. 27 taken through line 30-20. [Diagram 31] 28 illustrates the implantation of the occlusion device of FIG. 27 in an aneurysm in a patient's blood vessel. [Diagram 32] 28 is another view showing implantation of the occlusion device of FIG. 27 in an aneurysm in a patient's blood vessel. [Diagram 33] 1 is a perspective view of an occlusion device according to an alternative embodiment of the present disclosure. [Diagram 34] 1 is a perspective view of an occlusion device according to an alternative embodiment of the present disclosure. [Diagram 35] 1 is a perspective view of an occlusion device according to an alternative embodiment of the present disclosure. [Diagram 36] 1 is a perspective view of an occlusion device according to an alternative embodiment of the present disclosure. [Figure 37] 1 is a perspective view of an occlusion device according to an alternative embodiment of the present disclosure. [Figure 38] 1 is a longitudinal cross-sectional view of an occlusion device according to an alternative embodiment of the present disclosure. [Figure 39] 1 is a diagram of an occlusion device implanted within an aneurysm according to one embodiment of the present disclosure. [Diagram 40] 1 is a diagram of an occlusion device implanted within an aneurysm according to one embodiment of the present disclosure. [Diagram 41] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Diagram 42] FIG. 42 is a cross-sectional view of the occlusion device of FIG. 41. [Diagram 43] 1 is a cross-sectional view of an alternative occlusion device according to an embodiment of the present disclosure. [Diagram 44] 1 is a cross-sectional view of an alternative occlusion device according to an embodiment of the present disclosure. [Diagram 45] 1 is a cross-sectional view of an alternative occlusion device according to an embodiment of the present disclosure. [Diagram 46] FIG. 42 illustrates the implantation of the occlusion device of FIG. 41 in an aneurysm in a patient's blood vessel. [Figure 47] 42 is another view showing implantation of the occlusion device of FIG. 41 in an aneurysm in a patient's blood vessel. [Figure 48] 42 is yet another diagram showing implantation of the occlusion device of FIG. 41 in an aneurysm in a patient's blood vessel. [Figure 49] 42 is yet another diagram showing implantation of the occlusion device of FIG. 41 in an aneurysm in a patient's blood vessel. [Figure 50] 1 is a cross-sectional view of an alternative occlusion device according to an embodiment of the present disclosure. [Figure 51] 1 is a cross-sectional view of an alternative occlusion device according to an embodiment of the present disclosure. [Figure 52] 1 is a cross-sectional view of an alternative occlusion device according to an embodiment of the present disclosure. [Diagram 53] 1 is a cross-sectional view of an alternative occlusion device according to an embodiment of the present disclosure. [Figure 54] 1 illustrates an occlusion device according to an embodiment of the present disclosure implanted within an aneurysm. [Figure 55] 1 illustrates an occlusion device according to an embodiment of the present disclosure implanted within an aneurysm. [Figure 56] 1 shows an occlusion device according to one embodiment of the present disclosure implanted within an aneurysm. [Figure 57] 1 shows an occlusion device according to one embodiment of the present disclosure implanted within an aneurysm. [Figure 58] 1 illustrates an occlusion device according to one embodiment of the present disclosure. [Figure 59] 1 is a cross-sectional view of an unconstrained occlusion device according to one embodiment of the present disclosure. [Figure 60] 59A and 59B are occlusion devices constrained within a delivery catheter. [Figure 61] 59 is a view of the occlusion device of FIG. 59 constrained and delivered within an aneurysm. [Figure 62] 1 is a cross-sectional view of an occlusion device according to one embodiment of the present disclosure. [Figure 63] FIG. 1 is a side view of an occlusion device according to one embodiment of the present disclosure. [Figure 64] FIG. 1 is a plan view of an occlusion device according to one embodiment of the present disclosure. [Figure 65] FIG. 65 is a top view of the occlusion device of FIG. 64 releasably coupled to a pusher according to an embodiment of the present disclosure. [Figure 66] FIG. 65 is a perspective view of the occlusion device of FIG. 64 implanted within a simulated aneurysm according to one embodiment of the present disclosure. [Figure 67] FIG. 65 is a perspective view of the occlusion device of FIG. 64 implanted within a simulated aneurysm according to one embodiment of the present disclosure. [Figure 68] 1 is a cross-sectional view of an alternative occlusion device according to an embodiment of the present disclosure. [Figure 69] FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Figure 70] 1 is a cross-sectional view of an occlusion device according to one embodiment of the present disclosure. [Figure 71] FIG. 71 is a cross-sectional view of the occlusion device of FIG. 70 delivered within a microcatheter. [Figure 72] FIG. 71 is a cross-sectional view of the occlusion device of FIG. 70 being deployed from a microcatheter. [Figure 73] FIG. 71 is a detailed cross-sectional view of the distal end of the occlusion device of FIG. 70. [Fig. 74A]1 is a cross-sectional view of delivering an occlusion device of an occlusion system to an aneurysm according to an embodiment of the present disclosure. [Fig. 74B] 1 is another cross-sectional view of delivering an occlusion device of an occlusion system to an aneurysm in accordance with an embodiment of the present disclosure. [Fig. 74C] 13 is yet another cross-sectional view of delivering an occlusion device of an occlusion system to an aneurysm in accordance with an embodiment of the present disclosure. [Fig. 75A] 1 is a cross-sectional view of delivering an occlusion device of an occlusion system to an aneurysm according to an embodiment of the present disclosure. [Fig. 75B] 1 is another cross-sectional view of delivering an occlusion device of an occlusion system to an aneurysm in accordance with an embodiment of the present disclosure. [Fig. 75C] 13 is yet another cross-sectional view of delivering an occlusion device of an occlusion system to an aneurysm in accordance with an embodiment of the present disclosure. [Figure 76A] 1 is a cross-sectional view of delivering an occlusion device of an occlusion system to an aneurysm according to an embodiment of the present disclosure. [Figure 76B] 1 is another cross-sectional view of delivering an occlusion device of an occlusion system to an aneurysm in accordance with an embodiment of the present disclosure. [Figure 76C] 13 is yet another cross-sectional view of delivering an occlusion device of an occlusion system to an aneurysm in accordance with an embodiment of the present disclosure. [Figure 77] FIG. 1 is a plan view of an occlusion device according to one embodiment of the present disclosure. [Figure 78] FIG. 1 is a plan view of an occlusion device according to one embodiment of the present disclosure. [Figure 79] 1 is a perspective view of delivering an occlusion device of an occlusion system to an aneurysm according to one embodiment of the present disclosure. [Figure 80] 1 is a perspective view of delivering an occlusion device of an occlusion system to an aneurysm according to one embodiment of the present disclosure. [Figure 81] 1 is a perspective view of delivering an occlusion device of an occlusion system to an aneurysm according to one embodiment of the present disclosure. [Figure 82] 1 is a perspective view of delivering an occlusion device of an occlusion system to an aneurysm according to one embodiment of the present disclosure. [Figure 83]1 is a perspective view of delivering an occlusion device of an occlusion system to an aneurysm according to one embodiment of the present disclosure. [Figure 84] 1 is a perspective view of delivering an occlusion device of an occlusion system to an aneurysm according to one embodiment of the present disclosure. [Figure 85] FIG. 2 is a top view of a delivery catheter according to an embodiment of the present disclosure. [Figure 86] FIG. 86 is a side view of the delivery catheter of FIG. [Figure 87] FIG. 87 is an enlarged cross-sectional view taken along line 87 of FIG. 86. [Figure 88] FIG. 2 is a top view of a delivery catheter according to an embodiment of the present disclosure. [Figure 89] FIG. 89 is a side view of the delivery catheter of FIG. [Figure 90] FIG. 89 is an enlarged cross-sectional view taken along line 90 of FIG. [Figure 91] FIG. 1 is a perspective view of a loading sheath according to one embodiment of the present disclosure. [Figure 92] FIG. 92 is a perspective view of the loading sheath of FIG. 91 with the occlusion device restrained in a collapsed configuration. [Figure 93] FIG. 92 is a perspective view of the loading sheath of FIG. 91 modified to another configuration. [Figure 94] FIG. 92 is a perspective view of the loading sheath of FIG. 91 used to load the occlusion device into the proximal end of the delivery catheter. [Figure 95A] 1 is an alternative configuration of a lumen of a delivery catheter according to an embodiment of the present disclosure. [Figure 95B] 1 is another alternative configuration of a lumen of a delivery catheter according to an embodiment of the present disclosure. [Figure 95C] 13 is yet another alternative configuration of a lumen of a delivery catheter according to an embodiment of the present disclosure. [Fig. 95D] 1 is an alternative configuration of a lumen of a delivery catheter according to an embodiment of the present disclosure. [Figure 95E] 13 is yet another alternative configuration of a lumen of a delivery catheter according to an embodiment of the present disclosure. [Figure 96A]FIG. 1 is a perspective view of an occlusion device according to one embodiment of the present disclosure. [Figure 96B] FIG. 96B is a detailed view of an alternative distal end of the occlusion device of FIG. 96A in accordance with an embodiment of the present disclosure. [Figure 96C] FIG. 96B is a detailed view of an alternative distal end of the occlusion device of FIG. 96A in accordance with an embodiment of the present disclosure. [Figure 96D] FIG. 96B is a detailed view of an alternative distal end of the occlusion device of FIG. 96A in accordance with an embodiment of the present disclosure. [Figure 96E] FIG. 96B is a detailed view of an alternative distal end of the occlusion device of FIG. 96A in accordance with an embodiment of the present disclosure. [Figure 97A] FIG. 96B is a side view of the occlusion device of FIG. 96A. [Figure 97B] FIG. 96B is a detailed view of the removal portion of the occlusion device of FIG. 96A prior to removal. [Figure 97C] FIG. 96B is a detailed view of the removal portion of the occlusion device of FIG. 96A during removal. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0021]

[0122] An aneurysm is an abnormal bulging or weakening of a blood vessel, often an artery, that can lead to many complications. The bulging of the blood vessel can destroy or put pressure on the surrounding tissue. Cerebral aneurysms can cause various side effects, such as impaired vision, speech, and balance. In addition, aneurysms create a volume that is not in line with the main flow path of blood through the vessel. Thus, they can act as a place for blood to stagnate and can contribute to the formation of thromboembolic events due to swirling vortexes. If an aneurysm ruptures, it can cause severe internal bleeding, which in cerebral arteries can often be fatal.

[0022]

[0123] Aneurysms can be treated externally through open surgery. Such procedures typically involve closing the entrance or "neck" of the aneurysm with devices such as vascular clips, clamps, or ligatures. However, such open procedures are highly invasive and can cause trauma to adjacent tissues and other side effects.

[0023]

[0124] Aneurysms can also be treated by endovascular therapy. In one procedure, a removable length of wire (e.g., a coil) is inserted into the interior volume of the aneurysm using a catheter. The coils are intended to fill the aneurysm volume to reduce blood flow to the aneurysm, induce flow stagnation, and stimulate clotting within the aneurysm. In the setting of a large cerebral aneurysm, filling the aneurysm with multiple coils may induce brain swelling and cause a mass effect that may be an independent cause of new symptoms. In another procedure, for aneurysms with relatively large necks, the adjunctive use of a stent helps retain the coil within the aneurysm. This approach may be contraindicated for use in treating ruptured aneurysms due to the need for additional antithrombotic medications. In another procedure, the coils are retained in the aneurysm volume with a temporary balloon that expands within the vessel. Once the coil mass is fixed, the balloon is deflated and removed. In yet another procedure, a stent device is placed within the artery to facilitate blood flow through the aneurysm. This leads to stagnation of blood within the aneurysm and thrombosis within the aneurysm volume. However, the side branch of the main artery in which the stent device is placed may become blocked or "arrested," which may prevent access to the side branch. In other instances, the side branch may clot, causing a stroke. Furthermore, such procedures generally require the use of additional antithrombotic medications, which limits the use of such devices in the setting of treating ruptured aneurysms. Stent devices are often formed with a relatively tight weave. While the tight weave increases the effectiveness of the stent device in diverting blood flow, it also impedes or prevents access to the aneurysm or the arrested arterial volume. If the aneurysm does not clot, occlusion of the aneurysm with the stent device precludes the possibility of placing an embolic device within the aneurysm. Additional procedures, such as placement of additional stents or open surgery, may then be required to treat the remainder.

[0024]

[0125] Procedures that involve packaging the aneurysm volume can suffer from several common drawbacks. First, many wire coils may be required to fill the aneurysm volume, which is time consuming and increases the time it takes to complete the procedure. Additionally, the coils may compact over time such that they occupy a smaller percentage of the aneurysm's total volume. Sufficient compaction of the coils can be considered aneurysm recurrence and further treatment may be required.

[0025]

[0126] 1 and 5 show an occlusion device 420 having a double layer mesh and including a single D-shaped element 422 having a D-shaped longitudinal cross section. The occlusion device 420 is comprised of an inverted mesh tube 424 having a first end 426, a second end 428, and a wall 429. The inverted mesh tube 424 extends from the second end 428 past the proximal end 432 of the D-shaped element 422 along a hemispherical shape 434 on an outer layer 430 to a maximum diameter portion 436 having an acute angle 438. From the maximum diameter portion 436, the outer layer 430 extends radially inward along a substantially flattened portion 440 that substantially covers the cross section, culminating in an inverted fold 442 from the outer layer 430 to an inner layer 444, which follows the contour of the outer layer 430 from a distal opening 446 to the first end 426. The occlusion device 420 is fabricated as an inverted mesh tube 424 having a simple straight elongated configuration, which is then formed into the shape shown in Figures 1 and 5 and heat set into this shape. For example, the inverted mesh tube 424 may be constructed as a single layer mesh tube formed of at least some nickel-titanium alloy filaments and then inverted onto itself. The inverted mesh tube 424 may then be placed into a die or mold containing one or more parts to hold it in the shape of the D-shaped element 422. The D-shaped element 422 may then be exposed to an elevated temperature and then cooled to set the shape, resulting in a D-shaped element 422 having at least some superelastic properties. As with all of the occlusion devices described herein, the occlusion device 420 is configured to be delivered in a compressed form through the lumen of a delivery catheter and out the distal end of the lumen into the aneurysm. When the occlusion device 420 is released from the constraints of the lumen, the occlusion device self-expands into an expanded form within the aneurysm. The marker band 448 holds the first end 426 and the second end 428 together and may comprise a radiopaque material such as platinum or a platinum alloy, e.g., 90% platinum and 10% iridium, or 80% platinum and 20% iridium, or 75% platinum and 25% iridium. The D-shaped element 422 is configured to cover the neck portion of the aneurysm. The maximum diameter portion 436 may be configured to engage a wall portion of the aneurysm to maintain the occlusion device 420 in place.For example, the diameter of maximum diameter portion 436 can be larger than the diameter of the target aneurysm, e.g., 10% larger, 20% larger, etc. In some embodiments, occlusion device 420 in its expanded configuration has a generally isosceles trapezoidal cross-sectional shape in a plane that includes the longitudinal axis. In some embodiments, occlusion device 420 in its expanded configuration has a generally triangular cross-sectional shape in a plane that includes the longitudinal axis.

[0026]

[0127] Distal opening 446 can be sized to control the overall width of substantially flattened portion 440. The smaller the distal opening 446, the thicker the width of substantially flattened portion 440 (on either side of opening 446). The thicker the width of this portion, the more radial force (aneurysm gripping force) can be applied to the aneurysm wall by maximum diameter portion 436. In some embodiments, the inner diameter of opening 446 is about 35% to about 85% of the diameter of maximum outer diameter portion 463. In some embodiments, the inner diameter of opening 446 is about 45% to about 75% of the diameter of maximum outer diameter portion 463. In some embodiments, the inner diameter of opening 446 is about 50% to about 70% of the diameter of maximum outer diameter portion 463. In some embodiments, the inner diameter of opening 446 is about 55% to about 65% of the diameter of maximum outer diameter portion 463. In some embodiments, opening 446 is in the same plane as maximum outer diameter portion 463. In other embodiments, opening 446 is in a plane that is generally distal to the plane carrying maximum outer diameter portion 463. In other embodiments, opening 446 is in a plane that is generally proximal to the plane carrying maximum outer diameter portion 463.

[0027]

[0128] 2-4 show a bowl-shaped occlusion device 801 constructed from an everted mesh tube 803 and having a concave surface 805 at its distal end 807. The laser cut tapered coil 809 may be constructed from nickel titanium sheet material or nickel titanium tubing. The everted mesh tube 803 is not shown in FIGS. 2-4 to show the details of the coil 809. The everted mesh tube 803 is shown over the coil 809 in FIG. 6, with the occlusion device 801 positioned at the terminal aneurysm 471. In some embodiments, the coil 809 is between the outer layer 461 and the inner layer 463 of the everted mesh tube 803, exerting an outward radial force on the outer layer 461 and thus the aneurysm 471. In other embodiments, the coil 809 is within both the outer layer 461 and the inner layer 463 of the everted mesh tube 803, exerting an outward radial force on the inner layer 463 and the outer layer 461 together and thus the aneurysm 471. The coil 809 has a smaller diameter end 811 and a larger diameter end 813 that tapers or changes in diameter between the ends 811, 813, thus conforming to the bowl shape of the occlusion device 801. In some embodiments, the coil 809 presses the bowl shape at least partially into the outer layer 461, or into the inner layer 463 and the outer layer 461. In some embodiments, the coil 809 may even be outside of both the inner layer 463 and the outer layer 461 and may be bonded to one or both of the inner layer 463 or the outer layer 461 by adhesive bonding, epoxy bonding, hot melt, tying, sewing, weaving, welding, soldering, stapling, brazing, or other methods. Thus, the outward radial force exerted by the coil 809 pulls the outer layer 461 and / or the inner layer 463 outward. The maximum diameter of the occlusion device 801 (e.g., at the larger diameter end 813) can be configured to engage the wall portion 491 of the aneurysm 471 to maintain the occlusion device 801 in place. For example, the maximum diameter can be larger than the diameter of the target aneurysm, e.g., 10% larger, 20% larger, etc. In some embodiments, the occlusion device 801 in its expanded configuration has an approximately isosceles trapezoidal cross-sectional shape in a plane that includes the longitudinal axis. In some embodiments, the occlusion device 801 in its expanded configuration has an approximately triangular cross-sectional shape in a plane that includes the longitudinal axis.

[0028]

[0129] The occlusion device 801 is coupled to a pusher wire 481 and delivered through a microcatheter 485 placed through a main artery 495. After being deployed to a desired location, the occlusion device 801 is released from the pusher wire 481 by detachment at a detachable joint 489. The detachable joint 489 may include one of several detachment systems, including, but not limited to, pressurized detachment, electrolytic detachment mechanism, hydraulic detachment mechanism, mechanical or interlocking detachment mechanism, chemical detachment mechanism, heat activated detachment system, or friction detachment system. During delivery, the pusher wire 481 is held at its proximal end (not shown) and pushed longitudinally forward by the user to advance the occlusion device 801 into the distal end 493 of the delivery catheter (microcatheter) 485.

[0029]

[0130] FIG. 7 illustrates an occlusion device 815 having several wire forms 817 (three shown) that are positioned within the aneurysm and looped back to attach at each end (first end 475, second end 477) to a proximal end 819 of the occlusion device 815. The looped portion 479 of the wire form 817 is configured to grip within the aneurysm 829 by interfacing with the aneurysm wall 483. The proximal mesh 821 includes a circumferentially extending concave portion 823, as indicated by the curved arrows, that is configured to divert or direct blood flow toward a side artery 825, 827. The occlusion device 815 is illustrated in FIG. 7 within a terminal aneurysm 829 (e.g., the basilar artery tip or other terminal aneurysm). The occlusion device 815 is delivered through a microcatheter 485 positioned through the basilar artery 487 and, after deployment at a desired location, is released from the pusher wire 481 by detachment at the detachable joint 489. The detachable joint 489 may include one of several detachment systems, including, but not limited to, pressurized detachment, electrolytic detachment mechanism, hydraulic detachment mechanism, mechanical or interlocking detachment mechanism, chemical detachment mechanism, heat activated detachment system, or friction detachment system. During delivery, the pusher wire 481 is held at its proximal end (not shown) and pushed longitudinally forward by the user to advance the occlusion device 815 into the distal end 493 of the delivery catheter (microcatheter) 485.

[0030]

[0131] FIG. 8 is a perspective view of a basket-shaped occlusion device 831 having the general structure of occlusion device 815 of FIG. 7, but with a round wire form 833 configured to conform to the dome of the aneurysm and to force a proximal mesh portion 835 against the neck of the aneurysm.

[0031]

[0132] 9 shows an occlusion device 550 having a double layer mesh and including a disc-shaped element 552 having a disc-shaped longitudinal cross section. The occlusion device 550 is comprised of an inverted mesh tube 554 having a first end 556 and a second end 558, and a wall 560. The inverted mesh tube 554 extends from the second end 558 past the proximal end 564 of the disc-shaped element 552, along a hemispherical shape 566, on the outer layer 562, to a maximum diameter portion 568. From the maximum diameter portion 568, the outer layer 562 extends radially inward and distally along a frustoconical portion 570 and adjacent rounded portion 572, extending to an inverted fold 574 from the outer layer 562 to the inner layer 576, and following the contour of the outer layer 562 from a distal opening 578 to the first end 556. The occlusion device 550 is manufactured as an inverted mesh tube 554 having a simple straight elongated configuration, which is then formed into the shape shown in FIG. 9 and heat set into this shape. For example, the inverted mesh tube 554 may be constructed as a single layer mesh tube formed of at least some nickel titanium alloy filaments and then inverted onto itself. The inverted mesh tube 554 may then be placed into a die or mold containing one or more parts to hold it in the shape of the disc-shaped element 552. The disc-shaped element 552 may then be exposed to an elevated temperature and then cooled to set in that shape, resulting in a disc-shaped element 552 having at least some superelastic properties. An internal marker band 580 is attached at its proximal end 582 to the first end 556 and the second end 558 and may include a radiopaque material such as platinum, or a platinum alloy such as 90% platinum and 10% iridium, or 80% platinum and 20% iridium, or 75% platinum and 25% iridium. The internal marker band 580 has a distal end 584 and a hollow lumen 586. A pusher wire 588 is inserted through the lumen 586 of the internal marker band 580 and has a distal end 590 with a radially extending protrusion 592. The disc-shaped element 552 is configured to cover the neck portion of the aneurysm. The maximum diameter portion 568 can be configured to engage a wall portion of the aneurysm to maintain the occlusion device 550 in place.For example, the diameter of maximum diameter portion 568 may be larger than the diameter of the target aneurysm, eg, 10% larger, 20% larger, etc.

[0032]

[0133] 10A and 11A-11C show an occlusion device 1040 comprising a mesh covering 1042 including a distal concave surface 1044. An inner tube 1046 having a lumen 1048 and an outer wall 1050 is secured within the mesh covering 1042 such that its proximal end 1052 is flush with or closely adjacent to the proximal end 1054 of the mesh covering 1042. A pusher 1056 comprises a wire having a distal end 1058 including a plurality of radially extending fingers 1060 extending from the distal end 1058. The fingers 1060 are configured to be meltable, separable, unbendable, breakable, abradable, deformable, or otherwise alterable. Prior to detachment, the radially extending fingers 1060 create a maximum diameter greater than the diameter of the lumen 1048 of the inner tube 1046 such that pulling on the wires of the pusher 1056 causes the fingers 1060 to pull on the distal end of the outer wall 1050 of the inner tube 1046, and thus the entire occlusion device 1040. For example, the occlusion device 1040 can be advanced into the aneurysm, and if the user does not find the fit or configuration of the occlusion device 1040 within the aneurysm desirable, the user can pull on the pusher 1056 to pull the occlusion device 1040 out of the aneurysm and into the lumen of the delivery catheter. However, the occlusion device 1040 can then be delivered to the aneurysm in an acceptable manner and detached by the user by any detachment method (to deform, damage, or destroy the fingers 1060), including but not limited to, modes of pressurized detachment, electrolytic detachment mechanisms, hydraulic detachment mechanisms, mechanical or interlocking detachment mechanisms, chemical detachment mechanisms, heat activated detachment systems, or friction detachment systems. In one embodiment, mechanical separation is achieved by pushing the distal end of the microcatheter against the proximal end 1054 of the mesh covering 1042 while pulling on the pusher 1056, thus bending the fingers 1060 and removing the pusher 1056 from the occlusion device 1040. The inner tube 1046 provides a smooth proximal end 1054 of the mesh covering 1042, and thus, there is no residual wire protruding proximally. Residual protruding wire can cause thrombosis, which can lead to embolic stroke.In some embodiments, the distal end 1058 of the pusher 1056 may be tapered to 0.001 inch or 0.002 inch, for example, if the distal end 1058 comprises stainless steel wire. The inner tube 1046 may comprise a polyimide tubing and may have a small inner diameter of 0.002 inch to 0.010 inch and an outer diameter of about 0.003 inch to about 0.014 inch. In some embodiments, there may be two fingers 1060, or three fingers 1060, or four fingers 1060, five fingers 1060, or six fingers 1060, or more fingers 1060.

[0033]

[0134] The flush or adjacent relationship of the proximal end 1052 of the inner tube 1046 and the proximal end 1054 of the mesh cover 1042 ensures that there is no detachment residue extending substantially proximal to the proximal end 1054 of the mesh cover 1042 (and into the parent artery). Thus, in cases where such residue may be a risk, a potentially associated thromboembolic event may be avoided. In some embodiments, the minimum outer diameter of the mesh cover 1042 is about 70% to about 90% of the maximum outer diameter of the mesh cover 1042. FIG. 10B illustrates an alternative distal end 1058b comprising a ball 1062 having a spherical or spherical shape. The detachment may occur at the ball 1062, or at a portion 1064 of the distal end 1058b proximal to the ball 1062, or both. The ball 1064 may be attached to the pusher 1056 by epoxy, adhesive, welding, brazing, or soldering, or may be formed from the material of the distal end 1058b by welding. FIG. 10C illustrates an alternative distal end 1058c comprising a disk 1066 having a flattened circular shape. Separation may occur at the disk 1066, or at a portion 1068 of the distal end 1058c proximal to the disk 1066, or both. The disk 1066 may be attached to the pusher 1056 by epoxy, adhesive, welding, brazing, or soldering, or may be formed from the material of the distal end 1058c by welding. FIG. 10D illustrates an alternative distal end 1058d comprising a frusto-conical tip 1070. Separation may occur at the tip 1070, or at a portion 1072 of the distal end 1058d proximal to the tip 1070, or both. The tip 1070 may be attached to the pusher 1056 by epoxy, adhesive, welding, brazing, or soldering, or may be formed from the material of the distal end 1058d by welding. FIG. 10E shows an alternative distal end 1058e with a tip 1076 having a flattened inverted spear shape. Separation may occur at the tip 1076, or at a portion 1078 of the distal end 1058e proximal to the tip 1076, or both.The tip 1076 may be attached to the pusher 1056 by epoxy, adhesive, welding, brazing, or soldering, or may be formed from the material of the distal end 1058e by welding, or may be a flattened portion of the pusher 1056 wire, for example by rolling or pressing. In each of the alternative embodiments, the diameter (or maximum lateral dimension) of the ball 1062, the disk 1066, the proximal end 1074 of the tip 1070, or the distal end 1080 of the tip 1076 is larger than the diameter of the lumen 1048 of the inner tube 1046, thus allowing the occlusion device 1040 to be releasably locked to the pusher 1056.

[0034]

[0135] 12 shows an occlusion device 600 with a double layer mesh and comprising a single bowl-shaped element 602 with a trapezoidal shaped longitudinal cross section. The occlusion device 600 is constructed from an inverted mesh tube 604 with a first end and a second end (not shown), both inserted (in a folded state) and bonded into a marker band 606. The inverted mesh tube 604 extends over an outer layer 608 from the second end of the inverted mesh tube 604 past a proximal end 610 of the bowl-shaped element 602 along a first substantially flattened portion 612 that substantially covers the cross section to a maximum diameter portion 614 having a sharp angle 616. From the maximum diameter portion 614, the outer layer 608 extends distally and radially inward along a frustoconical portion 618, an obtuse angle 620, a second substantially flattened portion 622, an inverted fold 624 extending from the outer layer 608 to the inner layer 626, and follows the contour of the outer layer 608 from a distal opening 628 to a first end of the inverted mesh tube 604. The occlusion device 600 is manufactured as an inverted mesh tube 604 having a simple straight elongated configuration, and is subsequently formed into the shape shown in FIG. 12 and heat set into this shape. For example, the inverted mesh tube 604 may be constructed as a single layer mesh tube formed of at least some nickel-titanium alloy filaments and then inverted onto itself. The inverted mesh tube 604 may then be placed into a die or mold containing one or more parts to hold it in the shape of the bowl-shaped element 602. Bowl-shaped element 602 may then be exposed to an elevated temperature and then cooled to set in its shape, resulting in bowl-shaped element 602 having at least some superelastic properties. Marker band 606 holds the first and second ends of inverted mesh tube 604 together and may comprise a radiopaque material such as platinum or a platinum alloy, for example, 90% platinum and 10% iridium, or 80% platinum and 20% iridium, or 75% platinum and 25% iridium.

[0035]

[0136] The bowl-shaped element 602 is configured to cover the neck of the aneurysm. The maximum diameter portion 614 can be configured to engage the wall portion of the aneurysm to maintain the occlusion device 600 in place. For example, the diameter of the maximum diameter portion 614 can be larger than the diameter of the target aneurysm, e.g., 10% larger, 20% larger, etc. As shown in FIG. 13 , the maximum diameter portion 614 engages the aneurysm 630 at a proximal portion 632 just distal to the neck 634 of the aneurysm 630. Because the maximum diameter portion 614 is larger than the diameter of the proximal portion 632 of the aneurysm 630 and the maximum diameter portion 614 is in the proximal portion of the bowl-shaped element 602, the second substantially flattened portion 622 and / or the frusto-conical portion 618 can deform as needed to allow the bowl-shaped element 602 to adjust its shape to the shape of the aneurysm 630. Occlusion device 600 is removably coupled to pusher wire 636, which is a releasable joint 638. In some embodiments, the minimum outer diameter of bowl-shaped element 602 is about 70% to about 90% of the maximum outer diameter of bowl-shaped element 602.

[0036]

[0137] 14-15 show an occlusion device 837 constructed from an inverted mesh tube 839 and having a proximal end 715 and a concave surface 841 at its distal end 845. FIG. 14 shows an occlusion device 837 implanted within an aneurysm 847 having a neck 710 and a dome 712 with a microcatheter 714 and a pusher 716 as previously described herein. The inverted mesh tube 839 includes a support stent 718 secured between an outer layer 720 and an inner layer 722 of the inverted mesh tube 839. The stent 718 is configured to exert a supplemental radial force against the wall 724 of the aneurysm 847 to increase the grip of the occlusion device 837 within the aneurysm 847 adjacent the neck 710. The stent 718 allows for a greater radial force and a better snug fit than an inverted mesh tube 839 without a stent. The stent 718 may include a nickel titanium alloy and may be laser machined from a nickel titanium alloy tube. The tube may be machined by other techniques that allow for the formation of slot patterns in the wall. After machining, the stent 718 may be thermoformed to create an expanded diameter with superelastic properties. While a "zig-zag" shape 726 is shown in Figures 14-15, alternatively, the stent 718 may include modular sections of open or closed cell design. In some embodiments, the stent 718 may include braided rings. In other embodiments, the stent may include wire coils. In alternative embodiments, the stent is secured within both the outer layer 720 and the inner layer 722, which serves to force both of these layers toward a larger diameter. In some embodiments, the stent 718 may even be secured to the outside of both the outer layer 720 and the inner layer 722, which serves to "pull" both of these layers toward an increased outer diameter. The stent 718 may be secured to either of both the outer layer 720 and the inner layer 722 by tying, crimping, braiding, soldering, welding, brazing, adhesives, epoxies, or other types of bonding or attachment. In some embodiments, the stent is captured within the outer layer 720 and the inner layer 722 without being secured directly to either the mesh or any of the layers.

[0037]

[0138] 16 illustrates an occlusion device 730 with a single or double layer mesh covering 732 and having a radiopaque wiring 734 having a first end 736 and a second end 738 both secured to a proximal end 740 of the occlusion device 730. The radiopaque wiring 734 loops into a middle portion 742 at a distal end 744 of the occlusion device 730. The mesh covering 732 may include nickel titanium alloy, and / or DFT, and / or platinum filaments / wires. The mesh covering 732 does not need to include DFT, platinum, or other radiopaque materials because the radiopaque wiring 734 includes a radiopaque material and, because of its shape, represents the general size and shape of the occlusion device 730. In some embodiments, the radiopaque wiring 734 comprises platinum flat wire, providing sufficient mass to be clearly visible under fluoroscopy or x-ray, yet has a low profile when collapsed to a small size when the occlusion device is collapsed for placement through the lumen of a microcatheter, hi other embodiments, the radiopaque wiring 734 may comprise a woven rope of radiopaque strands having a flattened configuration.

[0038]

[0139] FIG. 17 shows an alternative version of an occlusion device 849 similar to the occlusion device 730, but with a first radiopaque wire ring 851 and a second radiopaque wire ring 853. As shown in FIG. 17, the two radiopaque wire rings 851, 853 may be generally orthogonal to one another. In a similar manner to the occlusion device 730 of FIG. 16, the two radiopaque wire rings 851, 853 are secured to a single or double layer mesh cover 855. The two radiopaque wire rings 851, 853 are configured to represent the general size and shape of the occlusion device 849 in multiple axes, for example, when biplane fluoroscopy is not used or to add additional precision to biplane fluoroscopy. The occlusion devices 730, 849 of FIGS. 16 and 17 may also be constructed with some of all of those filaments in the mesh cover 732, 855 including the DFT wire. A proximal marker band (not shown) may also be added to increase radiopacity.

[0039]

[0140] In some embodiments, the braided elements can then be etched (chemically, photochemically) to reduce the overall wire diameter and decrease stiffness.

[0040]

[0141] FIG. 18 illustrates an occlusion device 100 configured for placement within an aneurysm. The occlusion device 100 comprises a cover 102 having an outer diameter D. In some embodiments, the cover 102 is circular and has substantially the same diameter D at any lateral measurement of the circumference. In other embodiments, the cover 102 may be non-circular and include an ellipse, an oval, a polygon, or other shape. In non-circular embodiments, the cover 102 includes a minimum lateral dimension and a maximum lateral dimension. In the particular case of an ellipse or oval shape, the cover 102 includes a major axis and a minor axis. The minor axis or minimum lateral dimension is configured to be larger than the maximum lateral dimension of the opening to the aneurysm (neck portion). Thus, the cover 102 is configured to completely cover the neck portion, thus causing stagnation of blood within the aneurysm, resulting in occlusion. The cover 102 is constructed from a mesh (braided) Nitinol (nickel-titanium alloy) tube 105 everted onto itself. The mesh tube 105 has a first end 104 and a second end 106 (see FIG. 20). The second end 106 is folded back onto the outer diameter of the first end 104, thus providing an outward facing surface 108 and an inward facing surface 110. The mesh tube 105 is heat formed such that the cover 102 includes an expanded portion and the first end 104 and the second end 106 include a non-expanded (or partially expanded) portion. A smooth fold 112 extends around the circumference 114 of the cover 102 and represents the transition between the outward facing surface 108 and the inward facing surface 110. The fold 112 avoids sharp edges that may risk rupture of the aneurysm wall or other anatomical damage. The cover 102 includes a concave surface 116 that faces the distal end 118 of the occlusion device 100 and away from the proximal end 120 of the occlusion device 100. The cover 102 is manufactured as an inverted mesh tube 105 having a simple straight elongated configuration, which is then formed into the shape shown in Figure 18 and heat set into this shape. For example, the inverted mesh tube 105 may be constructed as a single layer mesh tube formed of at least some nickel-titanium alloy filaments and then inverted onto itself. The inverted mesh tube 105 may then be placed into a die or mold containing one or more parts to hold it in the shape of the cover 102.The cover 102 may then be exposed to an elevated temperature and then cooled to set in that shape, such that the cover 102 has at least some superelastic properties. The cover 102 includes a lower portion 107 opposite the fold 112. The lower portion 170 is substantially flat and generally defines a plane, although in other embodiments it may be more frustoconical or hemispherical.

[0041]

[0142] Once formed (e.g., thermoformed), the cover 102 has an expanded configuration (shown in FIG. 18) and a folded configuration, as shown in FIG. 19. The cover 102 includes two mesh layers provided by an outwardly facing surface 108 and an inwardly facing surface 110. In some embodiments, the cover 102 may include several nickel-titanium alloy filaments and several radiopaque elements including platinum, gold, tantalum, or alloys of any of these or other radiopaque materials. In some embodiments, the filaments may include a drawn fill tube (DFT), such as one including a nickel-titanium alloy outer wall and a platinum core. The radiopaque material allows the cover 102 to be visible on an x-ray or fluoroscopy. The occlusion device 100 may be configured by controlling the amount of radiopaque material used, either by the ratio of radiopaque to non-radiopaque filaments or the amount of platinum core in the drawn fill tube. In this manner, the cover 102 can be selectively manufactured to be sufficiently visible but not overly visible, e.g., not overly bright, so that other objects are obscured. In some embodiments, regardless of whether any of the filaments include a radiopaque material, the marker band can be attached to the proximal end 120 of the occlusion device 100 by adhesive or epoxy bonding, or by crimping, welding or other mechanical attachment.

[0042]

[0143] Extending from the concave surface 116 is a double or looped tubular mesh 122 having a smooth apex 124 configured to safely contact the inner wall of the aneurysm. The tubular mesh 122 has a first end 126 and a second end 128, and an intermediate portion 130 extending between the first end 126 and the second end 128. In the embodiment shown in FIG. 18, the first end 126 and the second end 128 are substantially unexpanded and are inserted into a lumen 132 in the everted mesh tube 105 forming the cover 102, particularly at the first end 104 and the second end 106 of the mesh tube 105 forming the cover 102 (FIG. 20). The first end 126 and the second end 128 of the tubular mesh 122 can be bonded to the lumen 132 with an adhesive 134, or epoxy, or welded or bonded with any other fastening technique. The first end 126 and the second end 128 may each be compressed or deformed into an oval, elliptical, or D-shape so that they may more efficiently fit the circular cross section of the lumen 132. An alternative configuration is shown in FIG. 21, where the first end 126 includes a cut 142 in its wall 144, which allows the second end 128 to be inserted into the interior space 146 at the first end 126. The second end 128 is thus held within the first end 126, and the first end 126 and the second end 128 are secured within the lumen 132, for example, by adhesive, epoxy, welding, or other fastening techniques. The tubular mesh 122 is constructed from a mesh (braided) Nitinol (nickel-titanium alloy) tube, which may also include filaments of platinum or other radiopaque material, as well as nickel-titanium filaments. A drawn fill tube may also be utilized.

[0043]

[0144] Between the apex 124 and the first and second ends 126, 128 of the intermediate portion 130, the tubular mesh 122 intermediate portion 130 also includes a first leg 136 and a second leg 138 extending therefrom. Each of the first leg 136 and the second leg 138 comprises a different section of the tubular mesh 122. Thus, the tubular mesh 122 is a single layer mesh (braided) tube that extends from its first end 126, through the first leg 136, around the apex 124, and then through the second leg 138 to the second end 128. In the embodiment shown in FIG. 18, the first leg 136 and the second leg 138 are shown in a substantially unconstrained expanded state, and in this embodiment, the first leg 136 and the second leg 138 each have a diameter large enough that they contact each other at a central axis 140. 22, it can be seen that the first leg 136 and the second leg 138 are each opposed to one another about a central axis 140, thereby forming a cross-sectional shape that is more oval or elliptical rather than circular. Additionally, the first leg 136 and the second leg 138 together define a first lateral dimension TD X and a second lateral dimension TD Y In this embodiment, the first lateral dimension TD X is the second transverse dimension TD Y In other embodiments, the first lateral dimension TD is greater than X is the second transverse dimension TD Y In some embodiments, the first lateral dimension TD is smaller than X is the second transverse dimension TD Y In some cases, the first lateral dimension TD X is configured to contact the inner wall of the aneurysm to stabilize the occlusion device 100 within the aneurysm, while the second transverse dimension TD Y In some cases, the second lateral dimension TD Y is configured to contact the inner wall of the aneurysm to stabilize the occlusion device 100 within the aneurysm, while the first transverse dimension TD XIn some cases, the occlusion device 100 may be placed in a non-circular aneurysm, and in these cases, the cross-section of the aneurysm may be more oval or elliptical, or another non-circular shape, and therefore the first transverse dimension TD X and a second lateral dimension TD Y can each be configured to contact the inner wall of the aneurysm at a different circumferential location.

[0044]

[0145] Returning to FIG. 19, the occlusion device 100 is shown with both the cover 102 and the tubular mesh 122 in a folded or compressed form while disposed in the lumen 148 of a delivery catheter 150 having a distal end 162 and a proximal end 164. The delivery catheter 150 may be a microcatheter having a lumen diameter of 0.017 inches or 0.021 inches, 0.025 inches, or 0.028 inches, or other sizes. An elongated pusher 152 having a distal end 154 and a proximal end 156 may comprise a wire, hypotube, or another elongated structure having column support, and is removably coupled at its distal end 154 to the proximal end 120 of the occlusion device 100. The removable joint 158 ​​may include one of several detachment systems, including, but not limited to, a pressurized detachment, an electrolytic detachment mechanism, a hydraulic detachment mechanism, a mechanical or interlocking detachment mechanism, a chemical detachment mechanism, a heat activated detachment system, or a friction detachment system. During delivery, the pusher 152 is held at its proximal end 156 and pushed in a forward longitudinal direction 160 by the user to advance the occlusion device 100 to a distal end 162 of the delivery catheter 150 .

[0045]

[0146] 23-26 show an aneurysm 10 having a neck portion 16. The occlusion device 100 is shown to be implanted in the aneurysm 10 by a user (e.g., a physician) via a delivery catheter 150 during use to impede or stop the flow of blood flow between the blood vessel 12 and the interior volume 14 of the aneurysm 10, thereby reducing the likelihood that the aneurysm 10 will rupture. Alternatively, if the aneurysm 10 has already ruptured, the occlusion device 100 is implanted to help heal the rupture and / or prevent re-rupture. The occlusion device 100 is configured to be an unobtrusive device that minimizes disruption to the surrounding body, such as the side branch 18 of the blood vessel 12. The blood vessel 12 has a vascular wall 13, and the aneurysm 10 has an aneurysm wall 11. In FIG. 23, the delivery catheter 150 is advanced through a sheath and / or guiding catheter (not shown) through a puncture or cut of a peripheral blood vessel, such as the femoral, brachial, or radial artery. The distal end 162 of the delivery catheter 150 may be shaped with a curve as shown by the manufacturer or prior to the procedure by the user to allow for improved back-up support when delivering the occlusion device 100 and to aid in delivery to the aneurysm 10. The distal end 162 of the delivery catheter 150 is positioned adjacent the neck portion 16 of the aneurysm 10. The delivery catheter 150 may first be advanced over a guidewire (not shown) that passes through the lumen 148. The guidewire may then be removed, leaving the lumen 148 as a delivery conduit and the delivery catheter 150 as a strut.

[0046]

[0147] In FIG. 24 , the occlusion device 100 is advanced through the lumen 148 of the delivery catheter 150 as described, and the distal end 118 of the occlusion device 100 having the smooth apex 124 (of the curve of the tubular mesh 122) is advanced from the lumen 148 into the interior volume 14 of the aneurysm 10. The smooth apex 124 is the first portion of the occlusion device 100 to exit the lumen 148, and is therefore the first portion of the occlusion device to enter the aneurysm 10. The smooth apex 124 is a blunt, soft, atraumatic element configured to first contact the inner surface 15 of the aneurysm 10 due to its curved, contoured surface as well as its flexible mesh wall. The smooth apex 124 is able to contact and slide around the inner surface 15, being less traumatic than most devices configured to be implanted in aneurysms, such as small diameter detachable coils. The atraumatic characteristics of the smooth apex 124 allow for full deployment in unruptured cerebral aneurysms as well as ruptured cerebral aneurysms where certain other devices may be contraindicated. In FIG. 25, the occlusion device 100 is shown in a substantially expanded configuration within the interior volume 14 of the aneurysm 10. The covering 102 is expanded against the interior surface 15 of the aneurysm 10 to cover the neck portion 16 of the aneurysm. The tubular mesh 122 is expanded in at least one or more portions against the interior surface 15 of the aneurysm 10 to serve to anchor or stabilize the covering 102 adjacent the neck portion 16 within the aneurysm 10.

[0047]

[0148] Also in FIG. 25, the removable joint 158 ​​has been removed so that the free end 154 of the pusher 152 can be retracted into the lumen 148 of the delivery catheter 150. In some embodiments, the delivery catheter 150 is maintained on the removable joint 158 ​​during the removal procedure to further protect the aneurysm 10. In FIG. 26, the delivery catheter 150 is removed and the deployed occlusion device 100 is in place to begin occluding the interior volume 14 of the aneurysm 10. The expanded tubular mesh 122 also functions to press the cover 102 against the neck portion 16 and / or the interior surface 15 (see straight arrows in FIG. 26). The double layer of mesh within the cover 102 of the lower portion 107 (FIGS. 18 and 26) helps impede blood flow to the aneurysm 10, thus causing thrombosis and isolating the interior volume 14 of the aneurysm 10 from blood flow through the vessel 12. The force (straight arrow) keeping the cover 102 in place further ensures this process and also protects against undesirable compression of the occlusion device 100 over time, whether it be longitudinal compression, lateral or radial compression.

[0048]

[0149] FIG. 27 illustrates an occlusion device 500 configured for placement within an aneurysm. The occlusion device 500 is an alternative configuration of the occlusion device 100 of FIG. 18 and includes a cover 502 having an outer diameter DD. In some embodiments, the cover 502 is circular and has substantially the same diameter DD at any measurement around the circumference of each cross section. In other embodiments, the cover 502 may be non-circular and include a cross section having an elliptical, oval, polygonal or other shape. In non-circular embodiments, the cover 502 includes a minimum transverse dimension and a maximum transverse dimension. In the particular case of an elliptical or oval shape, the cover 502 includes a major axis and a minor axis. The minor axis or minimum transverse dimension is configured to be larger than the maximum transverse dimension of the opening to the aneurysm (neck portion). Thus, the cover 502 is configured to completely cover the neck portion, thus causing stagnation of blood within the aneurysm, resulting in occlusion. The cover 502 is constructed from a mesh (braided) Nitinol (nickel-titanium alloy) tube 505 inverted onto itself. The mesh tube 505 has a first end 504 and a second end 506 (FIG. 28) similar to the first end 104 and the second end 106 of FIG. 20. The second end 506 is folded over onto the outer diameter of the first end 504, thus providing an outwardly facing surface 508 and an inwardly facing surface 510 (FIG. 30). The mesh tube 505 is heat formed such that the cover 502 includes an expanded portion and the first end 504 and the second end 506 include a non-expanded (or partially expanded) portion. The heat forming can be performed as described in connection with the occlusion device 100 of FIG. 18. The cover 502 has a general disk shape defined by the outwardly facing surface 508. In some embodiments, the cover 502 can include a toroidal, partially toroidal shape. The occlusion device 500 includes a distal end 518 and a proximal end 520. Once formed (e.g., thermoformed), cover 502 has an unfolded configuration (shown in FIG. 27) and a folded configuration (shown in FIG. 28). Cover 502 includes two mesh layers provided by outwardly facing surface 508 and inwardly facing surface 510.In some embodiments, the cover 502 may include some nickel-titanium alloy filaments and some radiopaque elements including platinum, gold, tantalum, or alloys of any of these or other radiopaque materials. In some embodiments, the filaments may include a pultruded fill tube (DFT), such as one including a nickel-titanium alloy outer wall and a platinum core. The radiopaque material allows the cover 502 to be visible on an x-ray or fluoroscopy. The occlusion device 500 may be configured by controlling the amount of radiopaque material used, either by the ratio of radiopaque to non-radiopaque filaments or the amount of platinum core in the pultruded fill tube. In this manner, the cover 502 may be selectively manufactured to be sufficiently visible but not overly visible, e.g., not overly bright, so that other objects are obscured. In some embodiments, whether or not any of the filaments include a radiopaque material, the marker band 521 may be attached to the proximal end 520 of the occlusion device 500 by adhesive or epoxy bonding, or by crimping, welding, or other mechanical attachment.

[0049]

[0150] Extending from the opening 503 of the distal portion 519 of the cover 502 are a first double or looped tubular mesh 522 and a second double or looped tubular mesh 523. The first looped tubular mesh 522 has a smooth apex 524 configured to securely contact the inner wall of the aneurysm. The second looped tubular mesh 523 has an apex 525 configured to fit within the central axis 540 of the first tubular mesh 522. The first tubular mesh 522 and the second tubular mesh 523 are oriented in non-parallel planes to each other. As shown in FIG. 29, in one embodiment, the first tubular mesh 522 and the second tubular mesh 523 are orthogonal to each other and are substantially aligned along orthogonal planes or planes perpendicular to each other. The first tubular mesh 522 has a first end 526 and a second end 528 and an intermediate portion 530 extending between the first end 526 and the second end 528. In the embodiment shown in FIG. 27, the first end 526 and the second end 528 are substantially unexpanded and are inserted into a lumen (not shown) in the everted mesh tube 505 forming the cover 502 in a manner similar to the first end 104 and the second end 106 of FIG. 20. Similarly, the second tubular mesh 523 has a first end 527 and a second end 529 and an intermediate portion 531 extending between the first end 527 and the second end 529. In the embodiment shown in FIG. 27, the first end 527 and the second end 529 are substantially unexpanded and are inserted into a lumen (not shown) in the everted mesh tube 505 forming the cover 502. The first ends 526, 527 and second ends 528, 529 of the first tubular meshes 522, 523 can be bonded to the lumen with adhesive, or epoxy, or welded or bonded with other fastening techniques. The first ends 526, 527 and second ends 528, 529, respectively, can be compressed or deformed into an oval, elliptical, or D-shape so that they can more efficiently fit the circular cross-section of the lumen. Alternative configurations to FIG. 21 can also be used. The first tubular meshes 522 and second tubular meshes 523, respectively, can be constructed from mesh (braided) Nitinol (nickel-titanium alloy) tubes and can include filaments of platinum or other radiopaque material, as well as nickel-titanium filaments.A draw-fill tube may also be utilized.

[0050]

[0151] Between the apex 524 and the first and second ends 526, 528 of the intermediate portion 530, the tubular mesh 522 intermediate portion 530 also includes a first leg 536 and a second leg 538 extending therefrom. Between the apex 525 and the first and second ends 527, 528 of the intermediate portion 531, the tubular mesh 523 intermediate portion 531 also includes a first leg 537 and a second leg 539 extending therefrom. In the embodiment shown in FIG. 27, the first legs 536, 537 and the second legs 538, 539 are shown in an expanded state. With reference to FIG. 29, the spacing between the first legs 536, the first legs 537, the second legs 538, and the second legs 539 can be seen. Each leg 536, 537, 538, 539 can form a circular cross-sectional shape when expanded because they oppose or interface with one another, or can form a more oval or elliptical cross-sectional shape. Each leg pair 536 / 538, 537 / 539, respectively, has a first lateral dimension TD X and a second lateral dimension TD Y (See FIG. 29). For example, in some embodiments, the first lateral dimension TD X is the second transverse dimension TD Y In some embodiments, the first lateral dimension TD may be greater than X is the second transverse dimension TD Y In some embodiments, the first lateral dimension TD may be smaller than X is configured to contact the inner wall of the aneurysm to stabilize the occlusion device 500 within the aneurysm, while the second transverse dimension TD Y In some embodiments, the second lateral dimension T D is not. Y is configured to contact the inner wall of the aneurysm, the first transverse dimension TD X In some embodiments, the first lateral dimension TD X and a second lateral dimension TD Y27, both of which are configured to contact the inner wall of the aneurysm. Alternatively, the cover 502 may have a distal concave surface, such as the cover 102 of the occlusion device 100 of FIG. 18. Additionally, the cover 102 of the occlusion device 100 of FIG. 18 may lack a distal concave surface and instead utilize a cover 502 with an opening 503, such as the occlusion device 500 of FIG.

[0051]

[0152] 28, the occlusion device 500 is shown with both the cover 502 and the tubular mesh 522, 523 in a folded or compressed form while disposed in the lumen 148 of a delivery catheter 150 having a distal end 162 and a proximal end 164. The delivery catheter 150 may be a microcatheter having a lumen diameter of 0.017 inches or 0.021 inches, 0.025 inches, or 0.028 inches, or other sizes. An elongated pusher 857 having a distal end 859 and a proximal end 861 may comprise a wire, hypotube, or another elongated structure having column support, and is removably coupled at its distal end 859 to the proximal end 520 of the occlusion device 500. The removable joint 863 may comprise one of several detachment systems, including, but not limited to, a pressurized detachment, an electrolytic detachment mechanism, a hydraulic detachment mechanism, a mechanical or interlocking detachment mechanism, a chemical detachment mechanism, a heat activated detachment system, or a friction detachment system. During delivery, the pusher 857 is held at its proximal end 861 and pushed in the forward longitudinal direction 160 by the user to advance the occlusion device 500 into the distal end 162 of the delivery catheter 150 .

[0052]

[0153] In FIG. 31, the occlusion device 500 is shown in a substantially expanded configuration within the interior volume 14 of the aneurysm 10 (see FIG. 23). The cover 502 is expanded against the inner surface 15 of the aneurysm 10 to cover the neck portion 16 of the aneurysm. One or both of the first tubular mesh 522 and the second tubular mesh 523 are expanded against the inner surface 15 of the aneurysm 10 (see FIG. 23) to help secure or stabilize the cover 502 adjacent the neck portion 16 within the aneurysm 10. Also in FIG. 31, the detachable joint 863 has been removed so that the free end 859 of the pusher 857 can be retracted into the lumen 148 of the delivery catheter 150. In some embodiments, the delivery catheter 150 is maintained on the detachable joint 863 during the removal procedure to further protect the aneurysm 10. In FIG. 32, the delivery catheter 150 is removed and the deployed occlusion device 500 is in place to begin occluding the interior volume 14 of the aneurysm 10. The expanded first tubular mesh 522 and the expanded second tubular mesh 523 also serve to press the cover 502 against the neck portion 16 and / or the interior surface 15 (see straight arrows in FIG. 32). The double layer of mesh within the cover 502 at the lower portion 507 helps impede blood flow to the aneurysm 10, thus causing thrombosis and isolating the interior volume 14 of the aneurysm 10 from blood flow through the vessel. 12. The force that keeps the cover 502 in place (straight arrows) further ensures this process and also protects against undesired compression of the occlusion device 500 over time.

[0053]

[0154] 33 illustrates an occlusion device 865 including a first double or looped tubular mesh 867 and a second double or looped tubular mesh 203. The occlusion device 865 is similar to the occlusion device 500 of FIG. 27, but without a cover (e.g., cover 502). The first tubular mesh 867 includes a first end 869 and a second end 871, and the second tubular mesh has a first end 873 and a second end 875. All four ends 869, 871, 873, 875 are held within a cylindrical marker band 877 in the collapsed or restrained configuration of the tubular meshes 867, 203. The marker band 877 may comprise a radiopaque material such as stainless steel or platinum, and the ends 869, 871, 873, 875 may be bonded with adhesive or epoxy within the lumen of the marker band 877, or may be brazed, soldered, or welded. The first looped tubular mesh 867 has an intermediate portion 211 with a smooth apex 879 configured to securely contact the inner wall of the aneurysm. The second looped tubular mesh 203 has an intermediate portion 213 with an apex 881 configured to fit within the central axis 883 of the first tubular mesh 867. The first tubular mesh 867 and the second tubular mesh 203 are oriented in non-parallel planes relative to one another. As shown in FIG. 33, the first tubular mesh 867 and the second tubular mesh 203 are substantially orthogonal to one another and substantially along orthogonal or perpendicular planes to one another. Absent a covering, the first and second proximal portions 885, 887 of the first tubular mesh 867 and the first and second proximal portions 889, 891 of the second tubular mesh 203 are shaped and configured (as is the covering 502) to be positioned against the proximal portion of the aneurysm adjacent the neck of the aneurysm and help to substantially provide occlusion of the neck.

[0054]

[0155] FIG. 34 illustrates an occlusion device 893 comprising a double or looped tubular mesh 895 and a cover 897. The cover 897 comprises a single layer mesh tube 900 that is thermoformed as described herein. The cover 897 comprises a proximal end 899 (bonded within the marker band 901) and a flared distal end 902 that is free to expand. The tubular mesh 895 comprises a first end 903 and a second end 904 that are also bonded within the marker band 901, and an intermediate portion 905 having a smooth apex 906. The inner surface 907 of the first leg 251 of the tubular mesh 895 can be configured to contact the inner surface 908 of the second leg 253 of the tubular mesh 895 when the tubular mesh 895 is in its expanded configuration. In other embodiments, the tubular mesh can be sized and configured such that the inner surfaces 907, 908 do not normally contact one another with the tubular mesh in its expanded configuration. The proximal surface 909 of the cover 897 is configured to be positioned against a proximal portion of the aneurysm adjacent the neck of the aneurysm to provide substantial occlusion of the neck. The maximum diameter portion 910 of the cover 897 can be configured to engage the wall of the aneurysm. Additionally, the maximum lateral dimension portion 258 of the intermediate portion 905 of the mesh tube 895 is configured to engage the wall of the aneurysm.

[0055]

[0156] FIG. 35 illustrates an occlusion device 300 comprising a cover 302 including a concave surface 304 facing a distal end 306 of the cover 302 and away from a proximal end 308 of the cover 302. The cover 302 is manufactured as an inverted mesh tube 310 having a simple straight elongated configuration, and is then formed into the shape shown in FIG. 35 and heat set into this shape as previously described herein. A smooth fold 316 extends around the distal end 306 of the cover 302 and represents the transition between an outward facing surface 318 and an inward facing surface 320. The occlusion device 300 is similar to the occlusion device 100 of FIG. 18, except that the opening 312 opening into the concave surface 304 is smaller than the maximum diameter 314 of the cover 302. The opening 312 has a diameter of about 35% to about 85%, or about 45% to about 75%, or about 50% to about 70%, or about 55% to about 65% of the maximum diameter 314. Extending from the concave surface 304 is a double or looped tubular mesh 322 having a smooth apex 324 configured to safely contact the inner wall of the aneurysm. The tubular mesh 322 has a first end 326 and a second end 328, and an intermediate portion 330 extending between the first end 326 and the second end 328. The cover 302 and the tubular mesh 322 may have different characteristics from one another to optimize their respective performance characteristics. In certain embodiments, the cover 302 may include 36 to 144 filaments, each having a diameter of about 0.00075 to 0.001 inches. In a particular embodiment, the cover 302 may include 72 nickel titanium filaments, each having a diameter of 0.00085 inches.

[0056]

[0157] In certain embodiments, the tubular mesh 322 may include 18 to 36 filaments, each having a diameter of about 0.00075 to 0.00125 inches. In the particular embodiment described with respect to the cover 302, the tubular mesh is constructed from 24 nickel titanium filaments, each having a diameter of 0.00093 inches. The particular diameters of 0.00085 inches and 0.00093 inches can be achieved by fabricating filaments having this diameter, or by etching filaments having a slightly larger diameter (e.g., 0.001 inches) until the desired diameter is reached. In certain embodiments, the cover 302 has a maximum diameter 314 (expanded state) of about 4 mm to about 8 mm, or about 5 mm to about 7 mm, or about 6 mm. The tubular mesh 322 has a diameter (expanded state) of about 2 mm to 3 mm, or about 2.5 mm. In some embodiments, some or all of the filaments may comprise drawn filled tubes (DFT) having a radiopaque cross-sectional fill area ratio of about 10% to about 70%, or about 51% to about 70%. The fill material may be platinum, gold, tantalum, or an alloy of any of these. Certain embodiments described have excellent compression to small diameters for delivery through small catheter lumens and have safe properties when expanded and delivered to the aneurysm.

[0057]

[0158] FIG. 36 shows an occlusion device 332 with a cover 334 similar to cover 302 of occlusion device 300 of FIG. 35, except that there are three double or looped tubular meshes 336, 338, 340, each with smooth vertices 342, 344, 346. The three double or looped tubular meshes 336, 338, 340 are arranged adjacent to each other like books on a bookshelf. In the unfolded configuration, the diameters of their middle portions 337, 339, 341 are greater than the diameters of their ends, so that the three double or looped tubular meshes 336, 338, 340 are unfolded in a fan shape. In some embodiments, the three double or looped tubular meshes 336, 338, 340 together form a fan angle α that is between about 15° and about 90°, or between about 20° and about 75°, or between about 30° and about 60°. In an alternative embodiment, the three double or looped tubular meshes 336, 338, 340 inhabit three substantially parallel planes that are not coplanar with one another, and thus the three double or looped tubular meshes 336, 338, 340 are linearly arranged in a dimension transverse to the longitudinal axis 348 of the cover 334.

[0058]

[0159] FIG. 37 shows an occlusion device 350 with a cover 352 having a concave surface 351, similar to cover 302 of occlusion device 300 of FIG. 35, except that there are three double or looped tubular meshes 354, 356, 358, each with smooth vertices 360, 362, 364. The three double or looped tubular meshes 354, 356, 358 are arranged adjacent to one another like the ribs of an open folding fan. In some embodiments, all three of the looped tubular meshes 354, 356, 358 together approximate a single plane. In other embodiments, each of the looped tubular meshes 354, 356, 358 approximates a different plane, and together resembles an open triptych painting. In some embodiments, the looped tubular meshes 354, 356, 358 together form a sector angle β between a centerline 355 of the first outer tubular mesh 354 and a centerline 357 of the second outer tubular mesh 358, the angle being between about 15° and about 120°, or between about 20° and about 90°, or between about 25° and about 75°, or between about 30° and about 60°. In some embodiments, the looped tubular meshes 354, 356, 358 together form a sector angle γ between a general outer contour 359 of the first outer tubular mesh 354 and a general outer contour 361 of the second outer tubular mesh 358, the angle being between about 20° and about 150°, or between about 30° and about 120°, or between about 30° and about 90°. The outer contour lines 359, 361 extend between the attachments 366 at the first and second ends of the tubular mesh and the maximum lateral extension points 368, 369. The maximum lateral dimension T is formed by the three looped tubular meshes 354, 356, 358 and is configured to contact the inner surface of the aneurysm on both sides to stabilize the occlusion device 350 within the aneurysm. The cover 352, like the other covers presented herein, is configured to seal or occlude the aneurysm adjacent the neck.

[0059]

[0160] FIG. 38 illustrates an occlusion device 370 comprising an outer cover 372 and an inner cover 374. The outer cover 372 includes a concave surface 376 that faces a distal end 378 of the outer cover 372 and away from a proximal end 380 of the outer cover 372. The inner cover 374 is disposed within the concave surface 376 of the outer cover 372 and includes a concave surface 386 that faces a distal end 388 of the inner cover 374 and away from a proximal end 390 of the outer cover 374. The outer cover 372 has a distal flare 392 and the inner cover 374 has a maximum diameter 394 and a distal opening 396 of reduced diameter. The covers 372, 374 are manufactured as inverted mesh tubes 382, ​​384, respectively, having a simple straight elongated configuration, which are then formed into the shapes shown in FIG. 38 and heat set into these shapes as previously described herein. Either of the covers 372, 374 may have the material or dimensional characteristics of any of the other covers described herein. OThe concave surface 386 has an increased braid density because the concave surface 386 is substantially the combined braid density (e.g., picks per inch) of the two covers 372, 374. Thus, substantial stasis of blood flow can be achieved at the neck of the aneurysm to thrombosing and occluding the aneurysm. Extending from the concave surface 386 is a double or looped tubular mesh 398 having a smooth apex 399 configured to safely contact the inner wall of the aneurysm. The tubular mesh 398 has a first end 397 and a second end 395 and an intermediate portion 393 extending between the first end 397 and the second end 395. The outer cover 372, the inner cover 374, and the tubular mesh 398 may each have different characteristics from one another to optimize their respective performance characteristics. In one embodiment, the inner cover 374 has a first braid density and the outer cover 372 has a second braid density that is greater than the first braid density. The tubular mesh 398 has a third braid density that is less than the first braid density. In some embodiments, the second braid density is between 110% and 200% of the first braid density. In some embodiments, the first braid density is between 110% and 200% of the third braid density. In certain embodiments, the outer cover 372 can include 24 to 48 filaments, the inner cover 374 can include 12 to 36 filaments, and the tubular mesh 398 can include 6 to 24 filaments. Each filament can have a diameter between about 0.0006 and about 0.0015 inches, or between about 0.00075 and about 0.00125 inches. In certain embodiments, the outer cover 372 can include 36 filaments, the inner cover 374 can include 24 filaments, and the tubular mesh 398 can include 12 filaments. The filaments may include nickel titanium alloy, or DFT wire, or a combination thereof. The inner covering 374 may further serve to stabilize the tubular mesh 398 such that its loops remain substantially upright. The outer covering 372 is configured with its distal flare 392 to grip the inner wall of the aneurysm.As with all occlusion devices, marker bands 379 may be mounted to the ends of occlusion device 370 to retain ends 395, 397 and may be configured to provide a radiopaque indicator of the proximal end of occlusion device 370 under x-ray or fluoroscopy.

[0060]

[0161] In any of the embodiments presented herein, the double or looped tubular mesh may be configured to engage a portion of the inner wall of the aneurysm up to and including a majority of the wall of the entire aneurysm sac. In any of the embodiments presented herein that include a cover, the cover may be configured to engage the inner wall of the aneurysm at or adjacent the neck of the aneurysm. The engagement may include a radial force. In some embodiments, the cover may be configured to cover the neck of the aneurysm without significantly engaging the aneurysm wall with a radial force.

[0061]

[0162] Additional material can be delivered to the proximal portion of the cover, or any portion of the occlusion device adjacent to the neck of the aneurysm, to facilitate healing of the neck of the aneurysm. FIG. 39 shows an occlusion device 301 comprising a cover 303 coupled to a double or looped tubular mesh 305 having a first leg 307 and a second leg 309. The cover 303 includes a biological layer 311 configured to promote growth. In some embodiments, the biological layer 311 can include an antibody to accelerate the formation of an endothelial layer, for example, by attracting endothelial progenitor cells (EPCs). In some embodiments, the biological layer 311 can include a natural membrane or structure, such as a membrane from the ear, the cornea, or a very thin ligament, or a membrane such as a blood vessel wall.

[0062]

[0163] 40 shows an occlusion device 313 comprising a covering 315 coupled to a double or looped tubular mesh 317 having a first leg 319 and a second leg 321. The covering 315 includes a polymer layer 323 configured to act as a simulated arterial wall. In some embodiments, the polymer layer 323 may include polytetrafluoroethylene, such as expanded polytetrafluoroethylene (ePTFE), such as that used in grafts.

[0063]

[0164] The following sections contain examples of devices of the present disclosure.

[0064]

[0165] Clause 1: In one example, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including a mesh material and a covering configured to be delivered in a collapsed configuration through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the covering further configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter, the covering including a diameter greater than a diameter or a maximum transverse dimension of a neck of the aneurysm, the covering including a distal concave surface configured to face away from the neck of the aneurysm, and a first end of the occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including a mesh material and a covering configured to be delivered in a collapsed configuration through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the covering further configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter, the covering including a diameter greater than a diameter or a maximum transverse dimension of a neck of the aneurysm, the covering including a distal concave surface configured to face away from the neck of the aneurysm. and a first tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the first tubular mesh being coupled to the central portion of the covering such that an intermediate portion of the first tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the first tubular mesh extending from the distal concave surface of the covering, the intermediate portion of the first tubular mesh having a collapsed configuration configured to be delivered through a lumen of a delivery catheter, and the intermediate portion of the first tubular mesh configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0065]

[0166] Clause 2: In some examples, the device includes clause 1, wherein the occlusion element is configured such that an intermediate portion of the first tubular mesh is the first portion delivered from a distal end of the lumen of the delivery catheter.

[0066]

[0167] Clause 3: In some examples, the device includes clause 2, wherein the intermediate portion of the first tubular mesh, when in its expanded configuration, includes a first leg and a second leg, and the first leg is configured to contact the second leg.

[0067]

[0168] Clause 4: In some examples, the device includes any one of clauses 1-3, wherein the cover is formed from a tube having a cover lumen, and the first end and the second end of the first tubular mesh are configured to be inserted into the cover lumen.

[0068]

[0169] Clause 5: In some examples, the device includes clause 4, wherein the first end and the second end of the first tubular mesh are configured to be secured adjacent to one another in a collapsed state within the covering lumen.

[0069]

[0170] Clause 6: In some examples, the device includes clause 4 and further includes an incision in the wall of the first tubular mesh at the first end, the second end being held within the first end in a folded state, and the first end and the second end being fixed within the covering lumen.

[0070]

[0171] Clause 7: In some examples, the device includes any one of clauses 5 or 6, wherein the first end and the second end of the first tubular mesh are fixed within the cover lumen at a position proximal to the distal concave surface of the cover.

[0071]

[0172] Clause 8: In some examples, the device includes clause 7 and further includes a pusher having a proximal end and a distal end, wherein the occlusion element is configured to be releasably coupled to the distal end of the pusher at a releasable joint.

[0072]

[0173] Clause 9: In some examples, the device includes clause 8, wherein the releasable joint is disposed within the cover lumen adjacent a location proximal to the distal concavity of the cover.

[0073]

[0174] Clause 10: In some examples, the device includes any one of clauses 1-3, wherein the intermediate portion of the first tubular mesh has a maximum lateral dimension greater than a diameter of the cover when in its expanded configuration.

[0074]

[0175] Clause 11: In some examples, the device includes any one of clauses 1-10, wherein the cover is circular.

[0075]

[0176] Clause 12: In some examples, the device includes any one of clauses 1-10, wherein the covering is elliptical or ovoid, and the covering has a minor diameter or minimum transverse dimension that is greater than the diameter or maximum transverse dimension of the neck of the aneurysm.

[0076]

[0177] Clause 13: In some examples, the device includes any one of clauses 1-12, wherein the cover includes two layers of mesh.

[0077]

[0178] Clause 14: In some examples, the device includes clause 13, wherein the cover comprises an inverted mesh tube.

[0078]

[0179] Clause 15: In some examples, the device includes any one of clauses 1-14, wherein the cover includes a nickel-titanium alloy.

[0079]

[0180] Clause 16: In some examples, the device includes any one of clauses 1-15, wherein the first tubular mesh includes a nickel-titanium alloy.

[0080]

[0181] Clause 17: In some examples, the device includes any one of clauses 1-16, wherein the occlusion element includes a radiopaque material.

[0081]

[0182] Clause 18: In some examples, the device includes any one of clauses 1-17, wherein the radiopaque material includes a marker band.

[0082]

[0183] Clause 19: In some examples, the device includes any one of clauses 1-18, wherein the marker band is coupled to the first end and the second end of the first tubular mesh.

[0083]

[0184] Clause 20: In some examples, the device includes either clause 18 or 19, wherein the marker band is coupled to the proximal end of the cover.

[0084]

[0185] Clause 21: In some examples, the device includes any one of clauses 1 or 2, wherein the occlusion element further includes a second tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the second tubular mesh are coupled to a central portion of the covering such that an intermediate portion of the second tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the second tubular mesh extends from the distal concave surface of the covering, the intermediate portion of the second tubular mesh has a folded configuration configured to be delivered through the lumen of the delivery catheter, and the intermediate portion of the second tubular mesh is configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0085]

[0186] Clause 22: In some examples, the device includes clause 21, wherein an intermediate portion of the first tubular mesh when in its expanded configuration includes a first leg and a second leg, and the second tubular mesh passes between the first leg and the second leg of the first tubular mesh.

[0086]

[0187] Clause 23: In some examples, the device includes clause 22, wherein the substantially 180 degree folds of the first tubular mesh generally define a first plane and the substantially 180 degree folds of the second tubular mesh generally define a second plane, the second plane not parallel to the first plane.

[0087]

[0188] Clause 24: In some examples, the apparatus includes clause 23, wherein the second plane is generally perpendicular to the first plane.

[0088]

[0189] Clause 25: In another example, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element comprising a mesh material and a covering configured to be delivered in a collapsed configuration through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the covering further configured to expand to an unfolded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm, the covering comprising a diameter greater than a diameter or a maximum transverse dimension of a neck portion of the aneurysm; and a first tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the first tubular mesh being coupled to a central portion of the cover such that an intermediate portion of the first tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the first tubular mesh extending from a distal concave surface of the cover and extending from a central concave surface of the first tubular mesh. and a second tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the second tubular mesh being coupled to the central portion of the covering such that an intermediate portion of the second tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the second tubular mesh extending from the distal concave surface of the covering, the intermediate portion of the second tubular mesh having a folded configuration configured to be delivered through the lumen of a delivery catheter, the intermediate portion of the second tubular mesh being configured to expand to an unfolded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm.

[0089]

[0190] Clause 26: In some examples, the device includes clause 25, wherein an intermediate portion of the first tubular mesh when in its expanded configuration includes a first leg and a second leg, and the second tubular mesh passes between the first leg and the second leg of the first tubular mesh.

[0090]

[0191] Clause 27: In some examples, the device includes clause 25, wherein a wall of the first tubular mesh has a first opening and a second opening, and the second tubular mesh enters the first opening and exits the second opening.

[0091]

[0192] Clause 28: In some examples, the device includes any one of clauses 25-27, wherein the cover includes an opening in the mesh material, and the first tubular mesh and the second tubular mesh pass through the opening.

[0092]

[0193] Clause 29: In another example, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including a mesh material and a covering configured to be delivered in a collapsed configuration through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the covering further configured to expand to an expanded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm, the covering in the expanded configuration having a lateral dimension greater than a maximum lateral dimension of a neck portion of the aneurysm; and a covering having a first end, a second end, a wall, and a lumen. and a first tubular mesh having a first end and a second end coupled to a central portion of the covering such that an intermediate portion of the first tubular mesh between the first and second ends includes a substantially 180 degree turn, the intermediate portion of the first tubular mesh extending distally from the central portion of the covering, the intermediate portion of the first tubular mesh having a folded configuration configured to be delivered through a lumen of a delivery catheter, and the intermediate portion of the first tubular mesh configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0093]

[0194] Clause 30 In some examples, the apparatus includes clause 29, wherein the occlusion element is configured such that an intermediate portion of the first tubular mesh begins to exit the distal end of the lumen of the delivery catheter before the cover.

[0094]

[0195] Clause 31: In some examples, the device includes clause 30, wherein the intermediate portion of the first tubular mesh, in its expanded configuration, includes a first leg and a second leg, and the first leg is configured to contact the second leg.

[0095]

[0196] Clause 32: In some examples, the device includes clause 29, wherein the cover is formed from a tube having a cover lumen, and the first end and the second end of the first tubular mesh are configured to be inserted into the cover lumen.

[0096]

[0197] Clause 33: In some examples, the device includes clause 32, wherein the first end and the second end of the first tubular mesh are configured to be secured adjacent to one another in a collapsed state within the covering lumen.

[0097]

[0198] Clause 34: In some examples, the device includes clause 33, wherein the covering includes a distal concave surface configured to face away from the neck of the aneurysm.

[0098]

[0199] Clause 35: In some examples, the device includes clause 34, wherein the first end and the second end of the first tubular mesh are secured within the cover lumen at a location proximal to the distal concave surface of the cover.

[0099]

[0200] Clause 36: In some examples, the device includes clause 32 and further includes a notch extending at least partially longitudinally in the wall of the first tubular mesh at the first end, the second end being surrounded by the first end in the folded state, and the first end and the second end being fixed within the covering lumen.

[0100]

[0201] Clause 37: In some examples, the device includes clause 29 and further includes a pusher having a proximal end and a distal end, wherein the occlusion element is releasably coupled to the distal end of the pusher at a releasable joint.

[0101]

[0202] Clause 38: In some examples, the device includes clause 29, wherein an intermediate portion of the first tubular mesh has a maximum lateral dimension in its expanded configuration that is greater than a maximum lateral dimension of the covering.

[0102]

[0203] Clause 39: In some examples, the device includes clause 29, and the cover includes two layers of mesh.

[0103]

[0204] Clause 40: In some examples, the device includes clause 39, wherein the cover comprises an inverted mesh tube.

[0104]

[0205] Clause 41: In some examples, the device includes clause 29, wherein the occlusion element further includes a second tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the second tubular mesh are coupled to a central portion of the covering such that an intermediate portion of the second tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the second tubular mesh extends from the central portion of the covering, the intermediate portion of the second tubular mesh has a folded configuration configured to be delivered through a lumen of a delivery catheter, and the intermediate portion of the second tubular mesh is configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0105]

[0206] Clause 42: In some examples, the device includes clause 41, wherein an intermediate portion of the first tubular mesh when in its expanded configuration includes a first leg and a second leg, and the second tubular mesh passes between the first leg and the second leg of the first tubular mesh.

[0106]

[0207] Clause 43: In some examples, the device includes clause 42, wherein the substantially 180 degree folds of the first tubular mesh generally define a first plane and the substantially 180 degree folds of the second tubular mesh generally define a second plane, the second plane not parallel to the first plane.

[0107]

[0208] Clause 44: In some examples, the apparatus includes clause 43, wherein the second plane is generally perpendicular to the first plane.

[0108]

[0209] Clause 45: In some examples, the device includes clause 41, wherein a wall of the first tubular mesh has a first opening and a second opening, and the second tubular mesh enters the first opening and exits the second opening.

[0109]

[0210] Clause 46: In some examples, the device includes clause 45, wherein the first opening includes a first cut in a wall of the first tubular mesh and the second opening includes a second cut in the wall of the tubular mesh.

[0110]

[0211] Clause 47: In some examples, the device includes clause 41, wherein an intermediate portion of the first tubular mesh has a maximum transverse dimension in its expanded configuration, and an intermediate portion of the second tubular mesh has a maximum transverse dimension in its expanded configuration, and the maximum transverse dimension of the intermediate portion of the first tubular member is greater than the maximum transverse dimension of the intermediate portion of the second tubular member.

[0111]

[0212] Clause 48: In some examples, the device includes clause 47, wherein a maximum lateral dimension of the intermediate portion of the first tubular mesh and a maximum lateral dimension of the intermediate portion of the second tubular mesh are each different from a maximum lateral dimension of the cover.

[0112]

[0213] Clause 49: In some examples, the device includes clause 41, wherein the cover includes an opening in the mesh material at a distal end of the cover, and wherein the intermediate portion of the first tubular mesh and the intermediate portion of the second tubular mesh pass through the opening.

[0113]

[0214] Clause 50: In some examples, the device includes clause 41, wherein an intermediate portion of the first tubular mesh when in its expanded configuration includes a first leg and a second leg, and the second tubular mesh when in its expanded configuration includes a first leg and a second leg, the first leg of the first tubular mesh adjacent to the first leg of the second tubular mesh on a first side of the first leg of the second tubular mesh, and the second leg of the first tubular mesh adjacent to the second leg of the second tubular mesh on a first side of the second leg of the second tubular mesh.

[0114]

[0215] Clause 51: In some examples, the device includes clause 29, wherein the cover includes an opening in the mesh material, and an intermediate portion of the first tubular mesh passes through the opening.

[0115]

[0216] Clause 52: In some examples, the device includes clause 29, wherein the cover has a circular profile.

[0116]

[0217] Clause 53: In some examples, the apparatus includes clause 29, wherein the cover has a longitudinal cross-section having a substantially trapezoidal shape.

[0117]

[0218] Clause 54: In some examples, the device includes clause 29, wherein at least the mesh of the cover includes a drawn fill tube having a radiopaque core and a nickel titanium alloy.

[0118]

[0219] Clause 55: In some examples, the device includes clause 54, wherein the radiopaque core of each of at least some of the drawn fill tubes has a cross-sectional area that is between about 51% and about 70% of a total cross-sectional area of ​​each of at least some of the drawn fill tubes.

[0119]

[0220] Clause 56: In some examples, the device includes clause 29, wherein the mesh of the cover is woven from filaments, and about 50 percent to about 100 percent of the filaments include drawn fill tubes.

[0120]

[0221] Clause 57: In another example, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including a first tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the first tubular mesh being coupled together at a proximal end of the occlusion element such that an intermediate portion of the first tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the first tubular mesh extending distally from the proximal end of the occlusion element, the intermediate portion of the first tubular mesh having a folded configuration configured to be delivered through a lumen of a delivery catheter, and the intermediate portion of the first tubular mesh configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0121]

[0222] Clause 58: In some examples, the device includes clause 57, wherein the occlusion element further includes a second tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the second tubular mesh are coupled to the proximal end of the occlusion element such that an intermediate portion of the second tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the second tubular mesh extends from the proximal end of the occlusion element, the intermediate portion of the second tubular mesh has a folded configuration configured to be delivered through the lumen of the delivery catheter, and the intermediate portion of the second tubular mesh is configured to expand to an unfolded configuration when advanced into the aneurysm from the distal end of the lumen of the delivery catheter.

[0122]

[0223] FIG. 41 illustrates an occlusion device 200 configured for placement within an aneurysm. The occlusion device 200 includes a proximal section 202 and a distal section 204, each constructed of a single continuous bilayer mesh. With reference to FIG. 42, the occlusion device 200 is constructed from an inverted mesh tube 206 having a first end 208, a second end 210, and a wall 209. The inverted mesh tube 206 extends on an outer layer 212 from the second end 210 past the proximal end 214 of the proximal section 202 along a proximal hemispherical shape 216 to a maximum diameter portion 218 having a sharp angle 219. From the maximum diameter portion 218, the outer layer 212 extends radially inward along a substantially flattened portion 220 to a central waist 222. The outer layer 212 then extends radially outward along the substantially flattened portion 224 of the distal section 204 to a maximum diameter portion 226 having an acute angle 227, a distal hemispherical shape 228, and a distal end 230 of the occlusion device 200. The hemispherical shape 228 is configured to contact at least a portion of the aneurysm dome. The maximum diameter portion 226 has a diameter approximately equal to the diameter of the maximum diameter portion 218, but may be different in other embodiments. The occlusion device 200 is substantially cylindrically symmetric about the central axis Z. However, in alternative embodiments, there may be certain portions that are asymmetric, such as one or more indents or expanded features at specific locations around the circumference. At the distal end 230, the wall 209 is everted inward at an inversion fold 232, creating a distal opening 234 and an interior volume 236. The wall 209 transitions from the outer layer 212 to the inner layer 238 at the inverted fold 232 and follows the contour of the outer layer 212 from the distal opening 234 to the first end 208. The inner layer 238 follows a hemispherical shape 240, a maximum diameter portion 242 having a sharp angle 244, a substantially flattened portion 246 of the distal section 204, a central waist 248, a substantially flattened portion 250 of the proximal section 202, a maximum diameter portion 252 having a sharp angle 254, and a hemispherical shape 256. The occlusion device 200 is manufactured as an inverted mesh tube 206 having a simple straight elongated configuration and is then formed into the shape shown in Figures 41 and 42 and heat set into this shape.For example, the occlusion device 200 may be constructed as a single layer mesh tube formed of at least some nickel-titanium alloy filaments and then inverted onto itself. The inverted mesh tube 206 may then be placed into a die or mold containing one or more parts to hold it in the shape of the occlusion device 200. The occlusion device 200 may then be exposed to an elevated temperature and then cooled to set in that shape, resulting in an occlusion device 200 having at least some superelastic properties. Each of the proximal and distal sections 202 and 204 are configured to be squeezed or compressed within the lumen 148 of the delivery catheter 150 (e.g., a microcatheter).

[0123]

[0224] In some embodiments, one or both of the proximal section 202 or the distal section 204 may include some nickel-titanium alloy filaments and some radiopaque elements including platinum, gold, tantalum, or alloys of any of these or other radiopaque materials. In some embodiments, the filaments may include a drawn-out fill tube, such as one including a nickel-titanium alloy outer wall and a platinum core. The radiopaque material allows the occlusion device 200 to be visible on an x-ray or fluoroscopy. The occlusion device 200 may be configured by controlling the amount of radiopaque material used, either by the ratio of radiopaque to non-radiopaque filaments or the amount of platinum core in the drawn-out fill tube. In this manner, the occlusion device 200 may be selectively manufactured to be sufficiently visible but not overly visible, e.g., not overly bright, so that other objects are obscured. In some embodiments, regardless of whether any of the filaments include a radiopaque material, the marker band may be attached to the proximal end 214 of the proximal section 202 by adhesive or epoxy bonding, or by crimping, welding or other mechanical attachment.

[0124]

[0225] FIG. 43 illustrates an occlusion device 260 that also includes an inverted mesh tube 262 and has an outer layer 264, an inner layer 266, and an inversion fold 268 that creates a distal opening 270 and serves as a transition between the outer layer 264 and the inner layer 266. The inverted mesh tube 262 has a first end 284 and a second end 286. The occlusion device 260 includes a proximal section 272 and a distal section 274. The proximal section 272 and the distal section 274 have substantially flattened portions 276, 278, and the distal section 274 has a distal hemispherical shape 280 configured to contact the aneurysm dome. A waist 281 exists between the substantially flattened portions 276, 278. The maximum diameter portion 279 has a diameter approximately equal to the diameter of the maximum diameter portion 277, but may differ in other embodiments. Proximal section 272 includes a concave conical shape 282 or circumferentially extending concave surface that may be configured to direct blood flow, particularly when occlusion device 260 is implanted within a bifurcation or terminal aneurysm, such that blood flow is directed along the path of arrows 288 or 290. Occlusion device 260 may include any material and may be made by any of the processes described in connection with occlusion device 200.

[0125]

[0226] FIG. 44 illustrates an occlusion device 911 that also includes an inverted mesh tube 913 and has an outer layer 914, an inner layer 915, and an inversion fold 916 that creates a distal opening 917 and serves as a transition between the outer layer 914 and the inner layer 915. The inverted mesh tube 913 has a first end 918 and a second end 919. The occlusion device 911 includes a proximal section 920 and a distal section 921. The proximal section 920 and the distal section 921 have substantially flattened portions 922, 923, and the distal section 921 has a distal hemispherical shape 924 configured to contact the aneurysm dome. A waist 912 exists between the substantially flattened portions 922, 923. The maximum diameter portion 926 on the distal section 921 has a diameter greater than the diameter of the maximum diameter portion 925 on the proximal section 920, such that the occlusion device 911 is configured to be implanted in an aneurysm having a larger dome (distal) portion of the aneurysm sac and a smaller proximal portion. The proximal section 920 of the occlusion device 911 includes a partially convex and partially concave shape 927, which may be configured to direct blood flow along concave portion 928 and also configured to interface with the proximal portion of the aneurysm at convex portion 929. Both concave portion 928 and convex portion 929 face substantially proximally. The occlusion device 911 may comprise any material and may be made by any of the processes described in connection with the occlusion device 200.

[0126]

[0227] FIG. 45 illustrates an occlusion device 931 that also includes an inverted mesh tube 932 and has an outer layer 933, an inner layer 934, and an inverted fold 935 that creates a distal opening 936 and serves as a transition between the outer layer 933 and the inner layer 934. The inverted mesh tube 932 has a first end 937 and a second end 938. The occlusion device 931 includes a proximal section 939 and a distal section 940. The proximal section 939 and the distal section 940 have curved portions 941, 942 that face each other, and the proximal section 939 has a hemispherical shape 943 configured to contact the proximal wall of the aneurysm. The maximum diameter portion 945 of the distal section 940 has a diameter smaller than the diameter of the maximum diameter portion 944 of the proximal section 939, such that the occlusion device 931 is configured to be implanted in an aneurysm having a smaller dome (distal) portion and a larger proximal portion of the aneurysm sac. Distal section 940 includes a smaller hemispherical shape 946. Occlusion device 931 may include any material and may be made by any of the processes described in connection with occlusion device 200.

[0127]

[0228] 46-49 show an aneurysm 10 having a neck portion 16. An occlusion device 200 is shown to be implanted in the aneurysm 10 via a delivery catheter 150 by a user (e.g., a physician) during use to impede or stop the flow of blood flow between the blood vessel 12 and the interior volume 14 of the aneurysm, thereby reducing the likelihood of the aneurysm 10 rupturing (or reducing the likelihood of re-rupturing if previously ruptured). The occlusion device 200 is configured to be an unobtrusive device that minimizes disruption to the surrounding body, such as the side branch 18 of the blood vessel 12. The blood vessel 12 has a vessel wall 13, and the aneurysm 10 has an aneurysm wall 11. In FIG. 46, the delivery catheter 150 is advanced through a sheath and / or guiding catheter (not shown) through a puncture or cut of a peripheral blood vessel, such as the femoral, brachial, or radial artery. The distal end 162 of the delivery catheter 150 may be shaped with a curve as shown by the manufacturer or prior to the procedure by the user to allow for improved back-up support when delivering the occlusion device 200. The distal end 162 of the delivery catheter 150 is positioned adjacent the neck portion 16 of the aneurysm 10. The delivery catheter 150 may be advanced over a guidewire (not shown) that passes through the lumen 148. The guidewire may then be removed, leaving the lumen 148 as a delivery conduit and the delivery catheter 150 as a strut.

[0128]

[0229] In FIG. 47, the occlusion device 200 is advanced through the lumen 148 of the delivery catheter 150 as described, and the distal section 204 of the occlusion device 200 is advanced from the lumen 148 into the interior volume 14 of the aneurysm 10. The distal end 230 is the first portion of the occlusion device 200 to exit the lumen 148 and is therefore the first portion of the occlusion device to enter the aneurysm 10. The distal end 230 is blunt, soft, atraumatic and configured to initially contact the inner surface 15 of the aneurysm 10. In FIG. 48, the occlusion device 200 is shown in a substantially expanded configuration within the interior volume 14 of the aneurysm 10. The proximal section 202 is expanded against the inner surface 15 of the aneurysm 10 and covers the neck portion 16 of the aneurysm. The distal section 204 is expanded against the inner surface 15 of the aneurysm 10 and serves to anchor or stabilize the proximal section 202 adjacent the neck portion 16 within the aneurysm 10.

[0129]

[0230] Also in FIG. 48, the removable joint 158 ​​(see FIG. 47) has been removed so that the free end 154 of the pusher 152 can be retracted into the lumen 148 of the delivery catheter 150. In some embodiments, the delivery catheter 150 is maintained on the removable joint 158 ​​during the removal procedure to further protect the aneurysm 10. In FIG. 49, the delivery catheter 150 is removed and the deployed occlusion device 200 is placed in place to begin occluding the interior volume 14 of the aneurysm. The distal section 204 also functions to force the proximal section 202 against the neck portion 16 and / or against the interior surface 15 (see straight arrows in FIG. 49). The double layer of mesh in the proximal section 202 of the lower portion 231 (FIGS. 42 and 49) helps impede blood flow to the aneurysm 10, thus causing thrombosis and isolating the interior volume 14 of the aneurysm 10 from blood flow through the vessel. 12. The waist 222 helps the distal section 204 transmit forces to the proximal portion 202, but the maximum diameter portions 218, 226 are also configured to transmit forces to the substantially flattened portions 220, 224 when the waist 222 is compressed longitudinally, or the substantially flattened portions 220, 224 transmit forces to each other. The force that keeps the proximal section 202 in place (straight arrow) further ensures this process and also protects against undesired compression of the occlusion device 200 over time. The double layer of mesh in the distal section 204 can aid in the healing of the dome. In an unruptured aneurysm, contact with the dome can cause healing and thicken the dome in this area where it is often at its thinnest and most stretched. In a ruptured aneurysm, contact with the dome can act like a bandage, accelerating or increasing the healing process to further avoid re-rupture.

[0130]

[0231] The occlusion devices 260, 911, 931 of Figures 43-45 are implanted into the aneurysm 10 in a manner similar to the occlusion device 200 described in connection with the implantation procedure of Figures 46-49. Alternative embodiments of the occlusion devices 200, 260, 911, 931 from Figures 41-45 are shown in Figures 50-53. The occlusion devices 947, 950, 954, 958 are similar to the occlusion devices 200, 260, 911, 931, respectively, except that the inner layers 948, 951, 955, 959 do not follow the contours of the outer layers 949, 952, 956, 960, but instead are substantially straight tubular columns. These columns may be the original tubular mesh diameter (braided) or expanded diameter (thermoformed). The inner layers 948, 951, 955, 959 can provide additional column strength and longitudinal support, which can help apply force against the aneurysm neck portion 16 at the proximal sections 391, 953, 957, 961, respectively.

[0131]

[0232] 54 shows occlusion device 400 implanted within an angulated sidewall aneurysm 19 with a dome 21 that is off-axis from the neck portion 16, which can be approximated by angle A. Occlusion device 400 is similar to occlusion device 200 and has a proximal section 402 separated from a distal section 404 by an elongated flexible extension 406. Flexible extension 406 can be similar to central waist 222 of occlusion device 200, but can vary in diameter and length to modify its flexibility characteristics and the total amount of angle possible between proximal section 402 and distal section 404. The structure of the occlusion device 400 may be the same as any of the embodiments described in connection with the occlusion devices 200, 260, 911, 931, 947, 950, 954, 958 of Figures 42-45 and 50-53, but the longer, more flexible extension 406 allows the distal section 404 to be more easily angled relative to the proximal section 402. It also allows a greater amount of angulation between the proximal section 402 and the distal section 404 due to the greater amount of space between them (e.g., due to the increased longitudinal distance). Thus, the occlusion device 400 can accommodate a number of different aneurysm shapes or aneurysm angle takeoff angles or general angles. The occlusion device 400 may be configured to allow angle A between 90° and 180°, or between about 135° and about 180°. Thus, angle A can be varied to a minimum angle between about 90° and about 135°. If the elongated flexible extension 406 is long enough, angles less than 90° may even be possible, which may occur in some aneurysms with very odd shapes. The substantially flattened portion may have a slight angle or taper, similar to the substantially flattened portions 220, 224, 276, 278 of Figures 42-43 or the portions of Figures 50-51, where the longitudinal spacing increases toward the outer diameter and angle A (Figure 54) decreases further. The overall length of the flexible extension 406 may be about 0.5 mm to about 30 mm, or about 0.5 mm to about 25 mm, or about 1 mm to about 10 mm, or about 1 mm to about 6 mm, or about 1 mm to about 3 mm.In the case of cerebral aneurysms, the occlusion device 400 may be configured such that the proximal and distal sections 402, 404 are each substantially hemispherical, but the flexible extensions provide an elongated spheroidal shape when straight. For example, if the proximal and distal sections 402, 404 each have a hemispherical shape with a diameter of about 6 mm, a 1 mm long flexible extension 406 would yield an implant that is 7 mm long by 6 mm in diameter. A 2 mm long flexible extension 406 would yield an implant that is 8 mm long by 6 mm in diameter. A 3 mm long flexible extension 406 would yield an implant that is 9 mm long by 6 mm in diameter. A wide range of sizes are possible, and the diameter of the proximal section 402 may be different from the diameter of the distal section 404, or they may be substantially the same as one another.

[0132]

[0233] FIG. 55 shows an occlusion device 410 implanted within an angulated sidewall aneurysm 19 via a delivery catheter 417. The occlusion device 410 is similar to the occlusion device 400 of FIG. 54, except that the elongated extension 416 extending between the proximal section 412 and the distal section 414 has a bellows configuration to further aid in its flexibility. Both the inner and outer layers of the mesh tube can include bellows-type features, or only the outer layer can include these features. In alternative embodiments, the flexible section 406 or the elongated extension 416 (e.g., including bellows-type features) can have an outer diameter that varies along its longitudinal axis. For example, the outer diameter may be gradually smaller in the middle and larger at the ends, thus having a concave cylindrical or hourglass shape. Alternatively, the outer diameter may be gradually larger in the middle and smaller at the ends, thus having a convex cylindrical or American football shape. FIG. 56 shows an occlusion device 450 implanted within an aneurysm 452. The aneurysm 452 terminates in a main artery 454 and several connecting arteries 456, 458, 460, 462. The occlusion device 450 of FIG. 56 has a proximal section 464 and a distal section 466 separated by an elongated flexible extension 468. The proximal section 464 includes a hemispherical proximal end 470 and a distal concave surface 472 opposite the proximal end 470. The distal section 466 includes a hemispherical distal end 474 and a proximal concave surface 476 opposite the distal end 474. The distal and proximal sections 466, 464 can each pivot (away from the longitudinal axis) relative to the elongated flexible extension 468, which allows the occlusion device 450, when delivered to the aneurysm 452, to conform to the shape of the interior contour of the aneurysm 452, thus providing a more snug fit therewith. As shown in FIG. 56, the apex 478 of the distal section 466 of the occlusion device 450 pivots slightly back and to the right. The proximal section 464 pivots slightly forward. The proximal section 464 has a maximum diameter that is larger than the diameter or transverse dimension of the aneurysm neck 480. The maximum diameter of the proximal section 464 may also be configured to be large relative to the aneurysm sac to apply a gripping radial force. The same is true for the distal section 466.Once in the desired location within the aneurysm 452 , the occlusion device 450 is then removed from the pusher 415 .

[0133]

[0234] FIG. 57 illustrates an occlusion device 482 being implanted within an aneurysm 484. The occlusion device 482 of FIG. 57 is similar to the occlusion device 200 of FIGS. 41-42, but has slightly different dimensions. When the occlusion device 482 is implanted within the aneurysm, the distal section 486 and the proximal section 488 are compressed longitudinally together. The waist 490 may deform somewhat (e.g., shorten and widen) to allow dynamic shaping of the occlusion device 482 to occur when implanted within the aneurysm 484. The proximal section 488 is pressed against the neck 492 (straight arrow). The substantially flattened portion 494 of the proximal section 488 and the substantially flattened portion 496 of the distal section 486 may each bend to form a ring-like depression. The bend acts as a spring to maintain the force of the proximal section 488 against the neck 492. An occlusion device 401 is shown in FIG. 58 having a relatively wide waist 403 and a relatively long flexible extension 405 between its proximal section 407 and its distal section 409. The waist 403 of the occlusion device of FIG. 58 has a circumferentially extending concave surface (hourglass shape) with a hemispherical proximal surface 411 and a hemispherical distal surface 413. The occlusion device of FIGS. 56-58 is still coupled to the pusher 415 and is shown being delivered via the delivery catheter 417. FIGS. 59-61 show three different configurations of the occlusion device 962. In FIG. 59, the thermoformed occlusion device 962 is in a fully unconstrained, expanded configuration. In FIG. 60, the occlusion device 962 is constrained within the microcatheter lumen 980. In FIG. 61, the occlusion device 962 has been delivered to the aneurysm 748.

[0134]

[0235] FIG. 59 illustrates an occlusion device 962 including proximal and distal sections 963, 964, and a waist 971, all of which are constructed from a single continuous double layer mesh. The occlusion device 962 is constructed from an inverted mesh tube 965 having a first end, a second end, and a wall (as in the occlusion device of FIGS. 41-42). The inverted mesh tube 965 extends past the proximal end 967 of the proximal section 963, on an outer layer 966, along a hemispherical shape 968 to a maximum diameter portion 969 having a sharp angle 719. From the maximum diameter portion 969, the outer layer 966 extends radially inward along a substantially flattened portion 970 to a central waist 971. The outer layer 966 then extends radially outward along the substantially flattened portion 972 of the distal section 964 to a maximum diameter portion 973 having an acute angle 727, a hemispherical shape 728, and a distal end 974 of the occlusion device 962. The hemispherical shape 728 is configured to contact at least a portion of the aneurysm dome. The maximum diameter portion 973 has a diameter approximately equal to the diameter of the maximum diameter portion 969, but may differ in other embodiments. At the distal end 974, the wall 709 is everted inwardly at an inversion fold 975, thereby creating a distal opening 976 and an interior volume 977. The wall 709 transitions from the outer layer 966 to the inner layer 978 at the inversion fold 975, following the contour of the outer layer 966 from the distal opening 976 to the first end. The occlusion device 962 is shown coupled to an elongated pusher 701 and a marker band 705.

[0135]

[0236] In FIG. 59, the occlusion device 962 is shown in an unconstrained state. Thus, if the mesh tube 965 is formed of at least some nickel titanium, or shape memory alloy, filaments and braided together, the shape shown in FIG. 59 can be heat formed as described herein. The occlusion device 962 is shown in a compressed configuration inserted through a lumen 980 of a delivery catheter 979 having a distal end 981 and a proximal end 746 in FIG. 60. FIG. 61 shows the occlusion device 962 in an aneurysm 748 having a neck 982 and a dome 983. The proximal and distal sections 963 and 964, respectively, are deformed from contact with the aneurysm wall 984 and thus are confirmed snugly against the aneurysm wall 984. The overall length L2 of the occlusion device 962 becomes shorter than the original length L1 (FIG. 59) due to the longitudinal compressive force F returned by the aneurysm wall 984. Thus, the overall shape of the occlusion device within the aneurysm 748 of FIG. 61 is more spherical than the unconstrained shape of FIG. 59. The proximal end 967 and marker band 705 are at or adjacent to the neck 982 of the aneurysm 748, while the distal section 964 is adjacent to the dome 983. FIG. 61 also shows the remnant 703 of the pusher 701 after separation has occurred. In some embodiments, no remnant of the pusher 701 remains after separation. The occlusion device 962 is highly adaptable to different aneurysm shapes and sizes. Because of this, the occlusion device 962 may also conform to aneurysms that are longer longitudinally and narrower diametrically than the aneurysm 748 of FIG. 61. The occlusion device 962 may also conform to aneurysms having significantly asymmetric shapes.

[0136]

[0237] 62, the occlusion device 985 is constructed from an inverted mesh tube 986 having a first end 987, a second end 988, and a wall 989. The inverted mesh tube 986 extends from the second end 988 past the proximal end 991 of the proximal section 992, on an outer layer 990, to a maximum diameter portion 994 along a lower mushroom shape 993. From the maximum diameter portion 994, the outer layer 990 extends radially inward along the mushroom shape 988 to a first central waist 995. The outer layer 990 then extends radially outward along a bulbous portion 996 having a maximum diameter portion 997, then to a second central waist 998. Although the bulbous portion 996 of the occlusion device 985 is relatively short and wide, in other embodiments, the opposite may be true, with the bulbous portion 996 having more of an American football shape. In other embodiments, the spherical portion 996 may be generally spherical. The outer layer 990 then forms an upper mushroom shape 999 having a maximum diameter 640 leading to the distal end 641 of the occlusion device 985. The hemispherical shape 642 of the upper mushroom shape 999 is configured to contact the aneurysm dome. The maximum diameter 640 is approximately equal to the maximum diameter 997, but may be different in other embodiments. The occlusion device 985 is substantially cylindrically symmetric about the central axis Z. However, in alternative embodiments, there may be certain portions of asymmetry, such as one or more indentations or dilated features at certain locations around the circumference. At the distal end 641, the wall 989 is inverted inward at an inversion fold 643, which creates a distal opening 644 and an interior volume 645. The wall 989 transitions from the outer layer 990 to the inner layer 646 at the inversion fold 643 and follows the contour of the outer layer 990 from the distal opening 644 to the first end 987. The occlusion device 985 is manufactured as an inverted mesh tube 986 having a simple straight elongated configuration, which is then formed and heat set into the shape shown in Figure 62. Each of the three sections, a proximal section 594, a central section 596, and a distal section 598, shown in Figure 62 in their expanded configuration, are configured to be squeezed or compressed within the lumen 148 of the delivery catheter 150 (e.g., a microcatheter).The proximal end 991, located below the proximal section 594, has a flat surface 599 or a substantially flat surface and is configured to engage and even grip the neck of the aneurysm inside the aneurysm. Engagement of the aneurysm neck by the flat surface 599 or a substantially flat surface may help seal the aneurysm and prevent endoleaks. The bulbous portion 996 / middle section 596 is configured to allow for an angle between the proximal section 594 and the distal section 598, while providing some body or stop / limit therebetween.

[0137]

[0238] In some embodiments, one or more of the proximal section 594, the central section 596, or the distal section 598 may include some nickel-titanium alloy filaments and some radiopaque elements including platinum, gold, tantalum, or an alloy of any of these or other radiopaque materials. In some embodiments, the filaments may include a drawn-out fill tube, such as one including a nickel-titanium alloy outer wall and a platinum core. The radiopaque material allows the occlusion device 985 to be visible on an x-ray or fluoroscopy. The occlusion device 985 may be configured by controlling the amount of radiopaque material used, either by the ratio of radiopaque to non-radiopaque filaments or the amount of platinum core in the drawn-out fill tube. In this manner, the occlusion device 985 may be selectively manufactured to be sufficiently visible but not overly visible, e.g., not overly bright, so that other objects are obscured. In some embodiments, regardless of whether any of the filaments include a radiopaque material, the marker band may be attached to the first end 987 and / or second end 988 of the inverted mesh tube 986 by adhesive or epoxy bonding, or by crimping, welding, or other mechanical attachment.

[0138]

[0239] FIG. 63 shows an occlusion device 647 having an inverted mushroom-shaped proximal section 648, a bulbous central section 649, and a mushroom-shaped distal section 650 having a distal apex 81. Each of the sections 648, 649, 650 are separated by a central waist 651, 653. Sections 648, 649 are separated by a central waist 651, and sections 649, 650 are separated by a central waist 653. Each of the sections 648, 649, 650 are formed from a braided mesh 607 having different stiffness characteristics from one another. Sections 648, 649, 650 are fully braided, but for simplicity, the braid is only shown in windows 654, 655, 656. The proximal section 648 is braided to be stiffer than either the central section 649 or the distal section 650. The proximal section 648 may be braided with larger diameter filaments and / or braided with a larger braid angle to achieve increased stiffness. The increased stiffness is configured to wed or seat securely against the neck of the aneurysm, for example to achieve better closure or destruction at the entrance to the aneurysm. The distal section 650 is braided to be less stiff / more flexible than either the central section 649 or the proximal section 648. The distal section 650 may be braided with smaller diameter filaments and / or braided with a smaller braid angle to achieve reduced stiffness. The reduced stiffness is configured to soften and pack against the aneurysm dome. This is particularly useful in avoiding rupture of aneurysms, such as high-risk aneurysms. A high-risk aneurysm may have a substantially larger diameter at the dome, or a substantially thinner wall. Another high-risk aneurysm may be a previously ruptured aneurysm that has at least partially healed but may be prone to re-rupture. The central section 649 may be braided with filaments and / or may be braided at a braid angle that achieves intermediate stiffness relative to the proximal section 648 and distal section 650. Variations in wire / filament diameter can be created after forming the braided mesh 607 from a single collection of wires by adjusting or repositioning the braid crossovers.In some embodiments, the distal section 650 can be subsequently etched (chemically, photochemically) to reduce the overall wire diameter and reduce stiffness. In some embodiments, both the distal section 650 and the central section 649 are etched in a first etching operation. Then, only the distal section 650 is etched in a second etching operation. This means that as initially formed, the proximal section 659, the central section 649, and the distal section 650 are formed from wires having the same diameter, but after the two etching operations, the distal section 650 has a smaller diameter wire than the central section 649, which has a smaller diameter wire than the proximal section 648. Thus, in some embodiments, the distal section 650 can be made more flexible than the proximal section 648 by etching alone.

[0139]

[0240] FIG. 64 illustrates an occlusion device 1000 having a proximal end 1002 and a distal end 1004 and configured for placement within an aneurysm. The occlusion device 1000 comprises a lower portion 1006 having a proximal outer diameter A and a distal outer diameter B, and a tapered frustoconical section 1008 extending between diameter A and diameter B. In some embodiments, the lower portion 1006 is circular and has substantially the same diameter in any transverse slice (around the circumference). In other embodiments, the lower portion 1006 is non-circular and may include an ellipse, an oval, a polygon, or other shape. The tapered frustoconical section 1008 is configured to be larger than the maximum transverse dimension of the opening into the aneurysm (neck portion) at least in a portion between A and B. In some embodiments, the diameter A is configured to be larger than the maximum transverse dimension of the opening into the aneurysm (neck portion). Thus, the lower portion 1006 is configured to completely cover the neck portion, thus causing stagnation of blood within the aneurysm, resulting in occlusion. The occlusion device 1000 is constructed from a mesh (braided) Nitinol (nickel titanium alloy) tube 1005 that is inverted onto itself. The mesh tube 1005 has a first end and a second end. The second end is folded back onto the outer diameter of the first end, thus providing an outward facing surface 1003 and an inward facing surface (not visible in FIG. 64). The mesh tube 1005 is heat formed such that the occlusion device 1000 includes several extension portions: a lower portion 1006, an upper portion 1010, and a mid-waist portion 1012. The upper portion 1010 has a length L, a maximum diameter C, and a width W of 1002. MAX and minimum diameter C MIN The waist portion 1012 has a diameter D and a length g.

[0140]

[0241] A particular ratio of dimensions of the occlusion device 1000 has been found to be effective in creating a simple and easily formed structure (body) that is particularly suitable for placement within an aneurysm that may have at least one elongated dimension. This may be, for example, a deep and narrow aneurysm, or a wide and short aneurysm. The length L of the upper portion 1010 may range from about 1 mm to about 25 mm. The diameter C may range from about 1 mm to about 25 mm. The diameter B may range from about 1 mm to about 25 mm. The diameter A may range from about 1 mm to about 24 mm. Generally, the diameter C is about 50% to about 100% of the diameter B. Furthermore, generally, the diameter A is about 50% to about 100% of the diameter B. In some embodiments, the diameter A is about 70% to about 90% of the diameter B.

[0141]

[0242] Once formed (e.g., thermoformed), the occlusion device 1000 has an expanded configuration (shown in FIG. 64) and a collapsed configuration and is configured for delivery through a lumen of a delivery catheter (e.g., a microcatheter). The occlusion device 1000 comprises two mesh layers provided by an outwardly facing surface 1003 and an inwardly facing surface. In some embodiments, the occlusion device 1000 may include several nickel-titanium alloy filaments and several radiopaque elements including platinum, gold, tantalum, or alloys of any of these or other radiopaque materials. In some embodiments, the filaments may include a drawn-fill tube (DFT), such as one including an outer wall of nickel-titanium alloy and a platinum core. The radiopaque material allows the occlusion device 1000 to be visible on an x-ray or fluoroscopy. The occlusion device 1000 may be configured by controlling the amount of radiopaque material used, either by the ratio of radiopaque to non-radiopaque filaments or the amount of platinum core in the drawn-fill tube. In this manner, the occlusion device 1000 can be selectively manufactured to be sufficiently visible but not overly visible, e.g., not overly bright, so that other objects are obscured. In some embodiments, regardless of whether any of the filaments include a radiopaque material, the marker bands can be attached to the proximal end 1002 of the occlusion device 1000 by adhesive or epoxy bonding, or by crimping, welding, or other mechanical attachment. The drawn fill tubes (DFTs) can each have a platinum core having a cross-sectional area that is about 10% to about 70% of the total cross-sectional area of ​​the DFTs. In some embodiments, all (100%) of the filaments can include DFT. In other embodiments, 50% to 100% of the filaments can include DFT, with the remainder of the filaments including only nickel titanium alloy.

[0142]

[0243] Referring to FIG. 65, the occlusion device 1000 may be coupled at or near its proximal end 1002 to a pusher 152 having a distal end 154 and a proximal end 156. The pusher 152 may include a wire, hypotube, or another elongated structure having a post support removably coupled to the proximal end 1002 of the occlusion device 1000 at its distal end 154. The detachable joint 158 ​​may include one of several detachment systems, including, but not limited to, pressurized detachment, electrolytic detachment mechanism, hydraulic detachment mechanism, mechanical or interlocking detachment mechanism, chemical detachment mechanism, heat activated detachment system, or friction detachment system. During delivery, the pusher 152 is held at its proximal end 156 and pushed forward longitudinally by a user to advance the occlusion device 1000 to the distal end of a delivery catheter (e.g., a microcatheter) having a delivery lumen. The delivery catheter may also include a proximal hub, such as a Luer connector.

[0143]

[0244] FIG. 66 shows a first view of the occlusion device 1000 delivered to a first aneurysm configuration 1020 including an aneurysm 1022, a neck 1024, a first parent vessel arm 1026, a second parent vessel arm 1028, and an additional connecting vessel 1030. FIG. 67 shows a different view. The waist portion 1012 allows some flexing between the upper portion 1010 and the lower portion 1006 as seen in FIG. 66 and FIG. 67, and thus the upper portion 1010 can compress somewhat within the lower portion 1006. Thus, the lower portion 1006 protects and covers the neck portion 1024 of the aneurysm 1022, and the upper portion 1010 allows the occlusion device 1000 to conform to the shape of the aneurysm 1022 for a snug fit with a secure fit. The waist portion 1012 also acts as a shock absorber.

[0144]

[0245] FIG. 68 illustrates an occlusion device 800 that also includes an inverted mesh tube 802 and has an outer layer 804, an inner layer 806, and an inversion fold 808 that creates a distal opening 810 and serves as a transition between the outer layer 804 and the inner layer 806. The inverted mesh tube 802 has a first end 812 and a second end 814. The occlusion device 800 includes a proximal section 816, a distal section 818, and a middle section 820. The proximal section 816 has a substantially flattened portion 822, and the distal section 818 has a spherical shape 824 configured to contact the aneurysm dome. The middle section 820 also has a spherical shape 826. There is a waist 828 between the proximal section 816 and the middle section 820, and there is a circumferentially extending concave surface 830 between the distal section 818 and the middle section 820. The proximal section 816 includes a concave surface of the proximal concavity 832 configured to clear the marker band 834. The proximal section 816 has a maximum diameter 836 configured to grip the inner wall of the aneurysm. The occlusion device 800 includes a cover 838 configured to seat adjacent the neck of the aneurysm. In some embodiments, the cover 838 is circular and has substantially the same diameter at any lateral measurement of the perimeter. In other embodiments, the cover 838 is non-circular and may include an ellipse, an oval, a polygon, or other shape. In non-circular embodiments, the cover 838 includes a minimum lateral dimension and a maximum lateral dimension. In the particular case of an ellipse or oval shape, the cover 838 includes a major axis and a minor axis. The minor axis or minimum lateral dimension is configured to be larger than the maximum lateral dimension of the opening to the aneurysm (neck portion). The cover 838 is thus configured to completely cover the neck portion, thus causing stagnation of blood within the aneurysm, resulting in occlusion. The cover 838 is constructed from a mesh (braided) Nitinol (nickel titanium alloy) tube 840 that is inverted onto itself. The mesh tube 840 has a first end 842 and a second end 844. The second end 844 is folded back onto the outer diameter of the first end 842. The mesh tube 840 is heat formed such that the cover 838 includes an expanded portion 843 and the first end 842 and second end 844 include non-expanded (or partially expanded) portions.Cover 838 may be fabricated as an inverted mesh tube 840 having a simple straight elongated configuration, which is then formed into the shape shown in FIG. 68 and heat set into this shape. For example, inverted mesh tube 840 may be constructed as a single layer mesh tube formed of at least some nickel titanium alloy filaments and then inverted onto itself. Inverted mesh tube 840 may then be placed into a die or mold containing one or more parts to hold it in the shape of cover 838. Cover 838 may then be exposed to an elevated temperature and then cooled to set in that shape, such that cover 838 has at least some superelastic properties.

[0145]

[0246] Occlusion device 800 may comprise any material and may be made with any of the processes described in connection with occlusion device 200 or any other occlusion device described herein. Occlusion device 800 is configured to have bending or articulating capabilities at waist 828 and circumferentially extending concave surface 830, thus allowing proximal section 816, distal section 818, and middle section 820 to bend and conform to complex and irregularly shaped aneurysms. Maximum diameter 836 is configured to apply a radial force to the aneurysm wall to maintain occlusion device 800 in place, while cover 838 facilitates thrombosis at the neck and closure of the aneurysm.

[0146]

[0247] The foregoing is directed to embodiments of the present disclosure, although other further embodiments may be devised without departing from the basic scope thereof. The filament diameter of the filaments comprising any of the mesh materials described herein (e.g., mesh tubes, including inverted mesh tubes) may be from about 0.0004 inches to about 0.003 inches, or from about 0.0005 inches to about 0.002 inches, or from about 0.0006 inches to about 0.002 inches, or from about 0.0006 inches to about 0.0015 inches. The drawn-fill tube (DFT) may comprise 0% to 100% of the total strands / filaments of any of the braided / mesh tubes. In some embodiments, the drawn-fill tube (DFT) comprises about 50% to about 100% of the total filaments of the cover and about 50% to about 100% of the total filaments of each of the double or looped tubular meshes. The radiopaque core of each of at least some of the pultruded fill tubes has a cross-sectional area of ​​about 10% to about 70% of the total cross-sectional area of ​​each of at least some of the pultruded fill tubes, or about 51% to about 70% of the total cross-sectional area of ​​each of at least some of the pultruded fill tubes. In some embodiments, NiTi#1-DFT® wire manufactured by Fort Wayne Metals Research Products Corp (Fort Wayne, Indiana, USA) can be utilized. The filaments can be braided in a pattern having filament crossovers that are any one or more of the following ratios of filaments: 1x1, 1x2, 2x1, 2x2, 2x3, 3x2, 3x3, etc. (e.g., warp and weft). Any low, medium, or high pick count can be used, for example, about 15 picks per inch to about 300 picks per inch, or about 20 picks per inch to about 160 picks per inch. Any of the filaments or any portion of the occlusion device can be coated with a compound that enhances endothelialization, thus improving the healing process and optimizing occlusion when implanted within an aneurysm.The pusher and occlusion device configurations presented herein can also be used with other types of implantable devices, such as stents, flow diverters, filters, and occlusion devices for structural heart defects.

[0147]

[0248] In some embodiments, the braided elements can then be etched (chemically, photochemically) to reduce the overall wire diameter and decrease stiffness.

[0148]

[0249] Additional material may be carried on the cover of the occlusion device, or any other proximal portion of the occlusion device, and configured to face the opposite side of the aneurysm neck. In some embodiments, the material on the occlusion device may include a biological layer configured to promote growth. In some embodiments, the biological layer may include antibodies to accelerate the formation of an endothelial layer, for example, by attracting endothelial progenitor cells (EPCs). In some embodiments, the biological layer may include a natural membrane or structure, such as a membrane from the ear, the cornea, or a very thin ligament, or a membrane such as a blood vessel wall. In some embodiments, the material on the occlusion device may include a polymer layer configured to function as a simulated arterial wall. In some embodiments, the polymer layer may include polytetrafluoroethylene, such as expanded polytetrafluoroethylene (ePTFE), such as that used in grafts. The occlusion devices described herein may incorporate a biological or polymer layer.

[0149]

[0250] The following sections contain examples of devices of the present disclosure.

[0150]

[0251] Clause 101: In one example, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including a mesh body configured to be delivered in a collapsed configuration through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the body further configured to expand to an unfolded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm, the body including a proximal portion having a proximal maximum transverse dimension A and a distal maximum transverse dimension B, and a frustoconical portion extending between the proximal maximum transverse dimension A and the distal maximum transverse dimension B, the body including a distal portion having a maximum transverse dimension C, and a waist portion between the proximal portion and the distal portion, the dimension A being between about 50% and about 100% of the dimension B.

[0151]

[0252] Item 102: In some examples, the device includes item 101, and dimension A is between about 70% and about 90% of dimension B.

[0152]

[0253] Clause 103: In some examples, the device includes clause 101, wherein dimension C is between about 50% and about 100% of dimension B.

[0153]

[0254] Clause 104: In another example, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning into the inner layer at an inverted fold, at least the outer layer formed into an expanded shape having a proximal section having a first diameter, a distal section having a second diameter, and a waist portion having a third diameter, the third diameter being smaller than the first diameter and the third diameter being smaller than the second diameter.

[0154]

[0255] Clause 105: In some examples, the device includes clause 104, wherein the inner layer has an expanded shape that matches the expanded shape of the outer layer.

[0155]

[0256] Clause 106: In some examples, the device includes any one of clauses 104 or 105, wherein the first diameter is approximately equal to the second diameter.

[0156]

[0257] Clause 107: In some examples, the device includes any one of clauses 104 or 105, wherein the first diameter is greater than the second diameter.

[0157]

[0258] Clause 108: In some examples, the device includes any one of clauses 104 or 105, wherein the first diameter is smaller than the second diameter.

[0158]

[0259] Clause 109: In some examples, the device includes any one of clauses 104-108, wherein the distal section is substantially hemispherical.

[0159]

[0260] Clause 110: In some examples, the device includes any one of clauses 104-109, wherein the proximal section is substantially hemispherical.

[0160]

[0261] Clause 111: In some examples, the device includes any one of clauses 104-109, wherein the proximal section includes a proximal portion having a concave conical shape.

[0161]

[0262] Clause 112: In some examples, the device includes any one of clauses 104-111, wherein the inversion fold is circular and surrounds an opening that communicates with the interior volume of the occlusion element.

[0162]

[0263] Clause 113: In some examples, the device includes clause 111, wherein the concave cone is configured to guide blood flow within a native blood vessel adjacent the aneurysm when the occlusion element is substantially embedded within the aneurysm.

[0163]

[0264] Clause 114: In some examples, the device includes any one of clauses 104-113, wherein the proximal section and the distal section are configured to bend relative to one another such that they do not share the same longitudinal axis.

[0164]

[0265] Clause 115: In some examples, the device includes clause 114, wherein the waist portion is provided by an elongated tubular section.

[0165]

[0266] Clause 116: In some examples, the device includes any one of clauses 114 or 115, wherein the waist portion is provided by a bellows-shaped element.

[0166]

[0267] Clause 117: In some examples, the device includes any one of clauses 114-116, wherein the longitudinal axis of the proximal section and the longitudinal axis of the distal section are configured to be movable between 90° and 180°.

[0167]

[0268] Clause 118: In some examples, the device includes clause 117, wherein the longitudinal axis of the proximal section and the longitudinal axis of the distal section are configured to be movable between 135° and 180°.

[0168]

[0269] Article 119: In some examples, the device includes article 115, wherein the tubular section has a length of about 1 mm to about 10 mm.

[0169]

[0270] Article 120: In some examples, the device includes article 115, wherein the tubular section has a length of about 1 mm to about 6 mm.

[0170]

[0271] Article 121: In some examples, the device includes article 115, wherein the tubular section has a length of about 1 mm to about 3 mm.

[0171]

[0272] Clause 122: In some examples, the device includes any one of clauses 104-121, wherein the occlusion element includes a nickel titanium alloy.

[0172]

[0273] Clause 123: In some examples, the device includes any one of clauses 104-122, wherein the occlusion element includes a radiopaque material.

[0173]

[0274] Clause 124: In some examples, the device includes clause 123, and the radiopaque material includes a marker band.

[0174]

[0275] Clause 125: In some examples, the device includes clause 124, wherein the marker band is coupled to the proximal section.

[0175]

[0276] Clause 126: In another example, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element including an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning into the inner layer at an inverted fold, at least the outer layer formed into an expanded shape having a proximal section having a first diameter, a distal section having a second diameter, a first waist portion having a third diameter, a middle section having a fourth diameter, and a second waist portion having a fifth diameter, the first diameter, the second diameter, and the fourth diameter each being greater than the third diameter, and the first diameter, the second diameter, and the fourth diameter each being greater than the fifth diameter.

[0176]

[0277] Clause 127: In some examples, the device includes clause 126, wherein the proximal section has a first stiffness and the distal section has a second stiffness, the first stiffness being greater than the second stiffness.

[0177]

[0278] Clause 128: In some examples, the device includes clause 127, wherein the central section has a third stiffness, the third stiffness being greater than the second stiffness, and the first stiffness being greater than the third stiffness.

[0178]

[0279] Clause 129: In some examples, the device includes any one of clauses 126-128, wherein the proximal section includes a collection of filaments, each of the filaments having a larger diameter than the filaments of the distal section.

[0179]

[0280] Clause 130: In another example, a method for forming a device for treating an aneurysm in a blood vessel includes forming a mesh tube, inverting the mesh tube to form an outer layer and an inner layer, where the outer layer transitions into the inner layer at the inverted fold, forming at least the outer layer into an expanded shape having a proximal section having a first diameter and a distal section having a second diameter, and etching the distal section to reduce its stiffness.

[0180]

[0281] Clause 131: In some examples, the method includes Clause 130, wherein after the etching step, the distal section has a stiffness less than a stiffness of the proximal section.

[0181]

[0282] Clause 132: In another example, an apparatus for treating an aneurysm in a blood vessel includes an occlusion element configured to be releasably coupled to an elongate delivery shaft, the occlusion element comprising an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning into the inner layer at an inverted fold, the occlusion element configured to be delivered in a folded configuration through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the occlusion element further configured to expand to an expanded configuration when advanced from the distal end of the lumen of the delivery catheter into the aneurysm, wherein in the expanded configuration, at least the outer layer of the inverted mesh tube is formed into an expanded shape including a proximal section having a first transverse dimension, a distal section having a second transverse dimension, and a waist portion having a third transverse dimension, the third transverse dimension being smaller than the first transverse dimension and the third transverse dimension being smaller than the second transverse dimension, and wherein in the expanded configuration, the waist portion is configured to be deformed by an externally applied force such that a distance between the distal section and the proximal section is decreased.

[0182]

[0283] Clause 133: In some examples, the device includes clause 132, wherein the waist portion has a longitudinal length, in a substantially undeformed state, of between about 0.05 mm and about 25 mm.

[0183]

[0284] Article 134: In some examples, the device includes article 132, wherein the distal section has a length of about 1 mm to about 25 mm.

[0184]

[0285] Clause 135: In some examples, the device includes clause 132, wherein the distal section has a first longitudinal axis and the proximal section has a second longitudinal axis, and in the expanded configuration, the waist portion is configured to deform due to an externally applied moment such that an angle between the first longitudinal axis and the second longitudinal axis changes.

[0185]

[0286] Clause 136: In some examples, the device includes clause 135, wherein the angle between the first longitudinal axis and the second longitudinal axis is alterable to a minimum angle of about 90 degrees to about 135 degrees.

[0186]

[0287] Clause 137: In some examples, the device includes clause 132, wherein the waist portion includes a bellows shape.

[0187]

[0288] Article 138: In some examples, the device includes article 132, wherein the waist portion includes a circumferential concave surface.

[0188]

[0289] Clause 139: In some examples, the device includes clause 132, wherein the proximal portion includes a proximal diameter A and a distal diameter B, and the distal portion includes a diameter C, wherein diameter A is about 50% to about 100% of diameter B.

[0189]

[0290] Article 140: In some examples, the device includes article 139 and further includes a frusto-conical portion extending between diameter A and diameter B.

[0190]

[0291] Clause 141: In some examples, the device includes clause 139, wherein diameter A is about 70% to about 90% of diameter B.

[0191]

[0292] Clause 142: In some examples, the device includes clause 139, wherein diameter C is between about 50% and about 100% of diameter B.

[0192]

[0293] Clause 143: In some examples, the device includes clause 132, wherein the inner layer has an expanded shape that matches the expanded shape of the outer layer.

[0193]

[0294] Article 144: In some examples, the device includes article 132, wherein the first lateral dimension is approximately equal to the second lateral dimension.

[0194]

[0295] Clause 145: In some examples, the device includes clause 132, wherein the first lateral dimension is greater than the second lateral dimension.

[0195]

[0296] Clause 146: In some examples, the device includes clause 132, wherein the distal section is substantially hemispherical.

[0196]

[0297] Clause 147: In some examples, the device includes clause 132, wherein the proximal section is substantially hemispherical.

[0197]

[0298] Clause 148: In some examples, the device includes clause 147, wherein the distal section is substantially hemispherical.

[0198]

[0299] Clause 149: In some examples, the device includes clause 132, wherein the inversion fold is circular and surrounds an opening that communicates with an interior volume of the occlusion element.

[0199]

[0300] Article 150: In some examples, the device includes article 132, wherein the distal section is generally cylindrical and has a blunt distal end.

[0200]

[0301] Clause 151: In some examples, the device includes clause 132, wherein the distal section has a length greater than the second lateral dimension.

[0201]

[0302] Clause 152: In some examples, the device includes clause 132, wherein the inverted mesh tube is formed from a plurality of filaments.

[0202]

[0303] Clause 153: In some examples, the device includes clause 152, wherein at least some of the filaments in the outer layer of the distal section have an etched surface.

[0203]

[0304] Clause 154: In some examples, the apparatus includes clause 152, wherein between about 50 percent and about 100 percent of the plurality of filaments include a draw fill tube.

[0204]

[0305] Clause 155: In some examples, the device includes clause 154, wherein at least some of the drawn fill tubes include a radiopaque core having a cross-sectional area between about 51% and about 70% of the total cross-sectional area.

[0205]

[0306] Clause 156: In some examples, the device includes clause 132 and further includes a pusher having a proximal end and a distal end, wherein the occlusion element is configured to be releasably coupled to the distal end of the pusher with a releasable joint.

[0206]

[0307] Clause 157: In some examples, the device includes clause 156 and further includes a connecting tube having a proximal end substantially flush with the proximal end of the occlusion element, a distal end extending into the occlusion element, and an inner lumen, wherein the distal end of the pusher extends through the lumen of the connecting tube and includes a plurality of radially extending protrusions located distal to the distal end of the connecting tube, the plurality of radially extending protrusions forming a maximum lateral dimension greater than a maximum diameter of the lumen of the connecting tube.

[0207]

[0308] Clause 158: In some examples, the device includes clause 157 and further includes an activator configured to modify the plurality of radially extending protrusions such that the distal end of the pusher can be completely removed from the lumen of the connecting tube.

[0208]

[0309] Clause 159: In some examples, the device includes clause 158, wherein the activator is configured to exert an action on the radially extending protrusions selected from the list consisting of melting, separating, unbending, breaking, ablation, and deformation.

[0209]

[0310] Article 160: In some examples, the device includes article 132, wherein the waist portion includes a circumferential convex surface.

[0210]

[0311] Clause 161: In some examples, the device includes clause 160 and further includes a first circumferential concave surface adjacent a first end of the circumferential convex surface and a second circumferential concave surface adjacent a second end of the circumferential convex surface.

[0211]

[0312] Aneurysms are often non-spherical in shape and may have mild to severe angulation relative to the vessel through which they bulge or protrude. This can make the delivery and application of one or more aneurysm embolization devices to an aneurysm technical and physical challenges. Presented herein is a system to solve problems that may arise.

[0212]

[0313] FIG. 69 illustrates an occlusion device 660 configured for placement within an aneurysm. The occlusion device 660 includes a cover 663 having an outer diameter D. In some embodiments, the cover 663 is circular and has substantially the same diameter D at any lateral measurement of the circumference. In other embodiments, the cover 663 may be non-circular and include an ellipse, an oval, a polygon, or other shape. In non-circular embodiments, the cover 663 includes a minimum lateral dimension and a maximum lateral dimension. In the particular case of an ellipse or oval shape, the cover 663 includes a major axis and a minor axis. The minor axis or minimum lateral dimension is configured to be greater than the maximum lateral dimension of the opening to the aneurysm (neck portion). Thus, the cover 663 is configured to completely cover the neck portion, thus causing stagnation of blood within the aneurysm, resulting in occlusion. The cover 663 is constructed from a mesh (braided) Nitinol (nickel-titanium alloy) tube 665 that is inverted onto itself, thus providing an outwardly facing surface 664 and an inwardly facing surface 661. The mesh tube 665 is heat formed such that the cover 663 includes an expanded portion and the first and second ends 675 and 674 (FIG. 2) of the tube 665 each include a non-expanded (or partially expanded) portion. A smooth fold 662 extends around the circumference 659 of the cover 663 and represents the transition between the outwardly facing surface 664 and the inwardly facing surface 661. The fold 662 avoids sharp edges that may risk rupture of the aneurysm wall or other anatomical damage. The cover 663 includes a concave surface 657 disposed about a longitudinal axis 668. The cover 663 is manufactured as an inverted mesh tube 665 having a simple straight elongated configuration and is then formed into the shape shown in FIG. 69 and heat set into this shape. For example, the inverted mesh tube 665 may be constructed as a single layer mesh tube formed of at least some nickel-titanium alloy filaments and then inverted onto itself. The inverted mesh tube 665 may then be placed into a die or mold containing one or more parts to hold it in the shape of the cover 663. The cover 663 may then be exposed to an elevated temperature and then cooled to set in that shape, such that the cover 663 has at least some superelastic properties.

[0213]

[0314] Once formed (e.g., thermoformed), the cover 663 has an unfolded configuration (as shown in FIG. 69) and a folded configuration, as shown in FIG. 71. The cover 663 includes two mesh layers provided by an outwardly facing surface 664 and an inwardly facing surface 661.

[0214]

[0315] In some embodiments, the cover 663 may include some nickel-titanium alloy filaments and some radiopaque elements including platinum, gold, tantalum, or alloys of any of these or other radiopaque materials. In some embodiments, the filaments may include a drawn-fill tube (DFT), such as one including a nickel-titanium alloy outer wall and a platinum core. The radiopaque material allows the cover 663 to be visible on an x-ray or fluoroscopy. The occlusion device 660 may be configured by controlling the amount of radiopaque material used, either by the ratio of radiopaque to non-radiopaque filaments or the amount of platinum core in the drawn-fill tube. In this manner, the cover 663 may be selectively manufactured to be sufficiently visible but not overly visible, e.g., not overly bright, so that other objects are obscured. In some embodiments, whether or not any of the filaments include radiopaque material, the marker band 119 may be attached to the proximal end 672 of the occlusion device 660 by adhesive or epoxy bonding, or by crimping, welding, or other mechanical attachment.

[0215]

[0316] The pusher 669 having a distal end 673 and a proximal end 667 may comprise a wire, a hypotube, or another elongated structure having a column support removably coupled at its distal end 673 to the proximal end 672 of the occlusion device 660. The detachable joint 670 may comprise one of several detachment systems, including, but not limited to, pressurized detachment, electrolytic detachment mechanism, hydraulic detachment mechanism, mechanical or interlocking detachment mechanism, chemical detachment mechanism, heat activated detachment system, or friction detachment system. During delivery, the pusher 669 is held at its proximal end 667 and pushed forward longitudinally 676 by the user to advance the occlusion device 660 to the distal end 679 of a delivery catheter 677 (e.g., a microcatheter) having a delivery lumen 678 (FIGS. 71-72). The delivery catheter 677 may also include a proximal hub 137, such as a Luer connector.

[0216]

[0317] In the embodiment of FIG. 70, the pusher 669 comprises an outer tube 153 and an internal wire 151 coupled to one another. Conductors (e.g., electrical wires) 147, 149 are electrically coupled distally to the internal wire 151 and outer tube 153 (e.g., in the case of metal tubes) and proximally to first and second circumferential contacts 143, 145 carried on a hub 141 that is attached to a proximal end 667 of the pusher 669. The hub 141 has a cavity 671 into which the proximal end 667 of the pusher 669 is inserted and coupled. The hub 141 and its circumferential contacts 143, 145 are reversibly coupleable to a connector (not shown) of a separation controller (not shown) such as those known in the art. Detachment of the occlusion device 660 from the pusher 669 may be accomplished by any separation system, including, but not limited to, pressurized separation, electrolytic separation mechanism, hydraulic separation mechanism, mechanical or interlocking separation mechanism, chemical separation mechanism, heat activated separation system, or friction separation system, using a separation controller.

[0217]

[0318] 73, the cover 663 of the occlusion device 660 in its expanded configuration includes a concave surface 657 generally disposed about a longitudinal axis 668. This is because the cover may or may not be elliptical or another non-circular shape, so the longitudinal axis 668 need not be a perfect axis of symmetry. The pusher 669 extends from the removable joint 670 along its own longitudinal axis 135 that is not collinear with the longitudinal axis 668. Thus, a non-zero angle θ is formed between the two longitudinal axes 668, 135. The angle θ can be between about 15 degrees and about 120 degrees, or between about 30 degrees and about 120 degrees, or between about 40 degrees and about 100 degrees, or between about 45 degrees and about 90 degrees, or between about 75 degrees and about 90 degrees. This angulation aids in the delivery of the occlusion device 660 to aneurysms that have angular take-offs and / or are located along arteries that are tortuous or have severe bends, as shown in Figures 74A-76C.

[0218]

[0319] Additionally, the outwardly facing surface 664 has a center point 133 generally on the longitudinal axis 668. The center point 133 (and the longitudinal axis 668) is separated from the releasable joint 670 by a non-zero distance r. Thus, the releasable joint 670 is radially offset from the longitudinal axis 668. The maximum radius r of the cover 663 MAX is the maximum radius measured from the longitudinal axis 668 to the circumference 131, for example, at any point on the circumference 131 on a generally circular cover, or at a point along the circumference 131 (or generally, the circumference), along the major axis in an ellipse. As used herein, the phrase "radial offset" should be interpreted to mean a radial offset of at least about 5%. In some embodiments, the distance r is greater than or equal to the maximum radius r MAX At least about 10% of the maximum radius r MAX At least about 25% of the maximum radius, or at least about 50% of the maximum radius r MAXThe offset (distance r) aids in delivery of the occlusion device 660 to aneurysms that have angular take-offs and / or are located along arteries that are tortuous or have severe bends, as shown in Figures 74A-76C.

[0219]

[0320] While in Fig. 73 there is both a non-zero angle θ and a non-zero distance r, in other embodiments there may be a non-zero angle θ but a substantially zero distance r, such as occlusion device 1114 in Fig. 78. In other embodiments there may be a non-zero distance r and a substantially zero angle θ, such as occlusion device 1109 in Fig. 77.

[0220]

[0321] 74A-76C show an artery 681, 802, 902 with a sidewall aneurysm 680, 800, 900. A catheter (e.g., delivery catheter / microcatheter 685) approach in a sidewall aneurysm is often difficult when placing a single occlusion device. The distal end 686 of the delivery catheter 685 may be supplied pre-shaped with a particular curve, or may be steam-shaped or shaped in other ways by the user to create a preferred curve, such that the delivery angle of the occlusion device 687, 692, 698 to the aneurysm 680, 800, 900 allows delivery along an axis that is substantially parallel or somewhat parallel to the longitudinal axis of the neck 683, 806, 906 of the aneurysm 680, 800, 900, or allows delivery along an axis that is substantially parallel or somewhat parallel to the longitudinal axis of the sac of the aneurysm 680, 800, 900 itself. However, the curvature of the arteries 681, 802, 902 or the small diameter of the arteries 681, 802, 902 may make it difficult for the curved tip of the delivery catheter 685 to fit into the arteries 681, 802, 902 adjacent to the necks 683, 806, 906. In other cases, the curved tip may not provide sufficient back-up support for delivering the implant (occlusion device). The occlusion devices 687, 692, 698 according to embodiments disclosed herein improve the effectiveness of embolization performed in these anatomical conditions by allowing the user to select specific device parameters that match the anatomy.

[0221]

[0322] In FIG. 74A, an occlusion device 687 including a cover 688 removably coupled to a pusher 691 at a detachable joint 1103 is delivered via a delivery catheter 685 to an aneurysm 680 extending from an artery 681. The aneurysm 680 includes a dome 682 and a neck 683. The occlusion device 687 is similar to the occlusion device 660, but has a different angle θ and offset distance r, as seen in FIG. 74A. The particular occlusion device 687 (e.g., size, specification, model) may be selected by the attending physician to fit the aneurysm 680, with the angle θ and offset distance r being specifically selected to aid in delivery through the artery 681 to the aneurysm 680, and to optimize the shape of the system (e.g., delivery catheter 685 and occlusion device 687) during removal. The cover 688 has a concave surface 690 and an outer periphery 1104, or circumference (FIG. 74C). In Fig. 74B, the cover 688 is detached from the pusher 691 via the releasable joint 1103 in any one of the manners described in connection with the occlusion device 660. The pusher 691 and delivery catheter 685 are then removed from the patient, leaving the occlusion device 687 deployed within the aneurysm 680, as shown in Fig. 74C. The outwardly facing surface 689 of the cover 688 seats against the neck 683 of the aneurysm 680, against the lower wall portion 708 of the aneurysm 680 sac. The periphery 1104 extends into the sac at least in some of its portions, and extends substantially away from the neck 683 of the aneurysm 680.

[0222]

[0323] In FIG. 75A, an occlusion device 692 including a cover 693 removably coupled to a pusher 696 at a removable joint 695 is delivered via a delivery catheter 685 to an aneurysm 800 extending from an artery 802. The aneurysm 800 includes a dome 804 and a neck 806. The occlusion device 692 is similar to the occlusion device 660, but has a different angle θ and offset distance r, as seen in FIG. 75A. The particular occlusion device 692 (e.g., size, specification, model) may be selected by the attending physician to fit the aneurysm 800, with the angle θ and offset distance r being specifically selected to aid in delivery through the artery 802 to the aneurysm 800, and to optimize the shape of the system (e.g., delivery catheter 685 and occlusion device 692) during removal. The cover 693 has a concave surface 697 and an outer periphery 1106, or circumference (FIG. 75C). In Fig. 75B, the cover 693 is detached from the pusher 696 via the releasable joint 695 in any one of the manners described in connection with the occlusion device 660. The pusher 696 and delivery catheter 685 are then removed from the patient, leaving the occlusion device 692 deployed within the aneurysm 800, as shown in Fig. 75C. The outwardly facing surface 694 of the cover 693 seats against the neck 806 of the aneurysm 800, against a lower wall portion 808 of the aneurysm 800 sac. The periphery 1106 extends into the sac at least in some of its portions, and extends substantially away from the neck 806 of the aneurysm 800.

[0223]

[0324] In FIG. 76A, an occlusion device 698 including a cover 699 removably coupled to a pusher 1101 at a removable joint 1102 is delivered via a delivery catheter 685 to an aneurysm 900 extending from an artery 902. The aneurysm 900 includes a dome 904 and a neck 906. The occlusion device 698 is similar to the occlusion device 660, but has a different angle θ and offset distance r, as seen in FIG. 76A. The particular occlusion device 698 (e.g., size, specification, model) may be selected by the attending physician to fit the aneurysm 900, with the angle θ and offset distance r being specifically selected to aid in delivery through the artery 902 to the aneurysm 900, and to optimize the shape of the system (e.g., delivery catheter 685 and occlusion device 698) during removal. The cover 699 has a concave surface 1100 and an outer periphery 1108, or circumference (FIG. 76C). In Fig. 76B, the cover 699 is detached from the pusher 1101 via the releasable joint 1102 in any one of the manners described in connection with the occlusion device 660. The pusher 1101 and delivery catheter 685 are then removed from the patient, leaving the occlusion device 698 deployed within the aneurysm 900, as shown in Fig. 76C. The outwardly facing surface 408 of the cover 699 seats against the neck 906 of the aneurysm 900, against a lower wall portion 908 of the aneurysm 900 sac. The periphery 1108 extends into the sac at least in some of its portions, and extends substantially away from the neck 906 of the aneurysm 900.

[0224]

[0325] As seen in Figures 74A-76C, a particular angle θ and / or offset distance r allows for optimized delivery and deployment of the occlusion device 687, 692, 698 within the aneurysm 680, 800, 900. In Figures 74A and 75A, the delivery catheter 685 is shown to have little or no curve formed on its distal end 686. However, in Figure 76A, the distal end 686 has a curve 163 that is preformed or formed by the physician to aid in the delivery of the occlusion device 698 to the aneurysm 900. The curve 163 is oriented more or less along the plane of the page, with a radius or curvature that is substantially orthogonal to the page (i.e., extends perpendicularly from the page). However, because the occlusion device 698 has a concave shape disposed about the longitudinal axis 418 and the occlusion device 698 and the pusher 1101 together form a structure that is asymmetric with respect to the longitudinal axis 418, it may be desirable to selectively control the orientation rotation of the occlusion device 698 with respect to its longitudinal axis 418, which would therefore further control the overall orientation of the occlusion device 698 relative to the aneurysm 900.

[0225]

[0326] Returning to FIG. 69, the cover 663 may be braided such that the braid, mesh, etc., is somewhat symmetrically disposed about the longitudinal axis 668. However, in alternative embodiments, it may be desirable to form the braid asymmetrically about the longitudinal axis 668 such that when the cover 663 is compressed into its collapsed configuration, it actually prefers to form a more linear configuration (through the structure and sliding mechanism) and is more oriented along the longitudinal axis 135 (FIG. 73). Thus, while compressed within the lumen 678 of the delivery catheter 677, the longitudinal axis 668 and the "pseudo" longitudinal axis 135 (now because the cover 663 is temporarily deformed) are forced into an angle θ of, now substantially 90 degrees (with respect to each other). That is, it is not until the cover 663 is delivered from the lumen 678 of the delivery catheter 677 that it is allowed to assume its expanded configuration and conform to its true angle θ through the memory of the braided material. Asymmetric braiding can be achieved by using a braiding process or automated braiding machine that varies the braid angle in an oscillatory or sinusoidal manner. For example, at a particular clock position (e.g., 6 o'clock) around circumference 659 of cover 663, the braid angle may be equal to a first value, X, and at another clock position (e.g., 9 o'clock) around circumference 659 of cover 663, the braid angle may be equal to a second value, 0.8X. In some embodiments, the second value may be about 40% to about 95% of the first value, or about 50% to about 90% of the first value, or about 60% to about 85% of the first value.

[0226]

[0327] 77 illustrates an occlusion device 1109 that includes a cover 1110 removably coupled to a pusher 1113 at a releasable joint 1112. The cover 1110 has an outer periphery 514. A longitudinal axis 1111 of the cover 1110 is radially offset from a longitudinal axis 535 of the pusher 1113 by a non-zero distance r. There is a substantially zero angle between the longitudinal axis 1111 of the cover and the longitudinal axis 535 of the pusher 1113.

[0227]

[0328] 78 illustrates an occlusion device 1114 that includes a cover 1115 removably coupled to a pusher 652 at a releasable joint 658. The cover 1115 has a periphery 1116. A longitudinal axis 1117 of the cover 1115 is angled at a non-zero angle θ from the longitudinal axis 635 of the pusher 652. There is a substantially zero distance r between the longitudinal axis 1117 of the cover 1115 and the longitudinal axis 635 of the pusher 652.

[0228]

[0329] Although the occlusion devices 660, 687, 692, 698, 1109, 1114 as described according to the embodiments disclosed herein are generally shown having a proximal convex surface and a distal concave surface and are configured to be placed primarily at the bottom (near the neck) of the aneurysm, any other configuration of aneurysm occlusion devices are also contemplated for use in combination with the attachment / detachment configurations taught in the disclosed embodiments. This includes devices configured to be the only device implanted in the aneurysm, as well as devices configured to be one or more devices implanted in the aneurysm. Figures 79-84 show six different occlusion systems 770, 772, 774, 776, 778, 780 utilized to deliver a braided shell 758 to an aneurysm 750 having a dome 752 and a neck 768. The braided shell 758 has a longitudinal axis 756 and is configured to fill a majority of the aneurysm 750, or in some cases substantially all of the aneurysm 750 sac. Braided shell 758 is braided or woven from filaments 760 and has a proximal end 751, a distal end 753, and an intermediate portion 782. Aneurysm 750 has the shape of a sidewall aneurysm associated with artery 762 extending to the left and artery 764 extending to the right. Alternatively, aneurysm 750 has the shape of an end aneurysm associated with artery 754. An additional blood vessel 766 may also be present. In the process of embolizing aneurysm 750, it may be desirable to avoid embolizing this blood vessel 766.

[0229]

[0330] In FIG. 79, occlusion system 770 includes a pusher 784 removably coupled to a proximal end 751 of braided shell 758 at a releasable joint 785. Pusher 784 extends from releasable joint 785 at a non-zero angle relative to a longitudinal axis 756 of braided shell 758. Releasable joint 785 is dimensionally offset a non-zero distance from the longitudinal axis 756 of braided shell 758. The offset side is the same as the side from which pusher 784 extends. Occlusion system 770 is shown delivered from artery 762 in FIG. 79, but may be delivered from one or more other arteries.

[0230]

[0331] In FIG. 80, occlusion system 772 includes a pusher 786 removably coupled to a proximal end 751 of braided shell 758 at a releasable joint 787. Pusher 786 extends from releasable joint 787 at a non-zero angle relative to a longitudinal axis 756 of braided shell 758. Releasable joint 787 is dimensionally offset from longitudinal axis 756 of braided shell 758 by a non-zero distance and is located on an opposite side of the longitudinal axis from the side from which pusher 784 extends. Occlusion system 772 is shown delivered from artery 762 in FIG. 80, but may be delivered from one or more other arteries.

[0231]

[0332] In FIG. 81 , occlusion system 774 includes a pusher 788 removably coupled to a proximal end 751 of braided shell 758 at a releasable joint 789. Pusher 788 extends from releasable joint 789 at a non-zero angle relative to a longitudinal axis 756 of braided shell 758. Releasable joint 789 is generally not offset from longitudinal axis 756 of braided shell 758, but instead is coupled substantially at longitudinal axis 756. Occlusion system 774 is shown delivered from artery 762 in FIG. 81 , but may be delivered from one or more other arteries.

[0232]

[0333] In FIG. 82, occlusion system 776 includes a pusher 790 removably coupled to a proximal end 751 of braided shell 758 at a releasable joint 791. Pusher 790 extends from releasable joint 791 at a substantially zero angle relative to a longitudinal axis 756 of braided shell 758. Releasable joint 791 is dimensionally offset a non-zero distance from the longitudinal axis 756 of braided shell 758. Occlusion system 776 is shown delivered from artery 754 in FIG. 82, but may be delivered from one or more other arteries.

[0233]

[0334] In FIG. 83 , occlusion system 778 includes a pusher 792 removably coupled to a proximal end 751 of braided shell 758 at a releasable joint 793. Pusher 792 extends from releasable joint 793 at a non-zero angle relative to a longitudinal axis 756 of braided shell 758. Releasable joint 793 is dimensionally offset a non-zero distance from the longitudinal axis 756 of braided shell 758. The offset side is opposite the side from which pusher 792 extends. Occlusion system 778 is shown delivered from artery 754 in FIG. 83 , but may be delivered from one or more other arteries.

[0234]

[0335] In FIG. 84 , occlusion system 780 includes a pusher 794 removably coupled to a proximal end 751 of a braided shell 758 at a releasable joint 795. The pusher 794 extends from the releasable joint 795 at a non-zero angle relative to a longitudinal axis 756 of the braided shell 758. The releasable joint 795 is not offset from the longitudinal axis 756 of the braided shell 758, but instead is coupled substantially at the longitudinal axis 756. Although the occlusion system 780 is shown delivered from the artery 754 in FIG. 84 , it may be delivered from one or more other arteries.

[0235]

[0336] As seen in FIGS. 79-84, the angle θ and / or offset distance r allow for optimized delivery and deployment of the occlusion device (braided shell 758) within the aneurysm 750.

[0236]

[0337] 85 and 86 show a delivery catheter 85 comprising a shaft 87 having a proximal end 89, a distal end 93 having a curve 97, and a non-circular lumen 99. A luer hub 91 is coupled to the proximal end 89 of the shaft 87. In some embodiments, the non-circular lumen 99 can extend through the entire shaft 87, but in the embodiment of FIGS. 85 and 86, the non-circular lumen 99 transforms into a circular lumen 83 (FIG. 87) at the proximal end 89. In some embodiments, the shaft 87 may be extruded with a circular lumen 83 throughout its entire length, and then a mandrel of non-circular cross section may be placed in the lumen 83 at the distal end 93 and heat may be applied to reshape the lumen 83 at the distal end 93 into the shape of the non-circular lumen 99. In other embodiments, a first tubular portion 22 having a circular lumen 83 may be thermally fused to a second tubular portion 24 having a non-circular lumen 99. The mandrel is positioned from the proximal end and can have a smooth transition between a circular and a non-circular outer cross-section to form a transition zone 26 with a continuously smooth lumen wall transition between the circular lumen 83 and the non-circular lumen 99. The non-circular lumen 99 is shown as an ellipse in FIG. 85 but can instead be oval, or any type of non-circular cross-sectional shape. For example, it can be polygonal, dog-bone shaped, guitar shaped, or U-shaped. Optionally, a radiopaque stripe 28 can be extruded or otherwise placed on one side of the wall 30 of the shaft 87 to further aid in visualization under fluoroscopy (e.g., biplane fluoroscopy). Thus, the physician delivering the delivery catheter 85 can better judge the orientation (clockwise position of rotation) of the curve 97 relative to the aneurysm. The non-circular lumen 99 allows an occlusion device, whose compressed or constrained shape is substantially oval or elliptical or otherwise non-circular, to be selectively rotated and oriented, for example, so that it can be positioned only at 0°, or so that it can be positioned at 180°, or so that it can be positioned at another rotational angle. Markings 95 on the luer hub 91 can be used to aid in the insertion of the occlusion device so that it can be oriented in a particular one of the 0° or 180° orientations by serving as a comparative visual aid.In some embodiments, longitudinal stripes can be placed on shaft 87 near distal end 93 to allow steam shaping of curve 97 (if not pre-shaped) or reshaping of curve 97 along a desired plane. In some embodiments, steam shaping can be accomplished by placing a bendable mandrel within non-circular lumen 99 to further or alternatively assist in shaping or reshaping curve 97 along a desired plane. In some embodiments, the bendable mandrel has a similar cross-sectional shape to non-circular lumen 99 so as to substantially fill non-circular lumen 99.

[0237]

[0338] 88 and 89 show a delivery catheter 32 including a shaft 34 having a proximal end 36, a distal end 38 having a curve 40, and a non-circular lumen 42. A luer hub 44 is coupled to the proximal end 36 of the shaft 34. In this particular embodiment, the non-circular lumen 42 extends through the entire shaft 34. The non-circular lumen 42 is shown in FIG. 88 as a guitar shape with a first smaller lobe 46 and a second larger lobe 48 coupled to one another by a waist 50. Thus, the guitar shape creates a key to allow only one specific rotational position of the occlusion device as it exits the lumen 42 at the distal end 38 of the shaft 34 and thus enters the aneurysm. In some embodiments, the non-circular lumen 42 may taper in size near the distal end 38 of the shaft 34. Thus, the occlusion device is substantially securely held near the distal end 38 of the shaft 34, but has more space throughout most of the length of the lumen 42 to minimize axial friction. Alternatively, other types of "keyed" shapes can be used for non-circular lumens 42. Optionally, a longitudinal radiopaque stripe 52 can be extruded or otherwise disposed on one side of the wall 54 of the shaft 34 to further aid in visualization under fluoroscopy (e.g., biplane fluoroscopy).

[0238]

[0339] 91-94, the loading sheath (or introducer sheath or insertion sheath) 56 is configured to aid in the insertion of the asymmetric occlusion device 58 (or asymmetric occlusion device 58 / pusher 59 / detachable joint 61 system) into the non-circular lumen 60 (FIG. 94) of the delivery catheter 62. The non-circular lumen 60 may extend only into the shaft 64 of the catheter 62, or the luer hub 66 itself may also have a non-circular lumen 60 (as shown in FIG. 94). A removable funnel 68 has a proximal end 70 attached to the distal end 72 of the loading sheath 56. The funnel 68 has a proximal inner diameter 74 (FIG. 93) that matches the diameter 76 of the distal end 72 of the loading sheath 56. The funnel 68 smoothly tapers to an increasing inner diameter 78 at the distal end 80. In use, the occlusion device 58 may be packaged inside the lumen 82 of the loading sheath 56 or may be packaged extending from the loading sheath 56. Prior to insertion into the non-circular lumen 60 of the delivery catheter 62, the occlusion device 58 may be prepared by priming or flushing the lumen 82 of the loading sheath 56 (FIG. 91). The occlusion device 58 may be primed or rinsed with saline or saline and heparin outside the loading sheath 56 as shown in FIG. 91. The user then carefully applies traction (pulls) on the pusher 59 to load the occlusion device 58 into the lumen 82 of the loading sheath 56 in a preferred compressed configuration. For example, the folded portion may be oriented so as to be least noticeable or configured so that a preferred distally extending portion exits the lumen 82 first. The inner contour of the funnel 68 optimizes the ability to preferentially load the occlusion device 58 into the lumen 82. For example, preferential loading may be done in a manner that obtains the smallest compressed or collapsed diameter possible. The loaded occlusion device 58 is shown in FIG 92, completely within the lumen 82 of the loading sheath 56. The funnel 68 can then be unsnapped, unscrewed, or otherwise removed from the loading sheath 56, as shown in FIG 93. The funnel 68 can then be removed and discarded.In some embodiments, the funnel 68 may be reattachable to the loading sheath 56. Referring to FIG. 94, the distal end 72 of the loading sheath 56 is positioned near the entrance of the non-circular lumen 60 such that, for example, the larger shaped lobe 84 of the compressed occlusion device 58 can be adapted for entry into the larger lobe 86 of the non-circular lumen 60 and the smaller shaped lobe 88 of the occlusion device 58 can be adapted for entry into the smaller lobe 90 of the non-circular lumen 60. The pusher 59 is then pushed by the user to load the occlusion device 58 into the non-circular lumen 60 and advance the occlusion device 58 towards the distal end (not shown) of the delivery catheter 62. The loading sheath 56 may be peeled back or simply pulled back into the proximal portion of the pusher 59. The occlusion device 58 may then be reliably delivered to the aneurysm in a selected orientation, for example, right side up, rather than upside down. In some embodiments, the loading sheath may have external longitudinal stripes on the tube to assist the user in applying a desired rotational orientation when inserting the occlusion device 58.

[0239]

[0340] Alternative lumen shapes and compressed shapes of the occlusion devices are shown in FIGS. 95A-E. In the embodiment of FIG. 95A, a distal end 852 of a delivery catheter 850 has a non-circular lumen 854 having a pentagonal shape. An occlusion device 856 in a compressed configuration is advantageously a substantially pentagonal shape that can key to the shape of the non-circular lumen 854. In the embodiment of FIG. 95B, a distal end 858 of a delivery catheter 860 has a non-circular lumen 862 having a diamond shape. An occlusion device 864 in a compressed configuration is advantageously a substantially diamond shape that can key to the shape of the non-circular lumen 862. In the embodiment of FIG. 95C, a distal end 866 of a delivery catheter 868 has a non-circular lumen 870 having a U-shape. An occlusion device 872 in a compressed configuration is advantageously a substantially U-shape that can key to the shape of the non-circular lumen 870. In the embodiment of FIG. 95D, the distal end 874 of the delivery catheter 876 has a non-circular lumen 878 having an elliptical shape. The occlusion device 880 in the compressed configuration is advantageously a substantially elliptical shape that can key to the shape of the non-circular lumen 878. In the embodiment of FIG. 95E, the distal end 882 of the delivery catheter 884 has a non-circular lumen 886 having a guitar shape. The occlusion device 888 in the compressed configuration is advantageously a substantially guitar shape that can key to the shape of the non-circular lumen 886.

[0240]

[0341] 96A and 97A-C show an occlusion device 2040 comprising a mesh covering 2042 including a distal concave surface 2044. A radially offset inner tube 2046 having a lumen 2048 and an outer wall 2050 is secured within the mesh covering 2042 such that its proximal end 2052 is flush with or adjacent to the proximal end 2054 of the mesh covering 2042. A pusher 2056 comprises a wire having a distal end 2058 including a plurality of radially extending fingers 2060 extending from the distal end 2058. The fingers 2060 are configured to be meltable, separable, unbendable, breakable, abradable, deformable, or otherwise alterable. Prior to separation, the radially extending fingers 2060 create a maximum diameter that is greater than the diameter of the lumen 2048 of the inner tube 2046 such that pulling on the wires of the pusher 2056 causes the fingers 2060 to pull on the distal end of the outer wall 2050 of the inner tube 2046, and thus the entire occlusion device 2040. For example, the occlusion device 2040 can be advanced into the aneurysm, and if the user does not find the fit or configuration of the occlusion device 2040 within the aneurysm desirable, the user can pull on the pusher 2056 to pull the occlusion device 2040 out of the aneurysm and into the lumen of the delivery catheter. However, the occlusion device 2040 can then be delivered to the aneurysm in an acceptable manner and separated by the user by any separation method (to deform, damage, or destroy the fingers 2060), including but not limited to, modes of pressurized separation, electrolytic separation mechanisms, hydraulic separation mechanisms, mechanical or interlocking separation mechanisms, chemical separation mechanisms, heat activated separation systems, or frictional separation systems. In one embodiment, mechanical separation is achieved by pushing the distal end of the microcatheter against the proximal end 2054 of the mesh covering 2042 while pulling on the pusher 2056, thus bending the fingers 2060 and removing the pusher 2056 from the occlusion device 2040. The inner tube 2046 provides a smooth proximal end 2054 of the mesh covering 2042, and thus, there is no residual wire protruding proximally. Residual protruding wire can cause thrombosis, which can lead to embolic stroke.In some embodiments, the distal end 2058 of the pusher 2056 can be tapered to 0.001 inch or 0.002 inch, for example, if the distal end 2058 comprises stainless steel wire. The inner tube 2046 can comprise a polyimide tubing and can have an inner diameter as small as 0.002 inch to 0.010 inch and an outer diameter of about 0.003 inch to about 0.014 inch. In some embodiments, there can be two fingers 2060, or three fingers 2060, or four fingers 2060, or six fingers 2060, or more than five fingers 2060.

[0241]

[0342] The flush or adjacent relationship of the proximal end 2052 of the inner tube 2046 and the proximal end 2054 of the mesh cover 2042 ensures that there is no detachment residue extending substantially proximal to the proximal end 2054 of the mesh cover 2042 (and into the parent artery). Thus, in cases where such residue may be a risk, possible associated thromboembolic events can be avoided. FIG. 96B illustrates an alternative distal end 2058b comprising a ball 2062 having a spherical or spherical shape. Detachment may occur at the ball 2062, or at a portion 2064 of the distal end 2058b proximal to the ball 2062, or both. The ball 2064 may be attached to the pusher 2056 by epoxy, adhesive, welding, brazing, or soldering, or may be formed from the material of the distal end 2058b by welding. FIG. 96C illustrates an alternative distal end 2058c comprising a disk 2066 having a flattened circular shape. The separation may occur at the disk 2066, or at a portion 2068 of the distal end 2058c proximal to the disk 2066, or both. The disk 2066 may be attached to the pusher 2056 by epoxy, adhesive, welding, brazing, or soldering, or may be formed from the material of the distal end 2058c by welding. FIG. 96D shows an alternative distal end 2058d with a frustoconical tip 2070. The separation may occur at the tip 2070, or at a portion 2072 of the distal end 2058d proximal to the tip 2070, or both. The tip 2070 may be attached to the pusher 2056 by epoxy, adhesive, welding, brazing, or soldering, or may be formed from the material of the distal end 2058d by welding. FIG. 96E shows an alternative distal end 2058e with a tip 2076 having a flattened inverted spear shape. The separation can occur at the tip 2076, or at a portion 2078 of the distal end 2058e proximal to the tip 2076, or both. The tip 2076 can be attached to the pusher 2056 by epoxy, adhesive, welding, brazing, or soldering, or can be formed from the material of the distal end 2058e by welding, or can be a flattened portion of the pusher 2056 wire, for example by rolling or pressing.In each of the alternative embodiments, the diameter (or maximum lateral dimension) of ball 2062, disk 2066, proximal end 2074 of tip 2070, or distal end 2080 of tip 2076 is larger than the diameter of lumen 2048 of inner tube 2046, thus allowing occlusion device 2040 to be releasably locked into push 2056. Any of the tip configurations shown in Figures 10A-10E and 96A-96E may be incorporated into a variety of different occlusion devices, including any of the occlusion devices disclosed herein.

[0242]

[0343] The following sections contain examples of devices of the present disclosure.

[0243]

[0344] Clause 201: In one example, a vaso-occlusion system configured to embolize an aneurysm, the aneurysm having a neck and a sac, includes an elongated pusher configured to be slidably disposed within a delivery catheter, the delivery catheter having a proximal end, a distal end, and a delivery lumen extending therebetween, and an implantable vaso-occlusion device coupled to the distal end of the pusher, the vaso-occlusion device configured to be implanted into the aneurysm sac ... and an implantable vaso-occlusion device having an expanded and deployed configuration, the vaso-occlusion device including a proximal surface configured to seat against a lower wall portion of the aneurysm sac against the neck of the aneurysm and a concave surface opposite the proximal surface, the vaso-occlusion device having a periphery that enters the sac and extends away from the neck of the aneurysm, the concave surface being disposed about the longitudinal axis, the vaso-occlusion device configured to be releasably coupled to a distal end of a pusher at a releasable joint, the distal end of the pusher extending from the releasable joint at an angle of about 30 degrees to about 120 degrees formed with the central longitudinal axis.

[0244]

[0345] Article 202: In some examples, the system includes article 201, wherein the pusher extends from the releasable joint at an angle between about 40 degrees and about 100 degrees formed with the central longitudinal axis.

[0245]

[0346] Article 203: In some examples, the system includes article 201, wherein the pusher extends from the releasable joint at an angle between about 45 degrees and about 90 degrees formed with the central longitudinal axis.

[0246]

[0347] Article 204: In some examples, the system includes article 201, wherein the pusher extends from the releasable joint at an angle between about 75 degrees and about 90 degrees formed with the central longitudinal axis.

[0247]

[0348] Clause 205: In some examples, the system includes any one of clauses 201-204, wherein the releasable joint is coupled to a proximal surface of the vaso-occlusive device.

[0248]

[0349] Clause 206: In some examples, the system includes clause 205, wherein the releasable joint is coupled at a location on the proximal surface of the vaso-occlusive device that is radially offset from the central longitudinal axis.

[0249]

[0350] Clause 207: In some examples, the system includes clause 206, wherein the vasoocclusive device in an expanded, deployed configuration has a maximum radius and the location on the proximal surface is offset by at least 50% of the maximum radius.

[0250]

[0351] Clause 208: In some examples, the system includes clause 206, wherein the vaso-occlusive device in an expanded, deployed configuration has a maximum radius and the location on the proximal surface is offset by at least 75% of the maximum radius.

[0251]

[0352] Clause 209: In some examples, the system includes clause 206, wherein the vaso-occlusive device in an expanded, deployed configuration has a maximum radius and the location on the proximal surface is at the radial edge.

[0252]

[0353] In another example, a vaso-occlusion system configured to embolize an aneurysm, the aneurysm having a neck and a sac, the delivery catheter having a proximal end, a distal end, and a delivery lumen extending therebetween, the delivery catheter including an elongated pusher configured to be slidably disposed within the delivery catheter, the delivery catheter having a proximal end, a distal end, and an implantable vaso-occlusion device coupled to the distal end of the pusher, the vaso-occlusion device configured to be implanted into the aneurysm sac ... and an implantable vaso-occlusive device having an expanded, deployed configuration of an expanded, expanded distal end of the pusher, the vaso-occlusive device including a proximal surface configured to seat against a lower wall portion of the aneurysm sac against the neck of the aneurysm and a concave surface opposite the proximal surface, the concave surface having a periphery extending into the sac and away from the neck of the aneurysm, the concave surface being disposed about the longitudinal axis, the vaso-occlusive device being configured to be releasably coupled to the distal end of the pusher at a releasable joint, the releasable joint being coupled at a location on the proximal surface of the vaso-occlusive device that is radially offset from the central longitudinal axis.

[0253]

[0354] Clause 211: In some examples, the system includes clause 210, wherein the vaso-occlusive device in an expanded, deployed configuration has a maximum radius and the location on the proximal surface is offset by at least 50% of the maximum radius.

[0254]

[0355] Clause 212: In some examples, the system includes clause 210, wherein the vaso-occlusive device in an expanded, deployed configuration has a maximum radius and the location on the proximal surface is offset by at least 75% of the maximum radius.

[0255]

[0356] Clause 213: In some examples, a system includes clause 210, wherein the vaso-occlusive device in its expanded, deployed configuration has a maximum radius and a location on the proximal surface is at the radial edge.

[0256]

[0357] Clause 214: In some examples, the system includes any one of clauses 201-213, wherein the vascular occlusion device includes a cover having a first side and a second side, and the proximal surface includes a concave surface that includes the first side of the cover and the second side of the cover.

[0257]

[0358] Clause 215: In some examples, the system includes any one of clauses 201-214, wherein the vaso-occlusive device is formed from a mesh material.

[0258]

[0359] Clause 216: In some examples, the system includes clause 215, wherein the mesh material includes a plurality of filaments.

[0259]

[0360] Clause 217: In some examples, the system includes clause 216, wherein the plurality of filaments includes a filament comprising a nickel titanium alloy.

[0260]

[0361] Clause 218: In some examples, the system includes clause 216, wherein the plurality of filaments includes a filament comprising a radiopaque material.

[0261]

[0362] Clause 219: In some examples, the system includes clause 216, wherein the plurality of filaments includes a filament that includes a draw-fill tube.

[0262]

[0363] Clause 220: In some examples, the system includes any one of clauses 217-219, wherein the plurality of filaments includes a filament comprising platinum.

[0263]

[0364] Clause 221: In another example, a vaso-occlusion system configured to embolize an aneurysm, the aneurysm having a neck and a sac, includes an elongated pusher configured to be slidably disposed within a delivery catheter, the delivery catheter having a proximal end, a distal end, and a delivery lumen extending therebetween, and an implantable vaso-occlusion device coupled to the distal end of the pusher, the vaso-occlusion device configured to be implanted into the aneurysm sac, the implantable vaso-occlusion device having a collapsed delivery configuration when restrained within the delivery lumen of the delivery catheter and an expanded, deployed configuration after exiting the delivery lumen of the delivery catheter and being delivered to the aneurysm sac, the vaso-occlusion device extending from the neck of the aneurysm to the distal end of the pusher. a proximal surface configured to seat against a lower wall portion of the aneurysm sac and a concave surface opposite the proximal surface, the concave surface being disposed about the longitudinal axis, the vaso-occlusive device being configured to be releasably coupled to a distal end of the pusher at a releasable joint, the releasable joint having characteristics selected from the list consisting of: (1) the distal end of the pusher extends from the releasable joint at an angle of about 30 degrees to about 120 degrees formed with the central longitudinal axis, and (2) the releasable joint is coupled at a location on the proximal surface of the vaso-occlusive device that is radially offset from the central longitudinal axis.

[0264]

[0365] Clause 222: In another example, a system for embolizing an aneurysm includes an expandable implant configured for placement within the aneurysm, the expandable implant having a collapsed configuration and an expanded configuration, the expanded configuration having an asymmetric shape relative to a longitudinal axis, and a delivery catheter having a proximal end, a distal end, and a lumen extending from the proximal end to the distal end, the lumen having a non-circular cross-section at least in a distal region adjacent the distal end of the delivery catheter, the expandable implant in the collapsed configuration configured to fit into the lumen of the distal region in a keyed manner such that the expandable implant is deliverable from the lumen of the distal end of the delivery catheter at a specific rotational position relative to the longitudinal axis.

[0265]

[0366] Clause 223: In some examples, the system includes clause 222 and further includes an elongate pusher having a distal end, the distal end releasably coupled to the expandable implant.

[0266]

[0367] Clause 224: In some examples, the system includes any one of clauses 222 or 223, wherein the non-circular cross-section of the lumen includes an oval shape.

[0267]

[0368] Clause 225: In some examples, the system includes any one of clauses 222 or 223, and the non-circular cross-section of the lumen includes an ellipse.

[0268]

[0369] Clause 226: In some examples, the system includes any one of clauses 222 or 223, wherein the non-circular cross-section of the lumen includes a dog-bone shape.

[0269]

[0370] Clause 227: In some examples, the system includes any one of clauses 222 or 223, wherein the non-circular cross-section of the lumen includes a guitar shape.

[0270]

[0371] Clause 228: In some examples, the system includes any one of clauses 222 or 223, and the non-circular cross-section includes a polygon.

[0271]

[0372] Clause 229: In some examples, the system includes any one of clauses 222 or 227, wherein the lumen of the delivery catheter has a circular cross-section at its proximal end.

[0272]

[0373] Clause 230: In some examples, the system includes clause 229, wherein the circular cross-section extends from the proximal end of the delivery catheter to the proximal end of the distal region.

[0273]

[0374] Clause 231: In some examples, the system includes any one of clauses 222-230, wherein the expandable implant in the collapsed configuration has a first lateral axis relative to the longitudinal axis and a second lateral axis relative to the longitudinal axis, the first lateral axis being perpendicular to the second lateral axis, and a first lateral dimension along the first lateral axis being different from a second lateral dimension along the second lateral axis.

[0274]

[0375] Clause 232: In some examples, the system includes any one of clauses 222-231 and further includes an introducer having a proximal end, a distal end, and an introducer lumen extending between the proximal end of the introducer and the distal end of the introducer, the introducer lumen configured to hold the expandable implant in its collapsed form while the expandable implant is introduced at its proximal end into the lumen of the delivery catheter.

[0275]

[0376] Article 233: In some examples, the system includes article 232, wherein the introducer includes an outwardly extending collar adjacent its distal end.

[0276]

[0377] Clause 234: In some examples, the system includes clause 233, wherein the collar has a proximal end coupled to the distal end of the introducer and a distal end, the collar having a first inner lateral dimension at its proximal end, the first inner lateral dimension being approximately the same as the lateral dimension of the introducer lumen at the distal end of the introducer.

[0277]

[0378] Clause 235: In some examples, the system includes clause 234, wherein the collar has a second medial lateral dimension at a distal end thereof, the second medial lateral dimension being greater than the first medial lateral dimension.

[0278]

[0379] Clause 236: In some examples, the system includes clause 235, wherein there is a gradual increase along the collar between the first medial lateral dimension and the second medial lateral dimension.

[0279]

[0380] Clause 237: In some examples, the system includes any one of clauses 233-236, wherein the collar is detachable from the introducer.

[0280]

[0381] Clause 238: In some examples, the system includes any one of clauses 229 or 230, and further includes a continuously smooth transition region between the circular cross-section and the non-circular cross-section.

[0281]

[0382] Clause 239: In another example, a method for inserting an expandable implant includes providing an introducer having a proximal end, a distal end, and an introducer lumen extending between the proximal end of the introducer and the distal end of the introducer, the introducer lumen configured to hold the expandable implant in its collapsed configuration while the expandable implant is introduced at its proximal end into a lumen of a delivery catheter, the lumen of the delivery catheter being non-circular and the expandable implant in its collapsed configuration having a substantially non-circular shape, pushing the expandable implant from the introducer lumen into the lumen of the delivery catheter such that the substantially non-circular shape of the expandable implant in its collapsed configuration is oriented in a keyed manner with the non-circular shape of the lumen of the delivery catheter, and advancing the expandable implant such that the expandable implant is completely within the lumen of the delivery catheter.

[0282]

[0383] Clause 240: In another example, a vaso-occlusion system configured to embolize an aneurysm, the aneurysm having a neck and a sac, includes an elongate pusher configured to be slidably disposed within a delivery catheter, the delivery catheter including a proximal end, a distal end, and a delivery lumen extending therebetween, and an implantable vaso-occlusion device coupled to the distal end of the pusher, the vaso-occlusion device configured to be implanted into the aneurysm sac, the implantable vaso-occlusion device having a collapsed delivery configuration when restrained within the delivery lumen of the delivery catheter and an expanded, deployed configuration after exiting the delivery lumen of the delivery catheter and being delivered to the aneurysm sac, the vaso-occlusion device comprising: the proximal end configured to seat against the aneurysm adjacent the neck of the aneurysm, a distal end configured to extend into the sac away from the neck of the aneurysm, and a central longitudinal axis, the vaso-occlusion device being configured to be releasably coupled to the distal end of the pusher at a releasable joint, the releasable joint including any one or both of the configurations in the list consisting of: (1) the distal end of the pusher extends from the releasable joint at an angle of about 30 degrees to about 120 degrees formed with the central longitudinal axis, and (2) the releasable joint is coupled at a location on the proximal end of the vaso-occlusion device that is radially offset from the central longitudinal axis.

[0283]

[0384] Article 241: In some examples, the system includes article 240, wherein a distal end of the pusher extends from the releasable joint at an angle between about 40 degrees and about 100 degrees formed with the central longitudinal axis.

[0284]

[0385] Clause 242: In some examples, the system includes clause 240, wherein a distal end of the pusher extends from the releasable joint at an angle between about 45 degrees and about 90 degrees formed with the central longitudinal axis.

[0285]

[0386] Clause 243: In some examples, the system includes clause 240, wherein a distal end of the pusher extends from the releasable joint at an angle of about 75 degrees to about 90 degrees formed with the central longitudinal axis.

[0286]

[0387] Clause 244: In some examples, the system includes clause 240, wherein the releasable joint is attached directly to the proximal end of the vaso-occlusive device.

[0287]

[0388] Clause 245: In some examples, the system includes clause 240, wherein the vasoocclusion device in an expanded, deployed configuration has a maximum radius and a location on the proximal end of the vasoocclusion device is radially offset from the central longitudinal axis by at least 10% of the maximum radius.

[0288]

[0389] Clause 246: In some examples, the system includes clause 240, wherein the vaso-occlusion device in an expanded, deployed configuration has a maximum radius and a location on the proximal end of the vaso-occlusion device is radially offset from the central longitudinal axis by at least 50% of the maximum radius.

[0289]

[0390] Clause 247: In some examples, the system includes clause 240, wherein the vasoocclusion device in an expanded, deployed configuration has a maximum radius and a location on the proximal end of the vasoocclusion device is radially offset from the central longitudinal axis by at least 75% of the maximum radius.

[0290]

[0391] Clause 248: In some examples, a system includes clause 240, wherein the vaso-occlusive device is in an expanded state and the location on the proximal end of the vaso-occlusive device is at a radial edge of the vaso-occlusive device.

[0291]

[0392] Clause 249: In some examples, the system includes clause 240, wherein the vaso-occlusive device includes a cover, the proximal end of the vaso-occlusive device includes a proximal surface of the cover, and the cover further includes a concave surface on a distal side opposite the proximal surface.

[0292]

[0393] Article 250: In some examples, the system includes article 249, where the concavities are generally disposed about the central longitudinal axis.

[0293]

[0394] Clause 251: In some examples, the system includes clause 249, wherein the cover has a generally circular profile.

[0294]

[0395] Clause 252: In some examples, the system includes clause 240, wherein the vaso-occlusive device is formed from a mesh material.

[0295]

[0396] Clause 253: In some examples, the system includes clause 252, wherein the mesh material includes a plurality of filaments.

[0296]

[0397] Clause 254: In some examples, the system includes clause 253, wherein the plurality of filaments includes a filament comprising a nickel titanium alloy.

[0297]

[0398] Clause 255: In some examples, the system includes clause 253, wherein the plurality of filaments includes a filament comprising a radiopaque material.

[0298]

[0399] Clause 256: In some examples, the system includes clause 253, wherein the plurality of filaments includes a filament that includes a pultruded fill tube.

[0299]

[0400] Clause 257: In some examples, the system includes clause 252, wherein the mesh material includes an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning into the inner layer at an inverted fold.

[0300]

[0401] Clause 258: In some examples, the system includes clause 240 and further includes a selectively orienting catheter having a proximal end, a distal end, and a lumen extending from the proximal end to the distal end, wherein the lumen of the selectively orienting catheter includes a non-circular cross-section at least in a distal region adjacent the distal end of the selectively orienting catheter, and wherein the vascular occlusion device in the collapsed delivery configuration has a substantially non-circular cross-section configured to fit in a keyed manner into at least the distal region of the lumen of the selectively orienting catheter such that the vascular occlusion device is deliverable from the lumen of the selectively orienting catheter at a particular rotational position.

[0301]

[0402] Clause 259: In some examples, the system includes clause 258, wherein the non-circular cross-section of the lumen of the selective orientation catheter includes an oval shape.

[0302]

[0403] Clause 260: In some examples, the system includes clause 258, wherein the non-circular cross-section of the lumen of the selective orientation catheter includes an ellipse.

[0303]

[0404] Clause 261: In some examples, the system includes clause 258, wherein the non-circular cross-section of the lumen of the selective orientation catheter includes a shape selected from the list consisting of a dog-bone shape, a guitar shape, and a polygon.

[0304]

[0405] Clause 262: In some examples, the system includes clause 258, wherein the lumen of the selective orientation catheter has a circular cross-section located at least at its proximal end.

[0305]

[0406] Clause 263: In some examples, the system includes clause 262, wherein the circular cross-section of the lumen of the selectively orienting catheter includes a circular cross-sectional area extending distally from the proximal end of the selectively orienting catheter toward the proximal end of the distal region.

[0306]

[0407] Clause 264: In some examples, the system includes clause 263 and further includes a continuously smooth transition region connecting the circular cross-sectional region and the distal region.

[0307]

[0408] Clause 265: In some examples, the system includes clause 258, wherein the vasoocclusion device in the collapsed delivery configuration has a first lateral axis and a second lateral axis, the first lateral axis being perpendicular to the second lateral axis, and a first lateral dimension along the first lateral axis being different from a second lateral dimension along the second lateral axis.

[0308]

[0409] Clause 266: In some examples, the system includes clause 258 and further includes an introducer having a proximal end, a distal end, and an introducer lumen extending between the proximal end of the introducer and the distal end of the introducer, the introducer lumen configured to hold the expandable implant in its collapsed configuration while the expandable implant is introduced at its proximal end into the lumen of the delivery catheter, and the introducer includes a collar adjacent its distal end having an inner lateral dimension that increases from the proximal collar end to the distal collar end, and the collar is configured to allow the vascular occlusion device to be easily transitioned from the expanded, deployed configuration to the collapsed delivery configuration when a user applies traction force to the elongate pusher.

[0309]

[0410] Clause 267: In some examples, the system includes clause 266, wherein the collar is removable from the introducer by a user after the vaso-occlusive device is positioned in the introducer lumen of the introducer in the collapsed delivery configuration.

[0310]

[0411] Clause 268: In some examples, the system includes clause 240 and further includes a connecting tube having a proximal end substantially flush with the proximal end of the vasoocclusion device, a distal end extending into the vasoocclusion device, and an inner lumen, wherein the distal end of the pusher extends through the lumen of the connecting tube and includes a plurality of radially extending protrusions located distal to the distal end of the connecting tube, the plurality of radially extending protrusions forming a maximum lateral dimension greater than a maximum diameter of the lumen of the connecting tube.

[0311]

[0412] Clause 269: In some examples, the system includes clause 258 and further includes an activator configured to modify the plurality of radially extending protrusions so that the distal end of the pusher can be completely removed from the lumen of the connecting tube.

[0312]

[0413] The ranges disclosed herein also encompass all overlaps, subranges, and combinations thereof. Language such as "up to," "at least," "greater than," "less than," "between" and the like includes the recited numbers. Numbers preceded by terms such as "approximately," "about," and "substantially" as used herein include the recited numbers (e.g., about 10%=10%) and also represent amounts close to the recited amount that still perform the desired function or achieve the desired result. For example, the terms "approximately," "about," and "substantially" can refer to amounts that are less than 10%, less than 5%, less than 1%, less than 0.1%, and less than 0.01% of the recited amount.

[0313]

[0414] For purposes of this disclosure and the appended claims, the conjunction "or" is to be interpreted inclusively (e.g., "apples or oranges" is to be interpreted as "apples or oranges, or both"; e.g., "apples, oranges, or avocados" is to be interpreted as "apples, or oranges, or avocados, or any two, or all three") unless: (i) it is expressly stated otherwise, e.g., using "or either," "only one of," or similar language; or (ii) if two or more of the listed alternatives are mutually exclusive within a particular context, then "or" includes only combinations that include non-mutually exclusive alternatives. For purposes of this disclosure and the appended claims, the words "comprising," "including," "having," and variations thereof, wherever they appear, shall be interpreted as open-ended terms with the same meaning as if the phrase "at least" had been added after each instance thereof.

Claims

1. 1. A device for treating an aneurysm in a blood vessel, comprising an occlusion element, 11. A device comprising: an occlusion element configured to be releasably coupled to an elongate delivery shaft and having a distal end, a proximal end, and a longitudinal axis extending between the distal end and the proximal end, the occlusion element configured to be delivered in a collapsed configuration through a lumen of a delivery catheter, the lumen having a proximal end and a distal end, the occlusion element further configured to expand to an unfolded configuration when advanced from the distal end of the lumen of the delivery catheter, the occlusion element comprising an inverted mesh tube having an outer layer and an inner layer, the outer layer transitioning into the inner layer at an inverted fold located at or adjacent the distal end of the occlusion element, the inverted fold defining an inner diameter, the occlusion element further having a maximum outer diameter, the inner diameter being between 35% and 85% of the maximum outer diameter, the outer diameter of the occlusion element increasing along the longitudinal axis to the maximum outer diameter.

2. The device of claim 1 , wherein the maximum outer diameter of the occlusion element is located at or adjacent the distal end of the occlusion element.

3. The device of claim 1 , wherein the maximum outer diameter of the occlusion element is located at or adjacent the proximal end of the occlusion element.

4. The device of claim 1 , wherein the inverted mesh tube includes a first end and a second end, the first end and the second end being joined together at the proximal end of the occlusion element.

5. The device of claim 1 , wherein the occlusion element in the expanded configuration has a generally D-shaped cross-section in a plane containing the longitudinal axis.

6. The device of claim 1 , wherein the occlusion element in the expanded configuration has a generally triangular cross-sectional shape in a plane containing the longitudinal axis.

7. The device of claim 1 , wherein the occlusion element in the expanded configuration has a generally isosceles trapezoidal cross-sectional shape in a plane containing the longitudinal axis.

8. The device of claim 1 , further comprising a frusto-conical outer surface extending between the maximum outer diameter of the occlusion element and one of the distal end or the proximal end of the occlusion element.

9. The device of claim 8, wherein the frustoconical surface has a minimum outer diameter, the minimum outer diameter being between 70% and 90% of the maximum outer diameter of the occlusion element.

10. The device of claim 1 , further comprising a convex surface extending between the maximum outer diameter of the occlusion element and one of the distal end or the proximal end of the occlusion element.

11. The device of claim 10, wherein the convex surface has a minimum outer diameter, the minimum outer diameter being between 70% and 90% of the maximum outer diameter of the occlusion element.

12. The device of claim 1 , wherein the distal end comprises a substantially planar surface.

13. The device of claim 1 , wherein the proximal end includes a substantially planar surface.

14. The apparatus of claim 1 , wherein the everted mesh tube comprises a collection of filaments comprising a nickel-titanium alloy.

15. The device of claim 14 , wherein at least some of the filaments further comprise a radiopaque material.

16. The device of claim 1 , wherein the inner layer of the everted mesh tube substantially conforms to the contour of the outer layer of the everted mesh tube when the occlusion element is in the expanded configuration.

17. The device of claim 1 , further comprising a pusher having a proximal end and a distal end, the occlusion element configured to be releasably coupled to the distal end of the pusher at a releasable joint.

18. The device of claim 1 , wherein the occlusion element is configured to engage a wall of the aneurysm at the maximum outer diameter.

19. The device of claim 1 , wherein the inner diameter is between 45% and 75% of the maximum outer diameter.

20. 10. The device of claim 1, wherein the occlusion element has a proximal end diameter at the proximal end and a distal end diameter at the distal end, the proximal end diameter being between 50% and 120% of the distal end diameter.

21. The device of any one of claims 1 to 20, wherein the occlusion element is heat set in the expanded configuration.

22. 22. The device of any one of claims 1-21, further comprising a first tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the first tubular mesh being joined together at the proximal end of the occlusion element such that an intermediate portion of the first tubular mesh between the first end and the second end includes a substantially 180 degree turn, the intermediate portion of the first tubular mesh extends distally from the proximal end of the occlusion element, the intermediate portion of the first tubular mesh comprising a first leg and a second leg, the first leg substantially contacting the second leg along a central axis when the occlusion element is in the unconstrained expanded configuration.

23. 23. The device of claim 22, further comprising a second tubular mesh having a first end, a second end, a wall and a lumen, the first end and the second end of the second tubular mesh being coupled to the occlusion element such that an intermediate portion of the second tubular mesh between the first end and the second end includes a substantially 180 degree turn.

Citation Information

Patent Citations

  • Features of a braided ball embolization device

    JP2013509972A

  • Devices for procedural vascular procedures

    JP2017511202A

  • occlusion device

    JP2017516605A

  • Occlusion device

    WO2019038293A1